# EDGAR Filing Document

**Accession Number:** 0001377936
**File Stem:** 0001213900-25-062051
**Filing Date:** 2025-7
**Character Count:** 572081
**Document Hash:** 7ca9ad311a9f0c4e0fd0325e5266a3a5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-062051.hdr.sgml**: 20250708

**ACCESSION NUMBER**: 0001213900-25-062051

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 84

**CONFORMED PERIOD OF REPORT**: 20250531

**FILED AS OF DATE**: 20250708

**DATE AS OF CHANGE**: 20250708

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SARATOGA INVESTMENT CORP.
- **CENTRAL INDEX KEY:** 0001377936

**ORGANIZATION NAME:**
- **EIN:** 204876925
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 814-00732
- **FILM NUMBER:** 251111025

**BUSINESS ADDRESS:**
- **STREET 1:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212 750-3343

**MAIL ADDRESS:**
- **STREET 1:** 535 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GSC INVESTMENT CORP.
- **DATE OF NAME CHANGE:** 20070321

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GSC Investment LLC
- **DATE OF NAME CHANGE:** 20061011

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the Quarterly Period Ended May 31, 2025**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**Commission File No. 814-00732**

**SARATOGA INVESTMENT CORP.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Maryland** | **20-8700615** |
| **(State or other jurisdiction of<br> incorporation or organization)** | **(I.R.S. Employer<br> Identification Number)** |

---

**535 Madison Avenue**

**New York, New York 10022**

**(Address of principal executive offices)**

**(212) 906-7800**

**(Registrant's telephone number, including area code)**

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.001 per share | SAR | The New York Stock Exchange |
| 6.00% Notes due 2027 | SAT | The New York Stock Exchange |
| 8.00% Notes due 2027 | SAJ | The New York Stock Exchange |
| 8.125% Notes due 2027 | SAY | The New York Stock Exchange |
| 8.50% Notes due 2027 | SAZ | The New York Stock Exchange |

---

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☒ <br> Non-accelerated filer ☐ Smaller reporting company ☐ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of outstanding common shares of the registrant as of July 7, 2025 was 15,668,131.

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| **PART I.** | [**FINANCIAL INFORMATION**](#a_001) | 1 |
| Item 1. | [Consolidated Financial Statements](#a_002) | 1 |
|  | [Consolidated Statements of Assets and Liabilities as of May 31, 2025 (unaudited) and February 28, 2025](#a_003) | 1 |
|  | [Consolidated Statements of Operations for the three months ended May 31, 2025 (unaudited) and May 31, 2024 (unaudited)](#a_004) | 2 |
|  | [Consolidated Statements of Changes in Net Assets for three months ended May 31, 2025 (unaudited) and May 31, 2024 (unaudited)](#a_005) | 3 |
|  | [Consolidated Statements of Cash Flows for the three months ended May 31, 2025 (unaudited) and May 31, 2024 (unaudited)](#a_006) | 4 |
|  | [Consolidated Schedules of Investments as of May 31, 2025 (unaudited) and February 28, 2025](#a_007) | 5 |
|  | [Notes to Consolidated Financial Statements as of May 31, 2025 (unaudited)](#a_008) | 29 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_009) | 108 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#a_010) | 148 |
| Item 4. | [Controls and Procedures](#a_011) | 149 |
| **PART II.** | [**OTHER INFORMATION**](#a_012) | 150 |
| Item 1. | [Legal Proceedings](#a_013) | 150 |
| Item 1A. | [Risk Factors](#a_014) | 150 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#a_015) | 150 |
| Item 3. | [Defaults Upon Senior Securities](#a_016) | 150 |
| Item 4. | [Mine Safety Disclosures](#a_017) | 150 |
| Item 5. | [Other Information](#a_018) | 150 |
| Item 6. | [Exhibits](#a_019) | 151 |
| [Signatures](#a_020) | [Signatures](#a_020) | 153 |

---

i

**PART I. FINANCIAL INFORMATION**

**Item 1. Consolidated Financial Statements**

**Saratoga Investment Corp.**

**Consolidated Statements of Assets and Liabilities**

---

| | | |
|:---|:---|:---|
|  | **May 31, <br> 2025** | **February 28,<br> 2025** |
|  | **(unaudited)** | |
| ASSETS |  |  |
| Investments at fair value |  |  |
| &nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments (amortized cost of $863,450,463 and $886,071,934, respectively) | $875410787 | $897660110 |
| &nbsp;&nbsp;&nbsp;Affiliate investments (amortized cost of $49,725,886 and $38,203,811, respectively) | 52023563 | 40547432 |
| &nbsp;&nbsp;&nbsp;Control investments (amortized cost of $76,213,218 and $75,817,587, respectively) | 40883612 | 39870208 |
| Total investments at fair value (amortized cost of $989,389,567 and $1,000,093,332, respectively) | 968317962 | 978077750 |
| Cash and cash equivalents | 131562513 | 148218491 |
| Cash and cash equivalents, reserve accounts | 92724212 | 56505433 |
| Interest receivable (net of reserve of $264,278 and $210,319, respectively) | 8000745 | 7477468 |
| Management fee receivable | 294307 | 314193 |
| Other assets | 1369594 | 950522 |
| Total assets | $1202269333 | $1191543857 |
| LIABILITIES |  |  |
| Revolving credit facilities | $70000000 | $52500000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, revolving credit facilities | (1037309) | (1254516) |
| SBA debentures payable | 170000000 | 170000000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, SBA debentures payable | (3831484) | (4041026) |
| 8.75% Notes Payable 2025 | - | 20000000 |
| &nbsp;&nbsp;&nbsp;Discount on 8.75% notes payable 2025 | - | (9055) |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 8.75% notes payable 2025 | - | (374) |
| 7.00% Notes Payable 2025 | 12000000 | 12000000 |
| &nbsp;&nbsp;&nbsp;Discount on 7.00% notes payable 2025 | (35844) | (68589) |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 7.00% notes payable 2025 | (4346) | (8345) |
| 7.75% Notes Payable 2025 | 5000000 | 5000000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 7.75% notes payable 2025 | (5860) | (19685) |
| 4.375% Notes Payable 2026 | 175000000 | 175000000 |
| &nbsp;&nbsp;&nbsp;Premium on 4.375% notes payable 2026 | 226581 | 287848 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 4.375% notes payable 2026 | (653235) | (865593) |
| 4.35% Notes Payable 2027 | 75000000 | 75000000 |
| &nbsp;&nbsp;&nbsp;Discount on 4.35% notes payable 2027 | (180419) | (213424) |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 4.35% notes payable 2027 | (601980) | (688786) |
| 6.25% Notes Payable 2027 | 15000000 | 15000000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 6.25% notes payable 2027 | (184171) | (202144) |
| 6.00% Notes Payable 2027 | 105500000 | 105500000 |
| &nbsp;&nbsp;&nbsp;Discount on 6.00% notes payable 2027 | (77798) | (87295) |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 6.00% notes payable 2027 | (1347571) | (1524089) |
| 8.00% Notes Payable 2027 | 46000000 | 46000000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 8.00% notes payable 2027 | (840029) | (927484) |
| 8.125% Notes Payable 2027 | 60375000 | 60375000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 8.125% notes payable 2027 | (1053557) | (1156234) |
| 8.50% Notes Payable 2028 | 57500000 | 57500000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs, 8.50% notes payable 2028 | (1170572) | (1273134) |
| Base management and incentive fees payable | 6869845 | 6230944 |
| Deferred tax liability | 4994417 | 4889329 |
| Payable from open trades | 6750000 | - |
| Accounts payable and accrued expenses | 1556106 | 1676335 |
| Interest and debt fees payable | 4598538 | 3909517 |
| Due to Manager | 553706 | 349189 |
| &nbsp;&nbsp;&nbsp;Total liabilities | 805900018 | 798878389 |
| Commitments and contingencies (See Note 9) |  |  |
| NET ASSETS |  |  |
| Common stock, par value $0.001, 100,000,000 common shares authorized, 15,529,391 and 15,183,078 common shares issued and outstanding, respectively | 15529 | 15183 |
| Capital in excess of par value | 421664914 | 412913597 |
| Total distributable deficit | (25311128) | (20263312) |
| &nbsp;&nbsp;&nbsp;Total net assets | 396369315 | 392665468 |
| Total liabilities and net assets | $1202269333 | $1191543857 |
| NET ASSET VALUE PER SHARE | $25.52 | $25.86 |

---

See accompanying notes to consolidated financial statements.

**Saratoga Investment Corp.**

**Consolidated Statements of Operations**

**(unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31,<br> 2025** | **May 31,<br> 2024** |
| INVESTMENT INCOME |  |  |
| Interest from investments |  |  |
| &nbsp;&nbsp;&nbsp;Interest income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | $25464663 | $31224277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments | 595624 | 496840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control investments | 1190661 | 1997112 |
| &nbsp;&nbsp;&nbsp;Payment in kind interest income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | 168229 | 63830 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliate investments | 584749 | 241104 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control investments | - | 283313 |
| Total interest from investments | 28003926 | 34306476 |
| Interest from cash and cash equivalents | 2027211 | 624631 |
| Management fee income | 705175 | 804456 |
| Dividend income: |  |  |
| &nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | 562183 | 249491 |
| &nbsp;&nbsp;&nbsp;Control investments | 436418 | 1297050 |
| Total dividend from investments | 998601 | 1546541 |
| Structuring and advisory fee income | 264375 | 410843 |
| Other income | 319329 | 985203 |
| &nbsp;&nbsp;&nbsp;Total investment income | 32318617 | 38678150 |
| OPERATING EXPENSES |  |  |
| Interest and debt financing expenses | 12451865 | 12962081 |
| Base management fees | 4333332 | 4982580 |
| Incentive management fees expense (benefit) | 2536513 | 3584734 |
| Professional fees | 699200 | 999310 |
| Administrator expenses | 1250000 | 1075000 |
| Insurance | 74310 | 77596 |
| Directors fees and expenses | 131500 | 113000 |
| General and administrative | 645411 | 609127 |
| Income tax expense (benefit) | 54454 | (60283) |
| &nbsp;&nbsp;&nbsp;Total operating expenses | 22176585 | 24343145 |
| NET INVESTMENT INCOME | 10142032 | 14335005 |
| REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS |  |  |
| Net realized gain (loss) from investments: |  |  |
| &nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | 2262984 | - |
| &nbsp;&nbsp;&nbsp;Control investments | 638355 | (21194997) |
| Net realized gain (loss) from investments | 2901339 | (21194997) |
| Net change in unrealized appreciation (depreciation) on investments: |  |  |
| &nbsp;&nbsp;&nbsp;Non-control/Non-affiliate investments | 372148 | 14156825 |
| &nbsp;&nbsp;&nbsp;Affiliate investments | (45944) | 601223 |
| &nbsp;&nbsp;&nbsp;Control investments | 617773 | (826617) |
| Net change in unrealized appreciation (depreciation) on investments | 943977 | 13931431 |
| Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments | (55085) | (461001) |
| Net realized and unrealized gain (loss) on investments | 3790231 | (7724567) |
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $13932263 | $6610438 |
| WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE | $0.91 | $0.48 |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED | 15344510 | 13683314 |

---

See accompanying notes to consolidated financial statements.

**Saratoga Investment Corp.**

**Consolidated Statements of Changes in Net Assets**

**(unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31,<br> 2025** | **May 31,<br> 2024** |
| INCREASE (DECREASE) FROM OPERATIONS: |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income | $10142032 | $14335005 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) from investments | 2901339 | (21194997) |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on investments | 943977 | 13931431 |
| &nbsp;&nbsp;&nbsp;Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments | (55085) | (461001) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase in net assets resulting from operations | 13932263 | 6610438 |
| DECREASE FROM SHAREHOLDER DISTRIBUTIONS: |  |  |
| &nbsp;&nbsp;&nbsp;Total distributions to shareholders | (18980079) | (9967036) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net decrease in net assets from shareholder distributions | (18980079) | (9967036) |
| CAPITAL SHARE TRANSACTIONS: |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock<sup>(1)</sup> | 6143820 | - |
| &nbsp;&nbsp;&nbsp;Capital contribution from Manager | 297770 | - |
| &nbsp;&nbsp;&nbsp;Stock dividend distribution | 2312153 | 987572 |
| &nbsp;&nbsp;&nbsp;Offering costs | (2080) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in net assets from capital share transactions | 8751663 | 987572 |
| Total increase (decrease) in net assets | 3703847 | (2369026) |
| Net assets at beginning of period | 392665468 | 370224108 |
| Net assets at end of period | $396369315 | $367855082 |

---

(1) See Note 11 to the Consolidated Financial Statements
contained herein for more information on share issuance.

See accompanying notes to consolidated financial statements.

**Saratoga Investment Corp.**

**Consolidated Statements of Cash Flows**

**(unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31,<br> 2025** | **May 31,<br> 2024** |
| **Operating activities** | | |
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $13932263 | $6610438 |
| ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS RESULTING |  |  |
| FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES: |  |  |
| &nbsp;&nbsp;&nbsp;Distributions from CLO, payment-in-kind and other adjustments to cost | (517108) | 383131 |
| &nbsp;&nbsp;&nbsp;Net accretion of discount on investments | (858544) | (814013) |
| &nbsp;&nbsp;&nbsp;Amortization of deferred debt financing costs | 1254331 | 1238632 |
| &nbsp;&nbsp;&nbsp;Income tax expense (benefit) | 50004 | (60283) |
| &nbsp;&nbsp;&nbsp;Net realized (gain) loss from investments | (2901339) | 21194997 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized (appreciation) depreciation on investments | (943977) | (13931431) |
| &nbsp;&nbsp;&nbsp;Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments | 55085 | 461001 |
| &nbsp;&nbsp;&nbsp;Proceeds from sales and repayments of investments | 65066218 | 75702723 |
| &nbsp;&nbsp;&nbsp;Purchases of investments | (50085463) | (39301058) |
| &nbsp;&nbsp;&nbsp;(Increase) decrease in operating assets: |  |  |
| &nbsp;&nbsp;&nbsp;Interest receivable | (523277) | 680549 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management fee receivable | 19886 | 7967 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (419072) | (522897) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivable from open trades | - | (1269231) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current income tax receivable | - | 84245 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in operating liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Base management and incentive fees payable | 638901 | 420098 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payable from open trades | 6750000 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (120229) | (13164) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and debt fees payable | 689021 | 1353253 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due to Manager | 204517 | (79909) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES | 32291217 | 52145048 |
| **Financing activities** |  |  |
| Borrowings on debt | 17500000 | 23000000 |
| Paydowns on debt | - | (12500000) |
| Repayments of notes | (20000000) | - |
| Payments of deferred debt financing costs | - | (875791) |
| Proceeds from issuance of common stock | 6143820 | - |
| Capital contribution from Manager | 297770 | - |
| Payments of cash dividends | (16667926) | (8979464) |
| Payments of offering costs | (2080) | - |
| NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | (12728416) | 644745 |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS | 19562801 | 52789793 |
| CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD | 204723924 | 40507124 |
| CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD (See note 2) | $224286725 | $93296917 |
| **Supplemental information:** |  |  |
| Interest paid during the period | $10508514 | $10370196 |
| &nbsp;&nbsp;&nbsp;Cash paid for taxes | 2762 | 54821 |
| &nbsp;&nbsp;&nbsp;**Supplemental non-cash information:** |  |  |
| Payment-in-kind interest income and other adjustments to cost | 721477 | (383131) |
| &nbsp;&nbsp;&nbsp;Net accretion of discount on investments | 858544 | 814013 |
| &nbsp;&nbsp;&nbsp;Amortization of deferred debt financing costs | 1254331 | 1238632 |
| &nbsp;&nbsp;&nbsp;Stock dividend distribution | 2312153 | 987572 |

---

See accompanying notes to consolidated financial statements.

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025 (unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| **Non-control/Non-affiliate investments - 220.9% (b)** |  |  |  | | | | |
| Altvia MidCo, LLC. | Alternative Investment Management Software | First Lien Term Loan<br> (3M USD TERM SOFR+8.50%), 12.82% Cash, 7/18/2027 | 7/18/2022 | $11313400 | $11236928 | $11338289 | 2.9% |
| Altvia MidCo, LLC. (h) | Alternative Investment Management Software | Series A-1 Preferred Shares | 7/18/2022 | 2083939 | 2083939 | 2806358 | 0.7% |
|  |  | Total Alternative Investment Management Software |  |  | 13320867 | 14144647 | 3.6% |
| BQE Software, Inc. (d) | Architecture & Engineering Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028 | 4/13/2023 | $24500000 | 24336623 | 24615150 | 6.2% |
| BQE Software, Inc. (j) | Architecture & Engineering Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028 | 4/13/2023 | $500000 | 499347 | 502350 | 0.1% |
|  |  | Total Architecture & Engineering Software |  |  | 24835970 | 25117500 | 6.3% |
| Golden TopCo LP (h) | Association Management Software | Class A-2 Common Units | 5/10/2023 | 1072394 | 1072394 | 1588532 | 0.4% |
|  |  | Total Association Management Software |  |  | 1072394 | 1588532 | 0.4% |
| Artemis Wax Corp. (d)(j) | Consumer Services | Delayed Draw Term Loan<br> (1M USD TERM SOFR+6.75%), 11.07% Cash, 5/20/2026 | 5/20/2021 | $57500000 | 57390336 | 57057250 | 14.4% |
| Artemis Wax Corp. (h) | Consumer Services | Series B-1 Preferred Stock | 5/20/2021 | 934463 | 1500000 | 227927 | 0.1% |
| Artemis Wax Corp. (h) | Consumer Services | Series D Preferred Stock | 12/22/2022 | 331640 | 1711866 | 1929104 | 0.5% |
|  |  | Total Consumer Services |  |  | 60602202 | 59214281 | 15.0% |
| Schoox, Inc. (h), (i) | Corporate Education Software | Series 1 Membership Interest | 12/8/2020 | 1050 | 548298 | 3924856 | 1.0% |
|  |  | Total Corporate Education Software |  |  | 548298 | 3924856 | 1.0% |
| Innergy, Inc. | Custom Millwork Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.50%), 9.82% Cash, 2/20/2030 | 2/20/2025 | $32000000 | 31738782 | 31721600 | 8.0% |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Innergy, Inc. (j) | Custom Millwork Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.50%), 9.82% Cash, 2/20/2030 | 2/20/2025 | $- | - | - | 0.0% |
|  |  | Total Custom Millwork Software |  |  | 31738782 | 31721600 | 8.0% |
| GreyHeller LLC (h) | Cyber Security | Common Stock | 11/10/2021 | 7857689 | 1906275 | 3746734 | 0.9% |
|  |  | Total Cyber Security |  |  | 1906275 | 3746734 | 0.9% |
| Gen4 Dental Partners Holdings, LLC | Dental Practice Management | First Lien Term Loan<br> (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030 | 5/13/2024 | $7089286 | 7029937 | 7160179 | 1.8% |
| Gen4 Dental Partners Holdings, LLC (j) | Dental Practice Management | Delayed Draw Term Loan<br> (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030 | 5/13/2024 | $- |  |  | 0.0% |
| Gen4 Dental Partners Holdings, LLC (j) | Dental Practice Management | Revolving Credit Facility<br> (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030 | 5/13/2024 | $- |  |  | 0.0% |
| Gen4 Dental Partners Holdings, LLC (h)(i) | Dental Practice Management | Series A Preferred Units | 2/8/2023 | 493999 | 1027519 | 1002819 | 0.3% |
| Modis Dental Partners OpCo, LLC | Dental Practice Management | First Lien Term Loan<br> (1M USD TERM SOFR+9.42%), 13.74% Cash, 4/18/2028 | 4/18/2023 | $7000000 | 6931105 | 7108500 | 1.8% |
| Modis Dental Partners OpCo, LLC (j) | Dental Practice Management | Delayed Draw Term Loan<br> (1M USD TERM SOFR+9.42%), 13.74% Cash, 4/18/2028 | 4/18/2023 | $13000000 | 12843206 | 13201500 | 3.3% |
| Modis Dental Partners OpCo, LLC (h) | Dental Practice Management | Class A Preferred Units | 4/18/2023 | 2950000 | 2950000 | 2979884 | 0.8% |
|  |  | Total Dental Practice Management |  |  | 30781767 | 31452882 | 8.0% |
| Exigo, LLC (d) | Direct Selling Software | First Lien Term Loan<br> (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027 | 3/16/2022 | $24002538 | 23915484 | 23373672 | 5.9% |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Exigo, LLC (j) | Direct Selling Software | Revolving Credit Facility<br> (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027 | 3/16/2022 | $- |  | (16375) | 0.0% |
| Exigo, LLC (h), (i) | Direct Selling Software | Common Units | 3/16/2022 | 1041667 | 1041667 | 808398 | 0.2% |
|  |  | Total Direct Selling Software |  |  | 24957151 | 24165695 | 6.1% |
| C2 Educational Systems, Inc. (d) | Education Services | First Lien Term Loan<br> (3M USD TERM SOFR+8.50%), 12.82% Cash, 11/30/2026 | 5/31/2017 | $23000000 | 22998485 | 22954000 | 5.8% |
| C2 Educational Systems, Inc. (h) | Education Services | Series A-1 Preferred Stock | 5/18/2021 | 3127 | 499904 | 613204 | 0.2% |
| Ready Education (d) | Education Software | First Lien Term Loan<br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 8/5/2027 | 8/5/2022 | $32000000 | 31827080 | 31910400 | 8.1% |
|  |  | Total Education Software |  |  | 55325469 | 55477604 | 14.1% |
| TG Pressure Washing Holdings, LLC (h) | Facilities Maintenance | Preferred Equity | 8/12/2019 | 488148 | 488148 | - | 0.0% |
|  |  | Total Facilities Maintenance |  |  | 488148 | - | 0.0% |
| GDS Software Holdings, LLC | Financial Services | First Lien Term Loan <br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026 | 12/30/2021 | $22713926 | 22664442 | 22659413 | 5.7% |
| GDS Software Holdings, LLC (d) | Financial Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026 | 12/30/2021 | $3286074 | 3268123 | 3278187 | 0.8% |
| GDS Software Holdings, LLC (h) | Financial Services | Common Stock Class A Units | 8/23/2018 | 250000 | 250000 | 370057 | 0.1% |
|  |  | Total Financial Services |  |  | 26182565 | 26307657 | 6.6% |
| Ascend Software, LLC | Financial Services Software | First Lien Term Loan<br> (3M USD TERM SOFR+7.50%), 12.09% Cash, 12/15/2026 | 12/15/2021 | $6000000 | 5979447 | 5985000 | 1.5% |
| Ascend Software, LLC (j) | Financial Services Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.50%), 12.09% Cash, 12/15/2026 | 12/15/2021 | $4050000 | 4041099 | 4039875 | 1.0% |
|  |  | Total Financial Services Software |  |  | 10020546 | 10024875 | 2.5% |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Inspect Point Holdings, LLC | Fire Inspection Business Software | First Lien Term Loan <br> (1M USD TERM SOFR+5.50%), 9.82% Cash, 07/19/2029 | 7/19/2023 | $18000000 | 17860836 | 18050400 | 4.6% |
| Inspect Point Holdings, LLC (j) | Fire Inspection Business Software | Delayed Draw Term Loan <br> (1M USD TERM SOFR+5.50%), 9.82% Cash, 07/19/2029 | 7/19/2023 | $- | - | - | 0.0% |
|  |  | Total Fire Inspection Business Software |  |  | 17860836 | 18050400 | 4.6% |
| Stretch Zone Franchising, LLC (d) | Health/Fitness Franchisor | First Lien Term Loan<br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028 | 3/31/2023 | $16228726 | 16126626 | 15722390 | 4.0% |
| Stretch Zone Franchising, LLC | Health/Fitness Franchisor | First Lien Term Loan<br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028 | 3/31/2023 | $8738545 | 8683564 | 8465902 | 2.1% |
| Stretch Zone Franchising, LLC (h) | Health/Fitness Franchisor | Class A Units | 3/31/2023 | 20000 | 2000000 | 1296329 | 0.3% |
|  |  | Total Health/Fitness Franchisor |  |  | 26810190 | 25484621 | 6.4% |
| Alpha Aesthetics Partners OpCo, LLC | Healthcare Services | First Lien Term Loan<br> (1M USD TERM SOFR+9.90%), 14.23% Cash, 3/20/2028 | 3/20/2023 | $3900000 | 3861753 | 3952260 | 1.0% |
| Alpha Aesthetics Partners OpCo, LLC | Healthcare Services | Delayed Draw Term Loan<br> (1M USD TERM SOFR+9.90%), 14.23% Cash, 3/20/2028 | 3/20/2023 | $15100000 | 14931725 | 15302340 | 3.9% |
| Alpha Aesthetics Partners OpCo, LLC (h) | Healthcare Services | Class A Preferred Units | 3/20/2023 | 3675000 | 3675000 | 3655853 | 0.9% |
| Axiom Medical Consulting, LLC | Healthcare Services | First Lien Term Loan<br> (3M USD TERM SOFR+6.00%), 10.32% Cash, 9/11/2028 | 9/11/2023 | $4400000 | 4370421 | 4400000 | 1.1% |
| Axiom Medical Consulting, LLC (j) | Healthcare Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+6.00%), 10.32% Cash, 9/11/2028 | 9/11/2023 | $- |  |  | 0.0% |
| Axiom Parent Holdings, LLC (h) | Healthcare Services | Class A Preferred Units | 6/19/2018 | 400000 | 258389 | 1146774 | 0.3% |
| ComForCare Health Care (d) | Healthcare Services | First Lien Term Loan<br> (3M USD TERM SOFR+6.25%), 10.57% Cash, 12/31/2027 | 1/31/2017 | $55000000 | 54788813 | 55137500 | 13.9% |
|  |  | Total Healthcare Services |  |  | 81886101 | 83594727 | 21.1% |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Procurement Partners, LLC | Healthcare Software | First Lien Term Loan<br> (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026 | 11/12/2020 | $35125000 | 35055019 | 35125000 | 8.9% |
| Procurement Partners, LLC | Healthcare Software | First Lien Term Loan<br> (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026 | 11/12/2020 | $10300000 | 10295530 | 10300000 | 2.6% |
| Procurement Partners Holdings LLC (h) | Healthcare Software | Class A Units | 11/12/2020 | 571219 | 571219 | 409459 | 0.1% |
| Procurement Partners Holdings LLC (h) | Healthcare Software | Class AA Units | 11/12/2020 | 220385 | 30994 | 109379 | 0.0% |
|  |  | Total Healthcare Software |  |  | 45952762 | 45943838 | 11.6% |
| Roscoe Medical, Inc. (h) | Healthcare Supply | Common Stock | 3/26/2014 | 5081 | 508077 | - | 0.0% |
|  |  | Total Healthcare Supply |  |  | 508077 | - | 0.0% |
| Granite Comfort, LP (d) | HVAC Services and Sales | First Lien Term Loan<br> (3M USD TERM SOFR+7.40%), 11.72% Cash, 5/16/2027 | 11/16/2020 | $43000000 | 42866512 | 42023900 | 10.6% |
| Granite Comfort, LP (j)(d) | HVAC Services and Sales | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.40%), 11.72% Cash, 5/16/2027 | 11/16/2020 | $12270550 | 12199358 | 11727851 | 3.0% |
|  |  | Total HVAC Services and Sales |  |  | 55065870 | 53751751 | 13.6% |
| Vector Controls Holding Co., LLC (h) | Industrial Products | Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027 | 5/31/2015 | 329 | - | 9499754 | 2.4% |
|  |  | Total Industrial Products |  |  | - | 9499754 | 2.4% |
| AgencyBloc, LLC | Insurance Software | First Lien Term Loan <br> (1M USD TERM SOFR+7.76%), 12.08% Cash, 10/1/2026 | 10/1/2021 | $15555682 | 15502457 | 15555682 | 3.9% |
| Panther ParentCo LLC (h) | Insurance Software | Class A Units | 10/1/2021 | 2500000 | 2500000 | 4976072 | 1.3% |
|  |  | Total Insurance Software |  |  | 18002457 | 20531754 | 5.2% |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Avantra | IT Services | First Lien Term Loan<br> (3M USD TERM SOFR+7.97%), 12.29% Cash, 9/20/2029 | 9/19/2024 | $17000000 | 16829022 | 16875900 | 4.3% |
| Maple Holdings Midco Limited (h) | IT Services | Class A Common Units | 9/19/2024 | 2000000 | 2000000 | 2182185 | 0.6% |
|  |  | Total IT Services |  |  | 18829022 | 19058085 | 4.9% |
| ActiveProspect, Inc. (d) | Lead Management Software | First Lien Term Loan<br> (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/9/2027 | 8/8/2022 | $11525624 | 11475531 | 11525624 | 2.9% |
| ActiveProspect, Inc. (j) | Lead Management Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/9/2027 | 8/8/2022 | $- | - | - | 0.0% |
|  |  | Total Lead Management Software |  |  | 11475531 | 11525624 | 2.9% |
| Madison Logic, Inc. (d)(m) | Marketing Orchestration Software | First Lien Term Loan<br> (1M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2028 | 12/30/2025 | $18905249 | 18724321 | 18525253 | 4.7% |
|  |  | Total Marketing Orchestration Software |  |  | 18724321 | 18525253 | 4.7% |
| ARC Health OpCo LLC (d) | Mental Healthcare Services | First Lien Term Loan<br> (3M USD TERM SOFR+8.35%), 12.67% Cash, 8/5/2027 | 8/5/2022 | $6500000 | 6458577 | 6185400 | 1.6% |
| ARC Health OpCo LLC (d) | Mental Healthcare Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+8.35%), 12.67% Cash, 8/5/2027 | 8/5/2022 | $26914577 | 26907069 | 25611911 | 6.5% |
| ARC Health OpCo LLC (h) | Mental Healthcare Services | Class A Preferred Units | 8/5/2022 | 3818400 | 4169599 | 127668 | 0.0% |
|  |  | Total Mental Healthcare Services |  |  | 37535245 | 31924979 | 8.1% |
| Chronus LLC | Mentoring Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.25%), 9.72% Cash, 8/26/2026 | 8/26/2021 | $15000000 | 14956281 | 14922000 | 3.8% |
| Chronus LLC (d) | Mentoring Software | First Lien Term Loan<br> (3M USD TERM SOFR+6.00%), 10.47% Cash, 8/26/2026 | 8/26/2021 | $5000000 | 4979867 | 4974000 | 1.3% |
| Chronus LLC (h) | Mentoring Software | Series A Preferred Stock | 8/26/2021 | 3000 | 3000000 | 1942213 | 0.5% |
|  |  | Total Mentoring Software |  |  | 22936148 | 21838213 | 5.6% |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Cloudpermit | Municipal Government Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029 | 9/5/2024 | $28000000 | 27759396 | 27829200 | 7.0% |
| Cloudpermit (j) | Municipal Government Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029 | 9/5/2024 | $- |  |  | 0.0% |
| Cloudpermit (h) | Municipal Government Software | Limited Partner Interests | 9/5/2024 | 2000 | 2000000 | 2176751 | 0.5% |
|  |  | Total Municipal Government Software |  |  | 29759396 | 30005951 | 7.5% |
| Omatic Software, LLC (d) | Non-profit Services | First Lien Term Loan<br> (3M USD TERM SOFR+8.00%), 12.59% Cash/1.00% PIK, 6/30/2025 | 5/29/2018 | $16463783 | 16461436 | 16555981 | 4.2% |
|  |  | Total Non-profit Services |  |  | 16461436 | 16555981 | 4.2% |
| Emily Street Enterprises, L.L.C. (d) | Office Supplies | Senior Secured Note<br> (3M USD TERM SOFR+6.75%), 11.07% Cash, 12/31/2028 | 1/1/2018 | $5300000 | 5285417 | 5339220 | 1.3% |
|  |  | Total Office Supplies |  |  | 5285417 | 5339220 | 1.3% |
| Buildout, Inc. (d) | Real Estate Services | First Lien Term Loan<br> (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025 | 7/9/2020 | $14000000 | 13995313 | 13589800 | 3.4% |
| Buildout, Inc. | Real Estate Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025 | 2/12/2021 | $38500000 | 38485527 | 37371950 | 9.3% |
| Buildout, Inc. (h)(i) | Real Estate Services | Limited Partner Interests | 7/9/2020 | 1250 | 1372557 | 697210 | 0.2% |
|  |  | Total Real Estate Services |  |  | 53853397 | 51658960 | 12.9% |
| Wellspring Worldwide Inc. | Research Software | First Lien Term Loan <br> (3M USD TERM SOFR+8.42%), 12.75% Cash, 12/22/2028 | 6/27/2022 | $9432000 | 9372843 | 9432000 | 2.4% |
| Wellspring Worldwide Inc. | Research Software | Delayed DrawTerm Loan <br> (3M USD TERM SOFR+8.42%), 12.75% Cash, 12/22/2028 | 6/27/2022 | $14400000 | 14267488 | 14400000 | 3.5% |
| Archimedes Parent LLC (h) | Research Software | Class A Common Units | 6/27/2022 | 2475160 | 2475160 | 2354214 | 0.6% |
|  |  | Total Research Software |  |  | 26115491 | 26186214 | 6.5% |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| LFR Chicken LLC | Restaurant | First Lien Term Loan<br> (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026 | 11/19/2021 | $12000000 | 11962729 | 12000000 | 3.0% |
| LFR Chicken LLC (j) | Restaurant | Delayed Draw Term Loan<br> (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026 | 11/19/2021 | $18000000 | 17929206 | 18000000 | 4.4% |
| LFR Chicken LLC (h) | Restaurant | Series B Preferred Units | 11/19/2021 | 497183 | 1000000 | 1656178 | 0.4% |
|  |  | Total Restaurant |  |  | 30891935 | 31656178 | 7.8% |
| Avionte Holdings, LLC (h) | Staffing Services | Class A Units | 1/8/2014 | 100000 | 100000 | 3541920 | 0.9% |
|  |  | Total Staffing Services |  |  | 100000 | 3541920 | 0.9% |
| AIMCO 2025-24A E (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+6.10%), 10.42% Cash, 4/19/2038 | 4/30/2025 | $1500000 | 1500000 | 1509576 | 0.4% |
| BSP 2025-40A E (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+5.25%), 9.57% Cash, 7/25/2038 | 5/22/2025 | $3000000 | 3000000 | 3019188 | 0.8% |
| NMC CLO-4A ER (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+6.91%), 11.23% Cash, 3/20/2038 | 4/17/2025 | $1000000 | 980000 | 1003680 | 0.3% |
| NMC CLO-7A E (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+5.00%), 9.32% Cash, 3/31/2038 | 3/13/2025 | $1000000 | 1000000 | 1025700 | 0.3% |
| OAKC 2016-13A ER2 (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+5.75%), 10.07% Cash, 10/21/2037 | 4/10/2025 | $1000000 | 976249 | 1009227 | 0.3% |
| OAKC 2025-22A E (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+5.55%), 9.87% Cash, 7/20/2038 | 5/9/2025 | $1250000 | 1250000 | 1257985 | 0.3% |
| OCP 2025-43A E (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+6.50%), 10.82% Cash, 7/20/2038 | 4/23/2025 | $1000000 | 1000000 | 1006380 | 0.3% |
| TREST 2017-1A ERR (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+5.95%), 10.27% Cash, 7/25/2037 | 3/7/2025 | $1250000 | 1257125 | 1262408 | 0.3% |
| WBOX 2023-4A ER (a) | Structured Finance Securities | First Lien Term Loan<br> (3M USD TERM SOFR+6.48%), 10.80% Cash, 4/20/2036 | 4/10/2025 | $2000000 | 1970000 | 2031980 | 0.5% |
|  |  | Total Structured Finance Securities |  |  | 12933374 | 13126124 | 3.5% |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| StockIQ Technologies, LLC | Supply Chain Planning Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.25%), 9.57% Cash, 3/26/2030 | 3/25/2025 | $10000000 | 9914569 | 9913000 | 2.4% |
| StockIQ Technologies, LLC (j) | Supply Chain Planning Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.25%), 9.57% Cash, 3/26/2030 | 3/25/2025 | $- |  |  | 0.0% |
| StockIQ Technologies, LLC (h) | Supply Chain Planning Software | Class A Units | 3/25/2025 | 200000 | 200000 | 200000 | 0.1% |
|  |  | Total Supply Chain Planning Software |  |  | 10114569 | 10113000 | 2.5% |
| JDXpert | Talent Acquisition Software | First Lien Term Loan<br> (3M USD TERM SOFR+8.50%), 13.09% Cash, 5/2/2027 | 5/2/2022 | $6000000 | 5971723 | 6000000 | 1.5% |
| JDXpert | Talent Acquisition Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+8.50%), 13.09% Cash, 5/2/2027 | 5/2/2022 | $1000000 | 994336 | 1000000 | 0.3% |
| JDXpert (j) | Talent Acquisition Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+8.50%), 13.09% Cash, 5/2/2027 | 3/31/2023 | $500000 | 496548 | 500000 | 0.1% |
| Jobvite, Inc. (d) | Talent Acquisition Software | First Lien Term Loan<br> (3M USD TERM SOFR+7.50%), 11.82% Cash, 8/5/2028 | 8/5/2022 | $20000000 | 19915453 | 19838000 | 5.0% |
|  |  | Total Talent Acquisition Software |  |  | 27378060 | 27338000 | 6.9% |
| VetnCare MSO, LLC (j) | Veterinary Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.75%), 10.07% Cash, 5/12/2028 | 5/12/2023 | $13290655 | 13190394 | 13273377 | 3.3% |
|  |  | Total Veterinary Services |  |  | 13190394 | 13273377 | 3.3% |
| **Sub Total Non-control/Non-affiliate investments** |  |  |  |  | **863450463** | **875410787** | **220.9%** |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| **Affiliate investments - 13.1% (b)** |  |  |  | | | | |
| ETU Holdings, Inc. (f) | Corporate Education Software | First Lien Term Loan<br> (3M USD TERM SOFR+9.00%), 13.47% Cash, 8/18/2027 | 8/18/2022 | $7000000 | 6964923 | 6980400 | 1.8% |
| ETU Holdings, Inc. (f) | Corporate Education Software | Second Lien Term Loan<br> 15.00% PIK, 2/18/2028 | 8/18/2022 | $7393154 | 7365722 | 6599868 | 1.7% |
| ETU Holdings, Inc. (f)(h) | Corporate Education Software | Series A Preferred Units | 8/18/2022 | 3000000 | 3000000 | - | 0.0% |
|  |  | Total Corporate Education Software |  |  | 17330645 | 13580268 | 3.5% |
| Axero Holdings, LLC (f) | Employee Collaboration Software | First Lien Term Loan<br> 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 | 6/30/2021 | $16214518 | 16196275 | 16248569 | 4.0% |
| Axero Holdings, LLC (f) | Employee Collaboration Software | Delayed Draw Term Loan<br> 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 | 6/30/2021 | $1150708 | 1146415 | 1153125 | 0.3% |
| Axero Holdings, LLC (f)(j) | Employee Collaboration Software | Revolving Credit Facility<br> 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 | 2/3/2022 | $- |  |  | 0.0% |
| Axero Holdings, LLC (f)(h) | Employee Collaboration Software | Series A Preferred Units | 6/30/2021 | 2055609 | 2055609 | 3741208 | 0.9% |
| Axero Holdings, LLC (f)(h) | Employee Collaboration Software | Series B Preferred Units | 6/30/2021 | 2055609 | 2055609 | 6360394 | 1.6% |
|  |  | Total Employee Collaboration Software |  |  | 21453908 | 27503296 | 6.8% |
| SmartAC.com, Inc. (f) | HVAC Monitoring Devices | First Lien Term Loan<br> (3M USD TERM SOFR+7.50%), 11.82% Cash, 4/7/2030 | 4/7/2025 | $8000000 | 7941334 | 7940000 | 2.0% |
| SmartAC.com, Inc. (f) | HVAC Monitoring Devices | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.50%), 11.82% Cash, 4/7/2030 | 4/7/2025 | $1262201 | 2999999 | 2999999 | 0.8% |
| SmartAC.com, Inc. (f)(j) | HVAC Monitoring Devices | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.50%), 11.82% Cash, 4/7/2030 | 4/7/2025 | $- | - | - | 0.0% |
|  |  | Total HVAC Monitoring Devices |  |  | 10941333 | 10939999 | 2.8% |
| **Sub Total Affiliate investments** |  |  |  |  | **49725886** | **52023563** | **13.1%** |

---

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment <br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| **Control investments - 10.3% (b)** |  |  |  |  |  |  |  |
| Zollege PBC (k)(g) | Education Services | First Lien Term Loan<br> 4.84% PIK, 8/9/2027 | 5/11/2021 | $1461250 | 1461250 | 1078695 | 0.3% |
| Zollege PBC (h)(g) | Education Services | Common Stock | 5/11/2021 | 7731294 | 558799 | 3960751 | 1.0% |
|  |  | Total Education Services |  |  | 2020049 | 5039446 | 1.3% |
| Pepper Palace, Inc. (k)(g) | Specialty Food Retailer | First Lien Term Loan<br> 4.42% PIK, 12/31/2028 | 6/30/2021 | $2400000 | 2400000 | 1313760 | 0.3% |
| Pepper Palace, Inc. (j)(k)(g) | Specialty Food Retailer | Delayed Draw Term Loan<br> 4.42% PIK, 12/31/2028 | 6/30/2021 | $- |  |  | 0.0% |
| Pepper Palace, Inc. (j)(k)(g) | Specialty Food Retailer | Revolving Credit Facility<br> 4.42% PIK, 12/31/2028 | 6/30/2021 | $1000000 | 1000000 | 547400 | 0.1% |
| Pepper Palace, Inc. (h)(g) | Specialty Food Retailer | Class A Units | 6/30/2021 | 100000 | 138561 | - | 0.0% |
|  |  | Total Specialty Food Retailer |  |  | 3538561 | 1861160 | 0.4% |
| Saratoga Investment Corp. CLO 2013-1, Ltd. (a)(e)(g) | Structured Finance Securities | Other/Structured Finance Securities<br> 0.00%, 4/20/2033 | 1/22/2008 | $111000000 | 14684668 | 156793 | 0.0% |
| Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a)(g) | Structured Finance Securities | Other/Structured Finance Securities<br> (3M USD TERM SOFR+10.00%), 14.58%, 4/20/2033 | 8/9/2021 | $9375000 | 9375000 | 1857189 | 0.5% |
| Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a)(g) | Structured Finance Securities | Other/Structured Finance Securities<br> (3M USD TERM SOFR+8.55%), 12.87%, 10/20/2033 | 10/28/2022 | $12250000 | 11392500 | 12250000 | 3.1% |
|  |  | Total Structured Finance Securities |  |  | 35452168 | 14263982 | 3.6% |
| Saratoga Senior Loan Fund I JV, LLC (a)(g)(j) | Investment Fund | Unsecured Loan<br> 10.00%, 10/20/2033 | 12/17/2021 | $17618954 | 17618954 | 16634935 | 4.2% |
| Saratoga Senior Loan Fund I JV, LLC (a)(g) | Investment Fund | Membership Interest | 12/17/2021 | 17583486 | 17583486 | 3084089 | 0.8% |
|  |  | Total Investment Fund |  |  | 35202440 | 19719024 | 5.0% |
| **Sub Total Control investments** |  |  |  |  | **76213218** | **40883612** | **10.3%** |
| **TOTAL INVESTMENTS - 244.3% (b)** |  |  |  |  | $**989389567** | $**968317962** | **244.3%** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of <br> Shares** | **Cost** | **Fair Value** | **% of<br> Net Assets** |
| **Cash and cash equivalents and cash and cash equivalents, reserve accounts - 33.2% (b)** |  |  |  |  |
| U.S. Bank Money Market (l) | 131562513 | $131562513 | $131562513 | 33.2% |
| **Total cash and cash equivalents and cash and cash equivalents, reserve accounts** | **131562513** | $**131562513** | $**131562513** | **33.2%** |

---

(1) Securities are exempt from registration under Rule 144A of the
Securities Act of 1933, as amended, and are restricted securities. Money market funds are valued at net asset value and are considered
level 1 investments within the fair value hierarchy.

(a) Represents an investment that is not a "qualifying asset"
under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act"). As of May 31, 2025, non-qualifying assets
represent 5.7% of the Company's portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets
in qualifying assets.

(b) Percentages are based on net assets of $396,369,315 as of May
31, 2025.

(c) Because there is no "readily available market quotations"
(as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable
inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy
(see Note 3 to the consolidated financial statements).

**Saratoga Investment Corp.**

**Consolidated Schedule of Investments**

**May 31, 2025**

**(unaudited)**

(d) These securities are either fully or partially pledged as collateral
under the Company's senior secured revolving credit facility (see Note 8 to the consolidated financial statements).

(e) This investment does not have a stated interest rate that is
payable thereon. As a result, the 0.00% interest rate in the table above represents the effective interest rate currently earned on the
investment cost and is based on the current cash interest and other income generated by the investment.

(f) As defined in the 1940 Act, this portfolio company is an "affiliate"
as we own between 5.0% and 25.0% of the outstanding voting securities. Transactions during the three months ended May 31, 2025 in which
the issuer was an affiliate are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Company** | **Purchases** | **Sales** | **Total Interest from Investments** | **Management Fee Income** | **Net Realized <br> Gain (Loss) from Investments** | **Net Change in Unrealized Appreciation (Depreciation)** |
| Axero Holdings, LLC | $- | $- | $503808 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | $21027 |
| ETU Holdings, Inc. | - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 531233 | - | - | (65637) |
| SmartAC.com Inc. | 10939999 | - | 145333 | - | - | (1334) |
| **Total** | $10939999 | $- | $1180374 | $- | $- | $(45944) |

---

(g) As defined in the 1940 Act, we "control" this portfolio
company because we own more than 25% of the portfolio company's outstanding voting securities. Transactions during the three months ended
May 31, 2025 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company** | **Purchases** | **Sales** | **Total Interest from Investments** | **Total Dividends from Investments** | **Management Fee Income** | **Net Realized <br> Gain (Loss) from Investments** | **Net Change in Unrealized Appreciation (Depreciation)** |
| Netreo Holdings, LLC | $- | $- | $- | $- | $- | $638355 | $- |
| Pepper Palace, Inc. | 600000 | - | - | - | - | - | (285840) |
| Zollege PBC | - | - | - | - | - | - | 1102296 |
| Saratoga Investment Corp. CLO 2013-1, Ltd. | - | - | - | - | 705175 | - | 120584 |
| Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note | - | - | 401732 | - | - | - | - |
| Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note | - | - | 348455 | - | - | - | (423749) |
| Saratoga Senior Loan Fund I JV, LLC | - | - | 440474 | - | - | - | 101309 |
| Saratoga Senior Loan Fund I JV, LLC | - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | - | 436418 | - | - | 3173 |
| **Total** | $600000 | $- | $1190661 | $436418 | $705175 | $638355 | $617773 |

---

(h) Non-income producing at May 31, 2025

(i) Includes securities issued by an affiliate of the company.

(j) All or a portion of this investment has an unfunded commitment
as of May 31, 2025. (See Note 9 to the consolidated financial statements).

(k) As of May 31, 2025, the investment was on non-accrual status.
The fair value of these investments was approximately $2.9 million, which represented 0.3% of the Company's portfolio (see Note 2 to
the consolidated financial statements).

(l) Included within cash and cash equivalents and cash and cash
equivalents, reserve accounts in the Company's consolidated statements of assets and liabilities as of May 31, 2025.

(m) This investment elected to PIK 20% of accrued interest, with
80% of accrued interest payable in cash.

SOFR - Secured Overnight Financing Rate

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of May 31, 2025 was 4.32%.

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of May 31, 2025 was 4.32%.

See accompanying notes to consolidated financial statements.

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| **Non-control/Non-affiliate investments - 229.3%(b)** |  |  |  | | | | |
| Altvia MidCo, LLC. | Alternative Investment Management Software | First Lien Term Loan<br> (3M USD TERM SOFR+8.50%), 12.82% Cash, 7/18/2027 | 7/18/2022 | $8835600 | $8775378 | $8845319 | 2.3% |
| Altvia MidCo, LLC. (h) | Alternative Investment Management Software | Series A-1 Preferred Shares | 7/18/2022 | 2000000 | 2000000 | 2730236 | 0.7% |
|  |  | Total Alternative Investment Management Software |  |  | 10775378 | 11575555 | 3.0% |
| BQE Software, Inc. (d) | Architecture & Engineering Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028 | 4/13/2023 | $24500000 | 24328507 | 24541650 | 6.3% |
| BQE Software, Inc. (j) | Architecture & Engineering Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.50%), 9.82% Cash, 4/13/2028 | 4/13/2023 | $750000 | 746569 | 751275 | 0.2% |
|  |  | Total Architecture & Engineering Software |  |  | 25075076 | 25292925 | 6.5% |
| GrowthZone, LLC | Association Management Software | First Lien Term Loan<br> (3M USD TERM SOFR+8.25%), 12.57% Cash, 5/10/2028 | 5/10/2023 | $23336753 | 23044093 | 23402096 | 6.0% |
| Golden TopCo LP (h) | Association Management Software | Class A-2 Common Units | 5/10/2023 | 1072394 | 1072394 | 1447602 | 0.4% |
|  |  | Total Association Management Software |  |  | 24116487 | 24849698 | 6.4% |
| Artemis Wax Corp. (d)(j) | Consumer Services | Delayed Draw Term Loan<br> (1M USD TERM SOFR+7.50%), 11.82% Cash, 5/20/2026 | 5/20/2021 | $57500000 | 57333736 | 56953750 | 14.5% |
| Artemis Wax Corp. (h) | Consumer Services | Series B-1 Preferred Stock | 5/20/2021 | 934463 | 1500000 | 338044 | 0.1% |
| Artemis Wax Corp. (h) | Consumer Services | Series D Preferred Stock | 12/22/2022 | 331640 | 1711866 | 2147020 | 0.5% |
|  |  | Total Consumer Services |  |  | 60545602 | 59438814 | 15.1% |
| Schoox, Inc. (h),(i) | Corporate Education Software | Series 1 Membership Interest | 12/8/2020 | 1050 | 475698 | 3978192 | 1.0% |
|  |  | Total Corporate Education Software |  |  | 475698 | 3978192 | 1.0% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Innergy, Inc. | Custom Millwork Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.50%), 9.82% Cash, 1/31/2030 | 2/20/2025 | $32000000 | 31721847 | 31721600 | 8.1% |
| Innergy, Inc. (j) | Custom Millwork Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.50%), 9.82% Cash, 1/31/2030 | 2/20/2025 | $- | - | - | 0.0% |
|  |  | Total Custom Millwork Software |  |  | 31721847 | 31721600 | 8.1% |
| GreyHeller LLC (h) | Cyber Security | Common Stock | 11/10/2021 | 7857689 | 1906275 | 3516571 | 0.9% |
|  |  | Total Cyber Security |  |  | 1906275 | 3516571 | 0.9% |
| Gen4 Dental Partners Holdings, LLC | Dental Practice Management | First Lien Term Loan<br> (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030 | 5/13/2024 | $7107143 | 7043790 | 7043179 | 1.8% |
| Gen4 Dental Partners Holdings, LLC (j) | Dental Practice Management | Delayed Draw Term Loan<br> (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030 | 5/13/2024 | $- | - | - | 0.0% |
| Gen4 Dental Partners Holdings, LLC (j) | Dental Practice Management | Revolving Credit Facility<br> (1M USD TERM SOFR+5.75%), 10.07% Cash, 5/13/2030 | 5/13/2024 | $- | - | - | 0.0% |
| Gen4 Dental Partners Holdings, LLC (h)(i) | Dental Practice Management | Series A Preferred Units | 2/8/2023 | 493999 | 1027519 | 972485 | 0.2% |
| Modis Dental Partners OpCo, LLC | Dental Practice Management | First Lien Term Loan<br> (1M USD TERM SOFR+9.41%), 13.74% Cash, 4/18/2028 | 4/18/2023 | $7000000 | 6925052 | 7079800 | 1.8% |
| Modis Dental Partners OpCo, LLC (j) | Dental Practice Management | Delayed Draw Term Loan<br> (1M USD TERM SOFR+9.41%), 13.74% Cash, 4/18/2028 | 4/18/2023 | $8600000 | 8498729 | 8698040 | 2.2% |
| Modis Dental Partners OpCo, LLC (h) | Dental Practice Management | Class A Preferred Units | 4/18/2023 | 2950000 | 2950000 | 2552488 | 0.7% |
| New England Dental Partners | Dental Practice Management | First Lien Term Loan<br> (3M USD TERM SOFR+8.00%), 12.47% Cash, 11/25/2025 | 11/25/2020 | $6555000 | 6541869 | 6636282 | 1.7% |
| New England Dental Partners | Dental Practice Management | Delayed Draw Term Loan<br> (3M USD TERM SOFR+8.00%), 12.47% Cash, 11/25/2025 | 11/25/2020 | $2150000 | 2148547 | 2176660 | 0.6% |
|  |  | Total Dental Practice Management |  |  | 35135506 | 35158934 | 9.0% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Exigo, LLC (d) | Direct Selling Software | First Lien Term Loan<br> (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027 | 3/16/2022 | $24065038 | 23961810 | 23352713 | 5.9% |
| Exigo, LLC (j) | Direct Selling Software | Revolving Credit Facility<br> (1M USD TERM SOFR+6.25%), 10.67% Cash, 3/16/2027 | 3/16/2022 | $- | - | (18500) | 0.0% |
| Exigo, LLC (h), (i) | Direct Selling Software | Common Units | 3/16/2022 | 1041667 | 1041667 | 729464 | 0.2% |
|  |  | Total Direct Selling Software |  |  | 25003477 | 24063677 | 6.1% |
| C2 Educational Systems, Inc. (d) | Education Services | First Lien Term Loan<br> (3M USD TERM SOFR+8.50%), 12.82% Cash, 5/31/2025 | 5/31/2017 | $23000000 | 22993974 | 22990800 | 5.9% |
| C2 Educational Systems, Inc. (j) | Education Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+8.50%), 12.82% Cash, 5/31/2025 | 4/28/2023 | $- | - | - | 0.0% |
| C2 Education Systems, Inc. (h) | Education Services | Series A-1 Preferred Stock | 5/18/2021 | 3127 | 499904 | 605383 | 0.2% |
|  |  | Total Education Services |  |  | 23493878 | 23596183 | 6.1% |
| GoReact | Education Software | First Lien Term Loan<br> (3M USD TERM SOFR+7.50%), 12.02% Cash/1.00% PIK, 4/17/2025 | 1/17/2020 | $8170158 | 8169876 | 8170158 | 2.1% |
| GoReact (j) | Education Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.50%), 12.02% Cash/1.00% PIK, 4/17/2025 | 1/18/2022 | $- | - | - | 0.0% |
| Identity Automation Systems (h) | Education Software | Common Stock Class A-2 Units | 8/25/2014 | 232616 | 232616 | 1182481 | 0.3% |
| Identity Automation Systems (h) | Education Software | Common Stock Class A-1 Units | 3/6/2020 | 43715 | 171571 | 329237 | 0.1% |
| Ready Education (d) | Education Software | First Lien Term Loan<br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 8/5/2027 | 8/5/2022 | $32000000 | 31801611 | 31913600 | 8.1% |
|  |  | Total Education Software |  |  | 40375674 | 41595476 | 10.6% |
| TG Pressure Washing Holdings, LLC (h) | Facilities Maintenance | Preferred Equity | 8/12/2019 | 488148 | 488148 | - | 0.0% |
|  |  | Total Facilities Maintenance |  |  | 488148 | - | 0.0% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Davisware, LLC | Field Service Management | First Lien Term Loan<br> (3M USD TERM SOFR+6.50%), 10.82% Cash, 11/30/2025 | 9/6/2019 | $6000000 | 6000000 | 6012000 | 1.5% |
| Davisware, LLC (j) | Field Service Management | Delayed Draw Term Loan <br> (3M USD TERM SOFR+6.50%), 10.82% Cash, 11/30/2025 | 9/6/2019 | $5727790 | 5725290 | 5739246 | 1.5% |
|  |  | Total Field Service Management |  |  | 11725290 | 11751246 | 3.0% |
| GDS Software Holdings, LLC | Financial Services | First Lien Term Loan <br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026 | 12/30/2021 | $22713926 | 22655802 | 22654870 | 5.8% |
| GDS Software Holdings, LLC (d) | Financial Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 12/30/2026 | 12/30/2021 | $3286074 | 3266913 | 3277530 | 0.8% |
| GDS Software Holdings, LLC (h) | Financial Services | Common Stock Class A Units | 8/23/2018 | 250000 | 250000 | 370057 | 0.1% |
|  |  | Total Financial Services |  |  | 26172715 | 26302457 | 6.7% |
| Ascend Software, LLC | Financial Services Software | First Lien Term Loan<br> (3M USD TERM SOFR+7.50%), 12.08% Cash, 12/15/2026 | 12/15/2021 | $6000000 | 5974824 | 5930400 | 1.5% |
| Ascend Software, LLC (j) | Financial Services Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.50%), 12.08% Cash, 12/15/2026 | 12/15/2021 | $4050000 | 4037989 | 4003020 | 1.0% |
|  |  | Total Financial Services Software |  |  | 10012813 | 9933420 | 2.5% |
| Inspect Point Holdings, LLC | Fire Inspection Business Software | First Lien Term Loan <br> (1M USD TERM SOFR+6.50%), 10.82% Cash, 07/19/2028 | 7/19/2023 | $10000000 | 9927042 | 10178000 | 2.6% |
| Inspect Point Holdings, LLC (j) | Fire Inspection Business Software | Delayed Draw Term Loan <br> (1M USD TERM SOFR+6.50%), 10.82% Cash, 07/19/2028 | 7/19/2023 | $- | - | - | 0.0% |
|  |  | Total Fire Inspection Business Software |  |  | 9927042 | 10178000 | 2.6% |
| Stretch Zone Franchising, LLC (d) | Health/Fitness Franchisor | First Lien Term Loan<br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028 | 3/31/2023 | $28717271 | 28525975 | 27327355 | 7.0% |
| Stretch Zone Franchising, LLC (j) | Health/Fitness Franchisor | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.00%), 11.32% Cash, 3/31/2028 | 3/31/2023 | $- | - | (72600) | 0.0% |
| Stretch Zone Franchising, LLC (h) | Health/Fitness Franchisor | Class A Units | 3/31/2023 | 20000 | 2000000 | 1198117 | 0.3% |
|  |  | Total Health/Fitness Franchisor |  |  | 30525975 | 28452872 | 7.3% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Alpha Aesthetics Partners OpCo, LLC | Healthcare Services | First Lien Term Loan<br> (1M USD TERM SOFR+9.92%), 14.25% Cash, 3/20/2028 | 3/20/2023 | $3900000 | 3858168 | 3952260 | 1.1% |
| Alpha Aesthetics Partners OpCo, LLC | Healthcare Services | Delayed Draw Term Loan<br> (1M USD TERM SOFR+9.92%), 14.25% Cash, 3/20/2028 | 3/20/2023 | $15100000 | 14915338 | 15302340 | 3.9% |
| Alpha Aesthetics Partners OpCo, LLC (h) | Healthcare Services | Class A Preferred Units | 3/20/2023 | 3675000 | 3675000 | 3822369 | 1.0% |
| Axiom Medical Consulting, LLC | Healthcare Services | First Lien Term Loan<br> (3M USD TERM SOFR+6.00%), 10.32% Cash, 9/11/2028 | 9/11/2023 | $6000000 | 5959513 | 6000000 | 1.5% |
| Axiom Medical Consulting, LLC (j) | Healthcare Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+6.00%), 10.32% Cash, 9/11/2028 | 9/11/2023 | $- | - | - | 0.0% |
| Axiom Parent Holdings, LLC (h) | Healthcare Services | Class A Preferred Units | 6/19/2018 | 400000 | 258389 | 884831 | 0.2% |
| ComForCare Health Care (d) | Healthcare Services | First Lien Term Loan<br> (3M USD TERM SOFR+6.25%), 10.57% Cash, 12/31/2027 | 1/31/2017 | $55000000 | 54766528 | 55187000 | 14.1% |
|  |  | Total Healthcare Services |  |  | 83432936 | 85148800 | 21.8% |
| Procurement Partners, LLC | Healthcare Software | First Lien Term Loan<br> (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026 | 11/12/2020 | $35125000 | 35033286 | 35125000 | 8.9% |
| Procurement Partners, LLC | Healthcare Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+6.50%), 10.82% Cash, 5/12/2026 | 11/12/2020 | $10300000 | 10287080 | 10300000 | 2.6% |
| Procurement Partners Holdings LLC (h) | Healthcare Software | Class A Units | 11/12/2020 | 571219 | 571219 | 442532 | 0.1% |
| Procurement Partners Holdings LLC (h) | Healthcare Software | Class AA Units | 11/12/2020 | 220385 | 30994 | 118529 | 0.0% |
|  |  | Total Healthcare Software |  |  | 45922579 | 45986061 | 11.6% |
| Roscoe Medical, Inc. (h) | Healthcare Supply | Common Stock | 3/26/2014 | 5081 | 508077 | - | 0.0% |
|  |  | Total Healthcare Supply |  |  | 508077 | - | 0.0% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Granite Comfort, LP (d) | HVAC Services and Sales | First Lien Term Loan<br> (3M USD TERM SOFR+7.41%), 11.72% Cash, 5/16/2027 | 11/16/2020 | $43000000 | 42842108 | 41937900 | 10.7% |
| Granite Comfort, LP (j)(d) | HVAC Services and Sales | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.41%), 11.72% Cash, 5/16/2027 | 11/16/2020 | $16207805 | 16101236 | 15520041 | 4.0% |
|  |  | Total HVAC Services and Sales |  |  | 58943344 | 57457941 | 14.7% |
| Vector Controls Holding Co., LLC (h) | Industrial Products | Warrants to Purchase Limited Liability Company Interests, Expires 3/6/2025 | 5/31/2015 | 329 | - | 9404077 | 2.4% |
|  |  | Total Industrial Products |  |  | - | 9404077 | 2.4% |
| AgencyBloc, LLC | Insurance Software | First Lien Term Loan <br> (1M USD TERM SOFR+7.76%), 12.09% Cash, 10/1/2026 | 10/1/2021 | $15615511 | 15553310 | 15615511 | 4.0% |
| Panther ParentCo LLC (h) | Insurance Software | Class A Units | 10/1/2021 | 2500000 | 2500000 | 4729353 | 1.2% |
|  |  | Total Insurance Software |  |  | 18053310 | 20344864 | 5.2% |
| Avantra | IT Services | First Lien Term Loan<br> (3M USD TERM SOFR+7.97%), 12.29% Cash, 9/20/2029 | 9/19/2024 | $17000000 | 16823180 | 16809600 | 4.3% |
| Maple Holdings Midco Limited (h) | IT Services | Class A Common Units | 9/19/2024 | 2000000 | 2000000 | 2000000 | 0.5% |
|  |  | Total IT Services |  |  | 18823180 | 18809600 | 4.8% |
| ActiveProspect, Inc. (d) | Lead Management Software | First Lien Term Loan<br> (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/8/2027 | 8/8/2022 | $11525624 | 11470461 | 11640880 | 3.0% |
| ActiveProspect, Inc. (j) | Lead Management Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+6.00%), 10.52% Cash, 8/8/2027 | 8/8/2022 | $- | - | - | 0.0% |
|  |  | Total Lead Management Software |  |  | 11470461 | 11640880 | 3.0% |
| Madison Logic, Inc. (d)(m) | Marketing Orchestration Software | First Lien Term Loan<br> (1M USD TERM SOFR+7.50%), 11.82% Cash, 12/30/2028 | 12/30/2022 | $18841634 | 18649126 | 18444075 | 4.7% |
|  |  | Total Marketing Orchestration Software |  |  | 18649126 | 18444075 | 4.7% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| ARC Health OpCo LLC (d) | Mental Healthcare Services | First Lien Term Loan<br> (3M USD TERM SOFR+8.40%), 12.72% Cash, 8/5/2027 | 8/5/2022 | $6500000 | 6455259 | 6184750 | 1.6% |
| ARC Health OpCo LLC (d) | Mental Healthcare Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+8.40%), 12.72% Cash, 8/5/2027 | 8/5/2022 | $26914577 | 26907840 | 25609220 | 6.5% |
| ARC Health OpCo LLC (h) | Mental Healthcare Services | Class A Preferred Units | 8/5/2022 | 3818400 | 4169599 | 610944 | 0.2% |
|  |  | Total Mental Healthcare Services |  |  | 37532698 | 32404914 | 8.3% |
| Chronus LLC | Mentoring Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.25%), 9.72% Cash, 8/26/2026 | 8/26/2021 | $15000000 | 14943520 | 14910000 | 3.8% |
| Chronus LLC (d) | Mentoring Software | First Lien Term Loan<br> (3M USD TERM SOFR+6.00%), 10.47% Cash, 8/26/2026 | 8/26/2021 | $5000000 | 4975736 | 4970000 | 1.3% |
| Chronus LLC (h) | Mentoring Software | Series A Preferred Stock | 8/26/2021 | 3000 | 3000000 | 2146574 | 0.5% |
|  |  | Total Mentoring Software |  |  | 22919256 | 22026574 | 5.6% |
| Cloudpermit | Municipal Government Software | First Lien Term Loan<br> (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029 | 9/5/2024 | $28000000 | 27750119 | 27720000 | 7.1% |
| Cloudpermit (j) | Municipal Government Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.75%), 10.07% Cash, 9/5/2029 | 9/5/2024 | $- | - | - | 0.0% |
| Cloudpermit (h) | Municipal Government Software | Limited Partner Interests | 9/5/2024 | 2000 | 2000000 | 2000000 | 0.5% |
|  |  | Total Municipal Government Software |  |  | 29750119 | 29720000 | 7.6% |
| Omatic Software, LLC (d) | Non-profit Services | First Lien Term Loan<br> (3M USD TERM SOFR+8.00%), 12.58% Cash/1.00% PIK, 6/30/2025 | 5/29/2018 | $16435922 | 16429958 | 16470437 | 4.2% |
|  |  | Total Non-profit Services |  |  | 16429958 | 16470437 | 4.2% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Emily Street Enterprises, L.L.C. (d) | Office Supplies | Senior Secured Note<br> (3M USD TERM SOFR+6.75%), 11.07% Cash, 12/31/2028 | 12/28/2012 | $5300000 | 5285054 | 5339220 | 1.4% |
|  |  | Total Office Supplies |  |  | 5285054 | 5339220 | 1.4% |
| Buildout, Inc. (d) | Real Estate Services | First Lien Term Loan<br> (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025 | 7/9/2020 | $14000000 | 13985556 | 13587000 | 3.5% |
| Buildout, Inc. | Real Estate Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+7.00%), 11.42% Cash, 7/9/2025 | 2/12/2021 | $38500000 | 38454669 | 37364250 | 9.5% |
| Buildout, Inc. (h)(i) | Real Estate Services | Limited Partner Interests | 7/9/2020 | 1250 | 1372557 | 798892 | 0.2% |
|  |  | Total Real Estate Services |  |  | 53812782 | 51750142 | 13.2% |
| Wellspring Worldwide Inc. | Research Software | First Lien Term Loan <br> (3M USD TERM SOFR+8.42%), 12.74% Cash, 12/22/2028 | 6/27/2022 | $9492000 | 9428229 | 9492000 | 2.4% |
| Wellspring Worldwide Inc. | Research Software | Delayed DrawTerm Loan <br> (3M USD TERM SOFR+8.42%), 12.74% Cash, 12/22/2028 | 6/27/2022 | $14400000 | 14259405 | 14400000 | 3.7% |
| Archimedes Parent LLC (h) | Research Software | Class A Common Units | 6/27/2022 | 2475160 | 2475160 | 2387902 | 0.6% |
|  |  | Total Research Software |  |  | 26162794 | 26279902 | 6.7% |
| LFR Chicken LLC | Restaurant | First Lien Term Loan<br> (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026 | 11/19/2021 | $12000000 | 11952144 | 12000000 | 3.1% |
| LFR Chicken LLC (j) | Restaurant | Delayed Draw Term Loan<br> (1M USD TERM SOFR+7.00%), 11.32% Cash, 11/19/2026 | 11/19/2021 | $18000000 | 17906382 | 18000000 | 4.6% |
| LFR Chicken LLC (h) | Restaurant | Series B Preferred Units | 11/19/2021 | 497183 | 1000000 | 1599989 | 0.4% |
|  |  | Total Restaurant |  |  | 30858526 | 31599989 | 8.1% |
| Avionte Holdings, LLC (h) | Staffing Services | Class A Units | 1/8/2014 | 100000 | 100000 | 3426460 | 0.9% |
|  |  | Total Staffing Services |  |  | 100000 | 3426460 | 0.9% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| JDXpert | Talent Acquisition Software | First Lien Term Loan<br> (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027 | 5/2/2022 | $6000000 | 5969521 | 6000000 | 1.5% |
| JDXpert | Talent Acquisition Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027 | 5/2/2022 | $1000000 | 993974 | 1000000 | 0.3% |
| JDXpert (j) | Talent Acquisition Software | Delayed Draw Term Loan<br> (3M USD TERM SOFR+8.50%), 13.08% Cash, 5/2/2027 | 3/31/2023 | $500000 | 496237 | 500000 | 0.1% |
| Jobvite, Inc. (d) | Talent Acquisition Software | First Lien Term Loan<br> (3M USD TERM SOFR+7.50%), 11.82% Cash, 8/5/2028 | 8/5/2022 | $20000000 | 19900196 | 19834000 | 5.1% |
|  |  | Total Talent Acquisition Software |  |  | 27359928 | 27334000 | 7.0% |
| VetnCare MSO, LLC (j) | Veterinary Services | Delayed Draw Term Loan<br> (3M USD TERM SOFR+5.75%), 10.07% Cash, 5/12/2028 | 5/12/2023 | $12680505 | 12580925 | 12666554 | 3.2% |
|  |  | Total Veterinary Services |  |  | 12580925 | 12666554 | 3.2% |
| **Sub Total Non-control/Non-affiliate investments** |  |  |  |  | **886071934** | **897660110** | **229.3%** |
| **Affiliate investments - 10.3% (b)** |  |  |  |  |  |  |  |
| ETU Holdings, Inc. (f) | Corporate Education Software | First Lien Term Loan<br> (3M USD TERM SOFR+9.00%), 13.47% Cash, 8/18/2027 | 8/18/2022 | $7000000 | 6959248 | 6980400 | 1.8% |
| ETU Holdings, Inc. (f) | Corporate Education Software | Second Lien Term Loan<br> 15.00% PIK, 2/18/2028 | 8/18/2022 | $7125931 | 7093577 | 6387685 | 1.6% |
| ETU Holdings, Inc. (f)(h) | Corporate Education Software | Series A Preferred Units | 8/18/2022 | 3000000 | 3000000 | - | 0.0% |
|  |  | Total Corporate Education Software |  |  | 17052825 | 13368085 | 3.4% |
| Axero Holdings, LLC (f) | Employee Collaboration Software | First Lien Term Loan<br> 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 | 6/30/2021 | $15933063 | 15913591 | 15933063 | 4.1% |
| Axero Holdings, LLC (f) | Employee Collaboration Software | Delayed Draw Term Loan<br> 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 | 6/30/2021 | $1130734 | 1126177 | 1130734 | 0.3% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Axero Holdings, LLC (f)(j) | Employee Collaboration Software | Revolving Credit Facility<br> 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 | 2/3/2022 | $- | - | - | 0.0% |
| Axero Holdings, LLC (f)(h) | Employee Collaboration Software | Series A Preferred Units | 6/30/2021 | 2055609 | 2055609 | 3529000 | 0.9% |
| Axero Holdings, LLC (f)(h) | Employee Collaboration Software | Series B Preferred Units | 6/30/2021 | 2055609 | 2055609 | 6586550 | 1.6% |
|  |  | Total Employee Collaboration Software |  |  | 21150986 | 27179347 | 6.9% |
| **Sub Total Affiliate investments** |  |  |  |  | **38203811** | **40547432** | **10.3%** |
| **Control investments - 10.2% (b)** |  |  |  |  |  |  |  |
| Zollege PBC (k)(g) | Education Services | First Lien Term Loan<br> 4.84% PIK, 8/9/2027 | 5/11/2021 | $1461250 | 1461250 | 1085855 | 0.3% |
| Zollege PBC (h)(g) | Education Services | Common Stock | 5/11/2021 | 7731294 | 558799 | 2851295 | 0.7% |
|  |  | Total Education Services |  |  | 2020049 | 3937150 | 1.0% |
| Pepper Palace, Inc. (k)(g) | Specialty Food Retailer | First Lien Term Loan<br> 4.42% PIK, 12/31/2028 | 6/30/2021 | $2400000 | 2400000 | 1326000 | 0.3% |
| Pepper Palace, Inc. (j)(k)(g) | Specialty Food Retailer | Delayed Draw Term Loan<br> 4.42% PIK, 12/31/2028 | 6/30/2021 | $- | - | - | 0.0% |
| Pepper Palace, Inc. (j)(k)(g) | Specialty Food Retailer | Revolving Credit Facility<br> 4.42% PIK, 12/31/2028 | 6/30/2021 | $400000 | 400000 | 221000 | 0.1% |
| Pepper Palace, Inc. (h)(g) | Specialty Food Retailer | Class A Units | 6/30/2021 | 100000 | 138561 | - | 0.0% |
|  |  | Total Specialty Food Retailer |  |  | 2938561 | 1547000 | 0.4% |

---

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company(1)** | **Industry** | **Investment<br> Interest Rate/<br> Maturity** | **Original<br> Acquisition<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair <br> Value (c)** | **% of<br> Net Assets** |
| Saratoga Investment Corp. CLO 2013-1, Ltd. (a)(e)(g) | Structured Finance Securities | Other/Structured Finance Securities<br> 0.00%, 4/20/2033 | 1/22/2008 | $111000000 | 14889037 | 240578 | 0.1% |
| Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a)(g) | Structured Finance Securities | Other/Structured Finance Securities<br> (3M USD TERM SOFR+10.00%), 14.58%, 4/20/2033 | 8/9/2021 | $9375000 | 9375000 | 2280938 | 0.6% |
| Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a)(g) | Structured Finance Securities | Other/Structured Finance Securities<br> (3M USD TERM SOFR+8.55%), 12.87%, 10/20/2033 | 10/28/2022 | $12250000 | 11392500 | 12250000 | 3.1% |
|  |  | Total Structured Finance Securities |  |  | 35656537 | 14771516 | 3.8% |
| Saratoga Senior Loan Fund I JV, LLC (a)(g)(j) | Investment Fund | Unsecured Loan<br> 10.00%, 10/20/2033 | 12/17/2021 | $17618954 | 17618954 | 16533626 | 4.2% |
| Saratoga Senior Loan Fund I JV, LLC (a)(g) | Investment Fund | Membership Interest | 12/17/2021 | 17583486 | 17583486 | 3080916 | 0.8% |
|  |  | Total Investment Fund |  |  | 35202440 | 19614542 | 5.0% |
| **Sub Total Control investments** |  |  |  |  | **75817587** | **39870208** | **10.2%** |
| **TOTAL INVESTMENTS - 249.8% (b)** |  |  |  |  | $**1000093332** | $**978077750** | **249.8%** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of<br> Shares** | **Cost** | **Fair Value** | **% of<br> Net Assets** |
| **Cash and cash equivalents and cash and cash equivalents, reserve accounts - 37.7% (b)** |  |  |  |  |
| U.S. Bank Money Market (l) | 148218491 | $148218491 | $148218491 | 37.7% |
| **Total cash and cash equivalents and cash and cash equivalents, reserve accounts** | **148218491** | $**148218491** | $**148218491** | **37.7%** |

---

(1) Securities are exempt from registration under Rule 144A of the
Securities Act of 1933, as amended, and are restricted securities. Money market funds are valued at net asset value and are considered
level 1 investments within the fair value hierarchy.

(a) Represents an investment that is not a "qualifying asset"
under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act"). As of February 28, 2025, non-qualifying assets
represent 4.0% of the Company's portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets
in qualifying assets.

(b) Percentages are based on net assets of $392,665,468 as of February
28, 2025.

**Saratoga Investment Corp**

**Consolidated Schedule of Investments**

**February 28, 2025**

(c) Because there is no "readily available market quotations"
(as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable
inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy
(see Note 3 to the consolidated financial statements).

(d) These securities are either fully or partially pledged as collateral
under the Company's senior secured revolving credit facility (see Note 8 to the consolidated financial statements).

(e) This investment does not have a stated interest rate that is
payable thereon. As a result, the 0.00% interest rate in the table above represents the effective interest rate currently earned on the
investment cost and is based on the current cash interest and other income generated by the investment.

(f) As defined in the 1940 Act, this portfolio company is an "affiliate"
as we own between 5.0% and 25.0% of the outstanding voting securities. Transactions during the year ended February 28, 2025 in which
the issuer was an affiliate are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Company** | **Purchases** | **Sales** | **Total<br> Interest from<br> Investments** | **Management<br> Fee Income** | **Net Realized<br> Gain (Loss)<br> from<br> Investments** | **Net Change<br> in Unrealized<br> Appreciation<br> (Depreciation)** |
| Axero Holdings, LLC | $10000000 | $&nbsp;&nbsp;&nbsp;&nbsp;- | $1327375 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | $2551701 |
| ETU Holdings, Inc. | - | - | 2035631 | - | - | (1249802) |
| **Total** | $10000000 | $- | $3363006 | $- | $- | $1301899 |

---

(g) As defined in the 1940 Act, we "control" this portfolio
company because we own more than 25% of the portfolio company's outstanding voting securities. Transactions during the year ended February
28, 2025 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Company** | **Purchases** | **Sales** | **Total<br> Interest from<br> Investments** | **Total<br> Dividends from<br> Investments** | **Management<br> Fee Income** | **Net Realized<br> Gain (Loss)<br> from<br> Investments** | **Net Change<br> in Unrealized<br> Appreciation<br> (Depreciation)** |
| Netreo Holdings, LLC | $- | $2260337 | $921530 | $- | $- | $(5445808) | $3802854 |
| Pepper Palace, Inc. | 1450000 | - | 1338 | - | - | (34007427) | (1391561) |
| Zollege PBC | 200707 | 209460 | 110862 | - | - | (15110835) | 1917101 |
| Saratoga Investment Corp. CLO 2013-1, Ltd. | - | - | - | - | 3114466 | - | (2147199) |
| Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note | - | - | 1685977 | - | - | - | - |
| Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note | - | - | 1452981 | - | - | - | (6594289) |
| Saratoga Senior Loan Fund I JV, LLC | - | - | 1761895 | - | - | - | 715329 |
| Saratoga Senior Loan Fund I JV, LLC | - | - | - | 3973584 | - | - | (6323079) |
| **Total** | $1650707 | $2469797 | $5934583 | $3973584 | $3114466 | $(54564070) | $(10020844) |

---

(h) Non-income producing at February 28, 2025.

(i) Includes securities issued by an affiliate of the company.

(j) All or a portion of this investment has an unfunded commitment
as of February 28, 2025. (See Note 9 to the consolidated financial statements).

(k) As of February 28, 2025, the investment was on non-accrual status.
The fair value of these investments was approximately $2.6 million, which represented 0.3% of the Company's portfolio (see Note 2 to
the consolidated financial statements).

(l) Included within cash and cash equivalents and cash and cash
equivalents, reserve accounts in the Company's consolidated statements of assets and liabilities as of February 28, 2025.

(m) This investment elected to PIK 20% of accrued interest, with
80% of accrued interest payable in cash.

SOFR - Secured Overnight Financing Rate

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of February 28, 2025 was 4.32%.

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of February 28, 2025 was 4.32%.

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

See accompanying notes to consolidated financial statements

**SARATOGA INVESTMENT CORP.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**May 31, 2025**

**(unaudited)**

**Note 1. Organization**

Saratoga Investment Corp. (the "Company", "we", "our" and "us") is a non-diversified closed end management investment company incorporated in Maryland that has elected to be regulated as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed the initial public offering ("IPO") on March 28, 2007. The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). The Company's investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

GSC Investment, LLC (the "LLC") was organized in May 2006 as a Maryland limited liability company. On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC's limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from "GSC Investment Corp." to "Saratoga Investment Corp." in connection with the consummation of a recapitalization transaction.

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the "Manager" or "Saratoga Investment Advisors"), pursuant to an investment advisory and management agreement (the "Management Agreement").

The Company has established wholly owned subsidiaries, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc., SIA-PP Inc., SIA-SIQ, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT, Inc. and SIA-Vector, Inc., which are structured as Delaware entities that are treated as corporations for U.S. federal income tax purposes and are intended to facilitate its compliance with the requirements to be treated as a RIC under the Code by holding equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). These entities are consolidated for accounting purposes but are not consolidated for U.S. federal income tax purposes and may incur U.S. federal income tax expenses as a result of their ownership of portfolio companies.

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC II LP ("SBIC II LP") and Saratoga Investment Corp. SBIC III LP ("SBIC III LP", and together with SBIC II LP, the "SBIC Subsidiaries"), received licenses to operate as small business investment companies from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provides up to $175.0 million in long-term capital in the form of debentures guaranteed by the SBA. Our wholly owned subsidiary Saratoga Investment Corp. SBIC LP ("SBIC LP") repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital.

The Company has formed wholly owned special purpose entities organized as Delaware limited liability companies, Saratoga Investment Funding II LLC ("SIF II") and Saratoga Investment Funding III LLC ("SIF III") for the purpose of the Encina Credit Facility and the Live Oak Credit Facility (each as defined below), respectively. The senior secured revolving credit facility (the "Encina Credit Facility) with Encina Lender Finance, LLC ("Encina") is supported by loans held by SIF II and pledged to Encina, and the senior secured revolving credit facility (the "Live Oak Credit Facility") with Live Oak Banking Company ("Live Oak") is supported by loans held by SIF III and pledged to Live Oak.

On October 26, 2021, the Company and TJHA JV I LLC ("TJHA") entered into a Limited Liability Company Agreement to co-manage Saratoga Senior Loan Fund I JV LLC ("SLF JV"). SLF JV is under joint control and is not consolidated. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1 Ltd. ("SLF 2022"), which is a wholly owned subsidiary of SLF JV. SLF 2022 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets. On October 28, 2022, SLF 2022 issued $402.1 million of debt (the "2022 JV CLO Notes") through a collateralized loan obligation trust (the "JV CLO trust"). The 2022 JV CLO Notes were issued pursuant to an indenture, dated October 28, 2022 (the "JV Indenture"), with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) (the "Trustee") serving as the trustee.

**Note 2. Summary of Significant Accounting Policies**

**Basis of Presentation**

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles ("U.S. GAAP"), are stated in U.S. Dollars and include the accounts of the Company and its wholly owned special purpose financing subsidiaries, SIF II, SIF III, SBIC II LP, SBIC III LP, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc., SIA-PP, Inc., SIA-SIQ, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., and SIA-Vector, Inc. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the "Company," "we," and "us" herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

The Company, SIF II, SIF III, SBIC II LP, and SBIC III LP are all considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 946, *Financial Services — Investment Companies* ("ASC 946"). There have been no changes to the Company, SIF II, SIF III, SBIC II LP, or SBIC III LP's status as investment companies during the three months ended May 31, 2025.

**Principles of Consolidation**

Under the investment company rules and regulations pursuant to ASC 946, the Company is precluded from consolidating any entity other than another investment company or controlled operating company whose business consists of providing services to the Company. As a result, the consolidated financial statements of the Company include only the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, *Consolidation*, concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate its investment in SLF JV.

**Use of Estimates in the Preparation of Financial Statements**

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

**Operating Segment**

In accordance with ASC Topic 280, *Segment Reporting*, the Company operates through two separate operating segments, with one primary core business segment and one non-core segment, assessed as immaterial by management, resulting in only one reportable segment. The Company's primary core segment invests in various industries and separately evaluates the performance of each of its investment relationships. However, because each of these investment relationships have similar business and economic characteristics, they have been aggregated into a single reportable segment. The Company's management and independent Board of Directors are the Chief Operating Decision Makers ("CODM"). The Company and the CODM evaluate and monitor performance of the business on an aggregated basis. Further, each investment is evaluated and managed using similar processes and shared operations support functions such as deal origination, underwriting, loan and compliance administration in addition to administrative functions of human resources, legal, finance and information technology. As the Company's operations comprise of a single reporting segment, the segment assets are reflected in the accompanying consolidated statement of operations.

The CODM uses our consolidated net investment income and net increase (decrease) in net assets resulting from operations as reported in the Consolidated Statements of Operations to assess the Company's performance and when allocating resources. Net investment income is comprised of total investment income ('segment revenues'), and total expenses ('total segment expenses') and operating expenses ("segment operating expenses"), which are considered the key segment measures of profit or loss received by the CODM. The expense categories included in the Company's consolidated statement of operations are fully reflective of the significant expense categories and amounts that are regularly provided to the CODM. For the quarters ended May 31, 2025 and 2024, operating expenses totaled $2.9 million and $2.8 million, respectively.

**Cash and Cash Equivalents**

Cash and cash equivalents include short-term, liquid investments in a money market fund. The Company places its cash in financial institutions and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits. Cash and cash equivalents are carried at cost which approximates fair value. Pursuant to Section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another investment company, such as a money market fund, if such investment would cause the Company to:

● own more than 3.0% of the investment company's total outstanding voting stock;

● hold securities in the investment company having an aggregate value in excess of 5.0% of the value of the Company's total assets; or

● hold securities in investment companies having an aggregate value in excess of 10.0% of the value of the Company's total assets.

As of May 31, 2025, the Company did not exceed any of these limitations.

**Cash and Cash Equivalents, Reserve Accounts**

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds, and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits, representing payments received on secured investments or other reserved amounts associated with the Encina Credit Facility or the Live Oak Credit Facility held by the Company's wholly owned subsidiaries, SIF II and SIF III, respectively. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the Encina Credit Facility and the Live Oak Credit Facility.

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within the Company's wholly owned subsidiaries, SBIC II LP and SBIC III LP.

The statements of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents when reconciling the beginning-of-period and end-of-period total amounts.

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:

---

| | | |
|:---|:---|:---|
|  | **May 31,<br> 2025** | **February 28, <br> 2025** |
| Cash and cash equivalents | 131562513 | $148218491 |
| Cash and cash equivalents, reserve accounts | 92724212 | 56505433 |
| Total cash and cash equivalents and cash and cash equivalents, reserve accounts | $224286725 | $204723924 |

---

**Investment Classification**

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, "control investments" are defined as investments in companies in which the Company owns more than 25.0% of the voting securities or maintains greater than 50.0% of the board representation. Under the 1940 Act, "affiliated investments" are defined as those non-control investments in companies in which the Company owns between 5.0% and 25.0% of the voting securities. Under the 1940 Act, "non-affiliated investments" are defined as investments that are neither control investments nor affiliated investments.

**Investment Valuation**

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820, *Fair Value Measurement* ("ASC 820"). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the measurement date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by the Company's board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. The Company values investments for which market quotations are not readily available at fair value as approved, in good faith, by the Company's board of directors based on input from the Manager, the audit committee of the board of directors and a third-party independent valuation firm.

The Company undertakes a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

● each investment is initially valued by the responsible investment professionals of the Manager and preliminary valuation conclusions are documented, reviewed and discussed with our senior management; and

● an independent valuation firm engaged by the Company's board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. The Company uses a third-party independent valuation firm to value its investment in the subordinated notes of Saratoga Investment Corp. CLO 2013-1, Ltd. ("Saratoga CLO"), the Class F-2-R-3 Notes of the Saratoga CLO, and the Class E Notes of the SLF 2022 every quarter.

In addition, all investments are subject to the following valuation process:

● the audit committee of the Company's board of directors reviews and approves each preliminary valuation and the Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

● the Company's board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of the Manager, independent valuation firm (to the extent applicable) and the audit committee of the board of directors.

The Company uses multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of the Company's investments include the nature and realizable value of any collateral, the portfolio company's ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

The Company's investments in the subordinated notes of Saratoga CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022 are carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds, when available, as determined by the Manager and recommended to the Company's board of directors. Specifically, the Company uses Intex cash flows, or an appropriate substitute, to form the basis for the valuation of its investment in the subordinated notes of Saratoga CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine the valuation for our investment in Saratoga CLO.

The Company's equity investment in SLF JV is measured using the proportionate share of the net asset value ("NAV"), or equivalent, of SLF JV as a practical expedient for fair value, provided by ASC 820. The Company's unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

The Company's investments in CLO BB and CLO BBB debt have been valued using recent actual market trades or an independent pricing service. The valuation methodology of the independent pricing service includes incorporating data comprised of observable market transactions, executable bids, broker quotes from dealers with two sided markets, as well as transaction activity from comparable securities to those being valued. As the independent pricing service contemplates real-time market data and no unobservable inputs or significant judgment has been used by the Manager in the valuation of the Company's investments in CLO BB and CLO BBB debt, such positions are considered level II assets.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. The Company's NAV could be materially affected if the determinations regarding the fair value of its investments were materially higher or lower than the values that the Company ultimately realizes upon the disposal of such investments.

Rule 2a-5 under the 1940 Act ("Rule 2a-5") establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards of directors, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are "readily available" for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act ("Rule 31a-4") provides for certain recordkeeping requirements associated with fair value determinations. While the Company's board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, the Company has established policies and procedures in compliance with the applicable requirements of Rule 2a-5 and Rule 31a-4.

**Derivative Financial Instruments**

The Company accounts for derivative financial instruments in accordance with FASB ASC Topic 815, *Derivatives and Hedging* ("ASC 815"). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

**Investment Transactions and Income Recognition**

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments up to the earliest call date.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management's judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management's judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At May 31, 2025 our investments in two portfolio companies were on non-accrual status with a fair value of approximately $2.9 million, or 0.3% of the fair value of our portfolio. At February 28, 2025, our investments in two portfolio companies were on non-accrual status with a fair value of approximately $2.6 million, or 0.3% of the fair value of our portfolio.

Interest income on our investment in the subordinated note of Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, *Investments-Other, Beneficial Interests in Securitized Financial Assets*, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

**Payment-in-Kind Interest**

The Company may hold debt and preferred equity investments in its portfolio that contain a payment-in-kind ("PIK") interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company stops accruing PIK interest if it is expected that the issuer will not be able to pay all principal and interest when due. The Company restores to accrual status when past due principal and interest is paid and, in management's judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

**Dividend Income**

Dividend income is recorded in the consolidated statements of operations when earned.

**Structuring and Advisory Fee Income**

Structuring and advisory fee income represents various fee income earned and received for performing certain investment structuring and advisory activities during the closing of new investments.

**Other Income**

Other income includes prepayment income fees, and monitoring, administration, redemption and amendment fees and is recorded in the consolidated statements of operations when earned.

**Deferred Debt Financing Costs**

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight-line method over the life of the respective facility and debt securities. Financing costs incurred in connection with the SBA debentures of SBIC II LP and SBIC III LP are deferred and amortized using the straight-line method over the life of the debentures. Any discount or premium on the issuance of any debt is accreted and amortized using the effective interest method over the life of the respective debt security.

The Company presents deferred debt financing costs on the balance sheet as a contra-liability, which is a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.

**Realized Loss on Extinguishment of Debt**

Upon the repayment of debt obligations that are deemed to be extinguishments, the difference between the principal amount due at maturity adjusted for any unamortized debt issuance costs is recognized as a loss (i.e., the unamortized debt issuance costs are recognized as a loss upon extinguishment of the underlying debt obligation).

**Contingencies**

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management reasonably believes that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

**Income Taxes**

The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. By meeting these requirements, the Company generally will not be subject to U.S. federal income tax on ordinary income or capital gains timely distributed to stockholders. Therefore, no provision has been recorded for federal income taxes, except as related to the Corporate Blockers (as defined below) and long-term capital gains, when applicable.

In order to qualify as a RIC, among other requirements, the Company generally is required to timely distribute to its stockholders at least 90% of its "investment company taxable income", as defined by the Code, for each fiscal tax year. The Company will be subject to U.S. federal income tax imposed at corporate rates on its investment company taxable income and net capital gains that it does not timely distribute to shareholders. The Company will be subject to a non-deductible U.S. federal excise tax of 4% on undistributed income if it does not distribute at least (1) 98% of its net ordinary income in any calendar year, (2) 98.2% of its capital gain net income for each one-year period ending on October 31and (3) any net ordinary income and capital gain net income that it recognized for preceding years, but were not distributed during such year, and on which the Company paid no U.S federal income tax.

Depending on the level of investment company taxable income earned in a tax year and the amount of net capital gains recognized in such tax year, the Company may choose to carry forward investment company taxable income and net capital gains in excess of current year dividend distributions into the next tax year and pay U.S. federal income tax, and possibly the 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual investment company taxable income will be in excess of estimated current year dividend distributions for U.S. federal excise tax purposes, the Company accrues the U.S. federal excise tax, if any, on estimated excess taxable income as taxable income is earned. For the years ended February 28, 2025, February 29, 2024 and February 28, 2023, the excise tax accrual on estimated excess taxable income was $2.4 million, $1.8 million and $1.1 million, respectively.

In accordance with U.S. Treasury regulations and published guidance issued by the Internal Revenue Service ("IRS"), a publicly offered RIC may treat a distribution of its own stock as counting toward its RIC distribution requirements if each stockholder may elect to receive his, her, or its entire distribution in either cash or stock of the RIC. This published guidance indicates that the rule will apply where the aggregate amount of cash to be distributed to all stockholders is not at least 20% of the aggregate declared distribution. Under the published guidance, if too many stockholders elect to receive cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S. federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

The Company may utilize wholly owned holding companies that are treated as corporations for U.S. federal income tax purposes when making equity investments in portfolio companies taxed as pass-through entities to meet its source-of-income requirements as a RIC ("Corporate Blockers"). Corporate Blockers are consolidated in the Company's U.S. GAAP financial statements and may result in current and deferred U.S. federal and state income tax expense with respect to income derived from those investments. Such income, net of applicable income taxes, is not included in the Company's tax-basis net investment income until distributed by the Corporate Blocker, which may result in timing and character differences between the Company's U.S. GAAP and tax-basis net investment income and realized gains and losses. Income tax expense or benefit from Corporate Blockers related to net investment income are included in total operating expenses, while any expense or benefit related to federal or state income tax originated for capital gains and losses are included together with the applicable net realized or unrealized gain or loss line item. Deferred tax assets of the Corporate Blockers are reduced by a valuation allowance when, in the opinion of management, it is more likely than-not that some portion or all of the deferred tax assets will not be realized.

FASB ASC Topic 740, *Income Taxes* ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions deemed to meet a "more-likely-than-not" threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 28, 2025, February 29, 2024 and February 28, 2023 the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2022, 2023, 2024 and 2025 federal tax years for the Company remain subject to examination by the IRS. At May 31, 2025 and February 28, 2025, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

**Dividends**

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain some or all of our net capital gains for reinvestment.

We have adopted a dividend reinvestment plan ("DRIP") that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not "opted out" of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

**Capital Gains Incentive Fee**

The Company records an expense accrual on the consolidated statements of operations relating to the capital gains incentive fee payable to the Manager, as recorded on the consolidated statements of assets and liabilities when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments, as a capital gains incentive fee would be owed to the Manager if the Company were to liquidate its investment portfolio at such time.

The actual incentive fee payable to the Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and only reflect those realized capital gains net of realized and unrealized losses for the period.

**Recent Accounting Pronouncements** 

In December 2023, the FASB issued ASU 2023-09, *Improvements to Income Tax Disclosures*. The amendments in this update require more disaggregated information on income taxes paid. ASU 2023-09 is effective for years beginning after December 15, 2024. Early adoption is permitted, however the Company has not elected to early adopt this provision as of the date of the financial statements contained in this report. The Company is still assessing the impact of the new guidance.

In November 2024, the FASB issued ASU 2024-03, "Disaggregation of Income Statement Expenses," which requires additional disclosure of the nature of expenses included in the income statement in response to requests from investors for more information about an entity's expenses. The new standard requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. The new guidance is effective for annual periods beginning after December 15, 2027. The Company is currently evaluating the impact of the new standard on the Company's consolidated financial statements and related disclosures and does not believe it will have a material impact on its consolidated financial statements or its disclosures.

**Risk Management**

In the ordinary course of its business, the Company manages a variety of risks, including market and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment's carrying amount. The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

**Note 3. Investments**

As noted above, the Company values all investments in accordance with ASC 820. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between independent market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

● Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

● Level 2— Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. Such inputs may be quoted prices for similar assets or liabilities, quoted markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full character of the financial instrument, or inputs that are derived principally from, or corroborated by, observable market information. Investments that are generally included in this category include illiquid debt securities and less liquid, privately held or restricted equity securities, for which some level of recent trading activity has been observed.

● Level 3—Pricing inputs are unobservable for the investment and includes situations where there is little, if any, market activity for the investment. The inputs may be based on the Company's own assumptions about how market participants would price the asset or liability or may use Level 2 inputs, as adjusted, to reflect specific investment attributes relative to a broader market assumption. Even if observable market data for comparable performance or valuation measures (earnings multiples, discount rates, other financial/valuation ratios, etc.) are available, such investments are grouped as Level 3 if any significant data point that is not also market observable (private company earnings, cash flows, etc.) is used in the valuation technique. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company's ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2. *Summary of Significant Accounting Policies*). Consistent with our valuation policy, the Company evaluates the source of inputs, including any markets in which its investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of May 31, 2025 (dollars in thousands), according to the fair value hierarchy:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fair Value Measurements** | **Fair Value Measurements** | **Fair Value Measurements** | | |
|  | **Level 1** | **Level 2** | **Level 3** | **Valued Using<br> Net Asset**<br>**Value\*** |<br>**Total** |
| First lien term loans | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | $- | $841577 | $- | $841577 |
| Second lien term loans | - | - | 6600 | - | 6600 |
| Unsecured term loans | - | - | 16635 | - | 16635 |
| Structured finance securities | - | 13126 | 14264 | - | 27390 |
| Equity interests | - | - | 73032 | 3084 | 76116 |
| Total | $- | $13126 | $952108 | $3084 | $968318 |

---

\* The Company's equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy. The Company's unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

The following table presents fair value measurements of investments, by major class, as of February 28, 2025 (dollars in thousands), according to the fair value hierarchy:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fair Value Measurements** | **Fair Value Measurements** | **Fair Value Measurements** | | |
|  | **Level 1** | **Level 2** | **Level 3** | **Valued Using<br> Net Asset**<br>**Value\*** |<br>**Total** |
| First lien term loans | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | $867866 | $- | $867866 |
| Second lien term loans | - | - | 6388 | - | 6388 |
| Unsecured term loans | - | - | 16534 | - | 16534 |
| Structured finance securities | - | - | 14772 | - | 14772 |
| Equity interests | - | - | 69437 | 3081 | 72518 |
| Total | $- | $- | $974997 | $3081 | $978078 |

---

\* The Company's equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy. The Company's unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2025 (dollars in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **First lien<br> term loans** | **Second lien<br> term loans** | **Unsecured<br> term loans** | **Structured<br> finance<br> securities** | **Equity<br> interests** | **Total** |
| Balance as of February 28, 2025 | $867866 | $6388 | $16534 | $14772 | $69437 | $974997 |
| Payment-in-kind and other adjustments to cost | 455 | 267 | - | (205) |  | 517 |
| Net accretion of discount on investments | 854 | 5 | - | - | - | 859 |
| Net change in unrealized appreciation (depreciation) on investments | 367 | (60) | 101 | (303) | 643 | 748 |
| Purchases | 33796 | - | - | - | 3356 | 37152 |
| Sales and repayments | (61761) | - | - | - | (3305) | (65066) |
| Net realized gain (loss) from investments | - | - | - | - | 2901 | 2901 |
| Balance as of May 31, 2025 | $841577 | $6600 | $16635 | $14264 | $73032 | $952108 |
| Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period | $850 | $(60) | $102 | $(110) | $1750 | $2532 |

---

Purchases, PIK and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK interests.

Sales and repayments represent net proceeds received from investments sold and principal paydowns received during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2, or 3 during the three months ended May 31, 2025.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2024 (dollars in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **First lien<br> term loans** | **Second lien<br> term loans** | **Unsecured<br> term loans** | **Structured<br> finance<br> securities** | **Equity<br> interests** | **Total** |
| Balance as of February 29, 2024 | $976423 | $18097 | $15818 | $30626 | $88426 | $1129390 |
| Payment-in-kind and other adjustments to cost | 1565 | 232 | - | (2180) | - | (383) |
| Net accretion of discount on investments | 811 | 3 | - | - | - | 814 |
| Net change in unrealized appreciation (depreciation) on investments | 15575 | 55 | - | (4392) | 3296 | 14534 |
| Purchases | 38975 | - | - | - | 325 | 39300 |
| Sales and repayments | (73442) | - | - | - | (2261) | (75703) |
| Net realized gain (loss) from investments | (14862) | - | - | - | (6333) | (21195) |
| Balance as of May 31, 2024 | $945045 | $18387 | $15818 | $24054 | $83453 | $1086757 |
| Net change in unrealized appreciation (depreciation) for the year relating to those Level 3 assets that were still held by the Company at the end of the period | $14874 | $55 | $- | $(4392) | $(540) | $9997 |

---

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2, or 3 during the three months ended May 31, 2024.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of May 31, 2025 were as follows (dollars in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fair Value** | **Valuation Technique** | **Unobservable Input** | **Range** | **Weighted Average\*** |
| First lien term loans | $841577 | Market Comparables | Market Yield (%) | 6.4% - 39.2% | 13.3% |
|  |  |  | Revenue Multiples (x) | 3.0x - 5.4x | 4.5x |
| Second lien term loans | 6600 | Market Comparables | Market Yield (%) | 20.2% | 20.2% |
| Unsecured term loans | 16635 | Discounted Cash Flow | Discount Rate (%) | 10.0% | 10.0% |
| Structured finance securities | 14264 | Discounted Cash Flow | Discount Rate (%) | 8.0% - 70.0% | 14.0% |
|  |  |  | Recovery Rate (%) | 70.00% | 70.0% |
|  |  |  | Prepayment Rate (%) | 20.0% | 20.0% |
| Equity interests | 73032 | Enterprise Value Waterfall | Revenue Multiples (x) | 0.1x - 8.5x | 6.3x |
|  |  |  | EBITDA Multiples (x) | 5.0x - 18.6x | 8.3x |
| Total | $952108 |  |  |  |  |

---

\* The weighted average in the table above is calculated based on each investment's fair value weighting, using the applicable unobservable input.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2025 were as follows (dollars in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Fair Value** | **Valuation Technique** | **Unobservable Input** | **Range** | **Weighted Average\*** |
| First lien term loans | $867866 | Market Comparables | Market Yield (%) | 9.8% - 22.0% | 12.4% |
|  |  |  | Revenue Multiples (x) | 2.5x | 2.5x |
|  |  |  | EBITDA Multiples (x) | 6.8x | 6.8x |
| Second lien term loans | 6388 | Market Comparables | Market Yield (%) | 19.7% | 19.7% |
| Unsecured term loans | 16534 | Discounted Cash Flow | Discount Rate (%) | 10.0% | 10.0% |
| Structured finance securities | 14772 | Discounted Cash Flow | Discount Rate (%) | 8.0% - 70.0% | 14.1% |
|  |  |  | Recovery Rate (%) | 70.0% | 70.0% |
|  |  |  | Prepayment Rate (%) | 20.0% | 20.0% |
| Equity interests | 69437 | Enterprise Value Waterfall | EBITDA Multiples (x) | 1.1x - 13.9x | 8.2x |
|  |  |  | Revenue Multiples (x) | 0.1x - 9.0x | 6.3x |
| Total | $974997 |  |  |  |  |

---

\* The weighted average in the table above is calculated based on each investment's fair value weighting, using the applicable unobservable input.

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the earnings before interest, tax, depreciation and amortization ("EBITDA") or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, and prepayment rate, in isolation, would result in a significantly lower (higher) fair value measurement while a significant increase (decrease) in recovery rate, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a market quote, third party bid or net asset value in deriving a value, a significant increase (decrease) in the market quote, bid or net asset value in isolation, would result in a significantly higher (lower) fair value measurement.

The composition of our investments as of May 31, 2025 at amortized cost and fair value was as follows (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Investments at<br> Amortized Cost** | **Amortized Cost<br> Percentage of Total<br> Portfolio** | **Investments at<br> Fair Value** | **Fair Value<br> Percentage of Total<br> Portfolio** |
| First lien term loans | $846686 | 85.6% | $841577 | 86.9% |
| Second lien term loans | 7366 | 0.7 | 6600 | 0.7 |
| Unsecured term loans | 17619 | 1.8 | 16635 | 1.7 |
| Structured finance securities | 48386 | 4.9 | 27390 | 2.8 |
| Equity interests | 69333 | 7.0 | 76116 | 7.9 |
| Total | $989390 | 100.0% | $968318 | 100.0% |

---

The composition of our investments as of February 28, 2025 at amortized cost and fair value was as follows (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Investments at<br> Amortized Cost** | **Amortized Cost<br> Percentage of Total<br> Portfolio** | **Investments at<br> Fair Value** | **Fair Value<br> Percentage of Total<br> Portfolio** |
| First lien term loans | $873342 | 87.3% | $867866 | 88.7% |
| Second lien term loans | 7094 | 0.7 | 6388 | 0.7 |
| Unsecured term loans | 17619 | 1.8 | 16534 | 1.7 |
| Structured finance securities | 35657 | 3.6 | 14772 | 1.5 |
| Equity interests | 66381 | 6.6 | 72518 | 7.4 |
| Total | $1000093 | 100.0% | $978078 | 100.0% |

---

For loans and debt securities for which market quotations are not readily available, the Company determines their fair value based on third party indicative broker quotes, where available, or the inputs that a hypothetical market participant would use to value the security in a current hypothetical sale using a market comparables valuation technique. In applying the market comparables valuation technique, the Company determines the fair value based on such factors as market participant inputs including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in the Company's judgment, the market comparables technique is not sufficient or appropriate, the Company may use additional techniques such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, the Company determines the fair value using an enterprise value waterfall valuation technique. Under the enterprise value waterfall valuation technique, the Company determines the enterprise fair value of the portfolio company and then waterfalls the enterprise value over the portfolio company's securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, the Company weighs some or all of the traditional market valuation techniques and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The techniques for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, the Company may estimate the liquidation or collateral value of the portfolio company's assets and liabilities. The Company also takes into account historical and anticipated financial results.

For CLO BB and CLO BBB debt, the Company determines the fair value by using recent actual market trades or an independent pricing service. The valuation methodology of the independent pricing service includes incorporating data comprised of observable market transactions, executable bids, broker quotes from dealers with two sided markets, as well as transaction activity from comparable securities to those being valued.

The Company's investments in Saratoga CLO and SLF 2022 are carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO and SLF 2022, when available, as determined by the Manager and recommended to the Company's board of directors. Specifically, the Company uses Intex cash flows, or an appropriate substitute, to form the basis for the valuation of the investment in Saratoga CLO and SLF 2022. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company ran Intex models based on inputs about the refinanced Saratoga CLO's structure and the SLF 2022 structure, including capital structure, cost of liabilities and reinvestment period. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investments in Saratoga CLO and SLF 2022 at May 31, 2025. The inputs at May 31, 2025 for the valuation model include:

● Default rate: 2.0%

● Recovery rate: 70%

● Discount rate: 8.0%–70.0%

● Prepayment rate: 20.0%

● Reinvestment rate / price: S+365bps / $99.00

The Company's equity investment in SLF JV is measured using the proportionate share of the NAV of SLF JV, or equivalent, as practical expedient.

**Investment Concentration**

Set forth is a brief description of each portfolio company in which the fair value of the Company's investment represents greater than 5% of the Company's total assets as of May 31, 2025, excluding Saratoga CLO, SLF JV and SLF 2022 (see Note 4. *Investment in Saratoga CLO* and Note 5. *Investment in SLF JV* for more information on Saratoga CLO, SLF JV and SLF 2022, respectively).

*Artemis Wax Corp.*

Artemis Wax Corporation is a U.S. based retail aggregator of European Wax Center ("EWC") franchise locations with a concentration in the northeast. Founded in 2004, EWC is the largest U.S. body waxing national chain with more than 800 locations across the country.

**Note 4. Investment in Saratoga CLO**

On January 22, 2008, the Company entered into a collateral management agreement with Saratoga CLO, pursuant to which the Company acts as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 and November 2016 with its reinvestment period extended to October 2016 and October 2018, respectively.

On December 14, 2018, the Company completed a third refinancing and upsize of the Saratoga CLO (the "2013-1 Reset CLO Notes"). The third Saratoga CLO refinancing, which, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030, and added a non-call period of January 2020. Following this refinancing, the Saratoga CLO portfolio increased its aggregate principal amount from approximately $300.0 million to approximately $500.0 million of predominantly senior secured first lien term loans.

On February 11, 2020, the Company entered into an unsecured loan agreement ("CLO 2013-1 Warehouse 2 Loan") with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. ("CLO 2013-1 Warehouse 2"), a wholly owned subsidiary of Saratoga CLO, which was fully repaid. During the fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd. was repaid in full.

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, which, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently with the fourth refinancing of the Saratoga CLO, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.

On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Note for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

On June 10, 2024, the Company completed its fifth refinancing of the Saratoga CLO, which adjusted the interest rate of two of the existing Notes. Saratoga CLO issued $422.5 million notes (the "2013-1 2024 Reset CLO Notes"), consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the indenture with the same trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $0.5 million of transaction costs related to the refinancing.

The Saratoga CLO remains effectively 100% owned and managed by the Company. The Company receives a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO's assets, paid quarterly to the extent of available proceeds. Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

For the three months ended May 31, 2025 and May 31, 2024, the Company accrued management fee income of $0.7 million and $0.8 million, respectively, and interest income of $0.0 million and $0.0 million, respectively, from the subordinated notes of Saratoga CLO.

As of May 31, 2025, the aggregate principal amounts of the Company's investments in the subordinated notes and Class F-2-R-3 Notes of the Saratoga CLO was $111.0 million and $9.4 million, respectively, which had a corresponding fair value of $0.2 million and $1.9 million, respectively. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. As of May 31, 2025, Saratoga CLO had investments with a principal balance of $504.6 million and a weighted average spread over SOFR of 3.6% and had debt with a principal balance of $498.8 million with a weighted average spread over SOFR of 2.3%. As a result, Saratoga CLO earns a "spread" between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. As of May 31, 2025, the present value of the projected future cash flows of the subordinated notes was approximately $0.2 million, using a 70.0% discount rate. The Company's total investment in the subordinate notes of Saratoga CLO is $57.8 million, which consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021; to date, the Company has received distributions of $91.9 million, management fees of $36.0 million and incentive fees of $1.2 million.

As of February 28, 2025, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $0.2 million. As of February 28, 2025, the fair value of its investment in the Class F-R-3 Notes of Saratoga CLO was $2.3 million. As of February 28, 2025, Saratoga CLO had investments with a principal balance of $527.1 million and a weighted average spread over SOFR of 3.7% and had debt with a principal balance of $524.2 million with a weighted average spread over SOFR of 2.3%. As of February 28, 2025, the present value of the projected future cash flows of the subordinated notes, was approximately $0.2 million, using a 40% discount rate. The Company's total investment in the subordinate notes of Saratoga CLO is $57.8 which consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021. To date the Company has since received distributions of $91.7 million, management fees of $38.3 million and incentive fees of $1.2 million.

Below is certain financial information from the separate financial statements of Saratoga CLO as of May 31, 2025 (unaudited) and February 28, 2025 and for the three months ended May 31, 2025 (unaudited) and May 31, 2024 (unaudited).

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Statement of Assets and Liabilities**

---

| | | |
|:---|:---|:---|
|  | **May 31, <br> 2025** | **February 28, <br> 2025** |
|  | **(unaudited)** | |
| ASSETS |  |  |
| Investments at fair value |  |  |
| &nbsp;&nbsp;&nbsp;Loans at fair value (amortized cost of $495,437,321 and $517,757,349, respectively) | $462635127 | $490510660 |
| &nbsp;&nbsp;&nbsp;Equities at fair value (amortized cost of $2,846,566 and $2,578,454, respectively) | 2485637 | 1684429 |
| Total investments at fair value (amortized cost of $498,283,887 and $520,335,803, respectively) | 465120764 | 492195089 |
| Cash and cash equivalents | 17490859 | 21272327 |
| Receivable from open trades | 1060286 | 1138899 |
| Interest receivable (net of reserve of $1,150,673 and $1,121,546, respectively) | 2495034 | 2380214 |
| Due from affiliate (See Note 7) | 86333 | 801 |
| Prepaid expenses and other assets | 108321 | 101453 |
| &nbsp;&nbsp;&nbsp;Total assets | $486361597 | $517088783 |
| LIABILITIES |  |  |
| Interest payable | $3753075 | $3739343 |
| Accrued base management fee | 64898 | 62839 |
| Accrued subordinated management fee | 229409 | 251354 |
| Accounts payable and accrued expenses | 258762 | 143135 |
| Saratoga Investment Corp. CLO 2013-1, Ltd. Notes: |  |  |
| &nbsp;&nbsp;&nbsp;Class A-1-R-4 Senior Secured Floating Rate Notes | 245263754 | 270719300 |
| &nbsp;&nbsp;&nbsp;Class A-2-R-4 Senior Secured Floating Rate Notes | 65000000 | 65000000 |
| &nbsp;&nbsp;&nbsp;Class B-FL-R-3 Senior Secured Floating Rate Notes | 60500000 | 60500000 |
| &nbsp;&nbsp;&nbsp;Class B-FXD-R-3 Senior Secured Fixed Rate Notes | 11000000 | 11000000 |
| &nbsp;&nbsp;&nbsp;Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes | 26000000 | 26000000 |
| &nbsp;&nbsp;&nbsp;Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes | 6500000 | 6500000 |
| &nbsp;&nbsp;&nbsp;Class D-R-3 Deferrable Mezzanine Floating Rate Notes | 39000000 | 39000000 |
| &nbsp;&nbsp;&nbsp;Discount on Class D-R-3 Notes | (189967) | (196033) |
| &nbsp;&nbsp;&nbsp;Class E-R-3 Deferrable Mezzanine Floating Rate Notes | 27625000 | 27625000 |
| &nbsp;&nbsp;&nbsp;Discount on Class E-R-3 Notes | (1973543) | (2036565) |
| &nbsp;&nbsp;&nbsp;Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes | 8500000 | 8500000 |
| &nbsp;&nbsp;&nbsp;Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes | 9375000 | 9375000 |
| &nbsp;&nbsp;&nbsp;Deferred debt financing costs | (1191959) | (1229456) |
| &nbsp;&nbsp;&nbsp;Subordinated Notes | 111000000 | 111000000 |
| &nbsp;&nbsp;&nbsp;Discount on Subordinated Notes | (31213700) | (32210459) |
| &nbsp;&nbsp;&nbsp;Total liabilities | 579500729 | 603743458 |
| Commitments and contingencies |  |  |
| NET ASSETS |  |  |
| Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 common shares issued and outstanding, respectively | 250 | 250 |
| Total distributable earnings (loss) | (93139382) | (86654925) |
| &nbsp;&nbsp;&nbsp;Total net deficit | (93139132) | (86654675) |
| &nbsp;&nbsp;&nbsp;Total liabilities and net assets | $486361597 | $517088783 |

---

See accompanying notes to financial statements

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Statements of Operations**

**(unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31, <br> 2025** | **May 31, <br> 2024** |
| INVESTMENT INCOME |  |  |
| Total interest from investments | $11413857 | $16074172 |
| Interest from cash and cash equivalents | 208109 | 233498 |
| Other income | 5859 | 634769 |
| &nbsp;&nbsp;&nbsp;Total investment income | 11627825 | 16942439 |
| EXPENSES |  |  |
| Interest and debt financing expenses | 9944361 | 15186421 |
| Base management fee | 147072 | 160891 |
| Subordinated management fee | 558103 | 643564 |
| Professional fees | 188125 | 58805 |
| Trustee expenses | 48860 | 62205 |
| Other expense | 136476 | 105538 |
| &nbsp;&nbsp;&nbsp;Total expenses | 11022997 | 16217424 |
| NET INVESTMENT INCOME (LOSS) | 604828 | 725015 |
| REALIZED AND UNREALIZED LOSS ON INVESTMENTS |  |  |
| Net realized loss from investments | (2066876) | (4398529) |
| Net change in unrealized depreciation on investments | (5022409) | 2942951 |
| Net realized and unrealized gain (loss) on investments | (7089285) | (1455578) |
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $(6484457) | $(730563) |

---

See accompanying notes to financial statements.

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset Type** | **Reference Rate/Spread** | **Reference Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair Value** |
| ALTISOURCE PORTFOLIO SOL | Banking, Finance, Insurance & Real Estate | Common Stock | Equity |  |  |  |  |  | 37028 | $216246 | $208099 |
| Altisource Portfolio Solutions - CS Warrant | Banking, Finance, Insurance & Real Estate | Warrants | Equity |  |  |  |  |  | 7917 | 3736 | 4996 |
| Altisource Portfolio Solutions - NS Warrant | Banking, Finance, Insurance & Real Estate | Warrants | Equity |  |  |  |  |  | 7917 | 3129 | 4258 |
| Endo Finance Holdings, Inc. | Healthcare & Pharmaceuticals | Common Stock | Equity |  |  |  |  |  | 23799 | 670107 | 507108 |
| Envision Parent Inc | Healthcare & Pharmaceuticals | Common Stock | Equity |  |  |  |  |  | 4410 | 175000 | 63945 |
| Envision Parent Inc | Healthcare & Pharmaceuticals | Warrants | Equity |  |  |  |  |  | 92837 |  | 4642 |
| Instant Brands Litigation Trust | Consumer goods: Durable | Equity Interests | Equity |  |  |  |  |  | 43556 | 36281 | 501034 |
| Isagenix International, LLC | Beverage, Food & Tobacco | Common Stock | Equity |  |  |  |  |  | 86398 |  |  |
| Resolute Investment Managers (American Beacon), Inc. | Banking, Finance, Insurance & Real Estate | Common Stock | Equity |  |  |  |  |  | 24320 | 1034581 | 510720 |
| Wellpath Recovery Solutions | Healthcare & Pharmaceuticals | Common Stock | Equity |  |  |  |  |  | 41758 | 501091 | 501091 |
| Wellpath Correct Care | Healthcare & Pharmaceuticals | Common Stock | Equity |  |  |  |  |  | 19309 |  |  |
| Wellpath Correct Care | Healthcare & Pharmaceuticals | Preferred Stock | Equity |  |  |  |  |  | 18608 | 242677 | 223301 |
| 1011778 B.C Unltd Liability Co | Beverage, Food & Tobacco | Term Loan B6 | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 9/20/2030 | $1433052 | 1416700 | 1426603 |
| 19TH HOLDINGS GOLF, LLC | Consumer goods: Durable | Term Loan | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.68% | 2/7/2029 | 2442255 | 2372917 | 2365934 |
| 888 Acquisitions Limited | Hotel, Gaming & Leisure | Term Loan B | Loan | 3M USD SOFR+ | 5.25% | 0.00% | 9.63% | 7/8/2028 | 3028929 | 2805280 | 2871818 |
| Adtalem Global Education Inc. | Services: Business | Term Loan B (08/24) | Loan | 1M USD SOFR+ | 2.75% | 0.75% | 7.08% | 8/12/2028 | 352462 | 350781 | 352684 |
| Aegis Sciences Corporation | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 5.50% | 1.00% | 10.06% | 5/9/2025 | 2256832 | 2256832 | 1015574 |
| Agiliti Health Inc. | Healthcare & Pharmaceuticals | Term Loan B (03/23) | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.30% | 5/1/2030 | 2148693 | 2136131 | 2082448 |
| AHEAD DB Holdings, LLC | Services: Business | Term Loan B3 (07/24) | Loan | 3M USD SOFR+ | 3.00% | 0.75% | 7.30% | 2/1/2031 | 2888380 | 2833712 | 2888784 |
| Air Canada | Transportation: Consumer | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.32% | 3/21/2031 | 990000 | 988078 | 990495 |
| AIT Worldwide Logistics Holdings, Inc. | Transportation: Cargo | Term Loan B (01/25) | Loan | 3M USD SOFR+ | 4.00% | 0.75% | 8.26% | 4/8/2030 | 2449557 | 2340557 | 2437922 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| AlixPartners, LLP | Banking, Finance, Insurance & Real Estate | Term Loan B (01/21) | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.94% | 2/4/2028 | 239999 | 239973 | 240210 |
| Allen Media, LLC | Media: Diversified & Production | Term Loan (7/21) | Loan | 3M USD SOFR+ | 5.50% | 0.00% | 9.95% | 2/10/2027 | 4292579 | 4282023 | 2639936 |
| Alliant Holdings Intermediate, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B6 (09/24) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.07% | 9/19/2031 | 795024 | 795024 | 791422 |
| Allied Universal Holdco LLC | Services: Business | Term Loan 4/21 | Loan | 1M USD SOFR+ | 3.75% | 0.50% | 8.18% | 5/12/2028 | 1930000 | 1926130 | 1931814 |
| Alterra Mountain Company (Intrawest Resort Holdings) | Hotel, Gaming & Leisure | First Lien Term Loan | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 5/31/2030 | 248752 | 248752 | 249063 |
| Altisource Solutions S.a r.l. | Banking, Finance, Insurance & Real Estate | Term Loan (Specified) B | Loan | 3M USD SOFR+ | 6.50% | 3.50% | 10.90% | 2/20/2029 | 500000 | 488274 | 500000 |
| Altium Packaging LLC | Containers, Packaging & Glass | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.83% | 6/11/2031 | 481363 | 480399 | 474946 |
| American Axle & Manufacturing Inc. | Automotive | Term Loan (12/22) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.33% | 12/13/2029 | 480000 | 469796 | 475200 |
| American Greetings Corporation | Media: Advertising, Printing & Publishing | Term Loan B (04/24) | Loan | 1M USD SOFR+ | 5.75% | 0.00% | 10.08% | 10/30/2029 | 2908164 | 2907204 | 2902348 |
| American Trailer World Corp | Automotive | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.18% | 3/3/2028 | 1357439 | 1357373 | 1114607 |
| Anastasia Parent LLC | Consumer goods: Non-durable | Term Loan | Loan | 3M USD SOFR+ | 3.75% | 0.00% | 8.31% | 8/11/2025 | 935000 | 934940 | 775274 |
| Anchor Packaging, LLC | Containers, Packaging & Glass | Term Loan (12/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.58% | 7/18/2029 | 1939511 | 1924334 | 1945330 |
| AP Core Holdings II LLC | High Tech Industries | Term Loan B1 | Loan | 1M USD SOFR+ | 5.50% | 0.75% | 9.94% | 9/1/2027 | 1649944 | 1639441 | 1489768 |
| AP Core Holdings II LLC | High Tech Industries | Term Loan B2 | Loan | 1M USD SOFR+ | 5.50% | 0.75% | 9.94% | 9/1/2027 | 500000 | 496822 | 450000 |
| APEX GROUP TREASURY LLC | Banking, Finance, Insurance & Real Estate | Term Loan (2/25) | Loan | 3M USD SOFR+ | 3.50% | 0.00% | 7.83% | 2/27/2032 | 490038 | 469431 | 489018 |
| Apollo Commercial Real Estate Finance, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.19% | 5/15/2026 | 2870558 | 2862296 | 2849029 |
| Apollo Commercial Real Estate Finance, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B1 (2/21) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.94% | 3/6/2028 | 960000 | 955700 | 952800 |
| Aramark Services, Inc. | Services: Consumer | Term Loan B7 (03/24) | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.33% | 4/6/2028 | 1753715 | 1750340 | 1755907 |
| Aramark Services, Inc. | Services: Consumer | Term Loan B8 (03/24) | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.33% | 6/22/2030 | 2272969 | 2248915 | 2273446 |
| ARC FALCON I INC. | Chemicals, Plastics, & Rubber | Term Loan | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.92% | 9/23/2028 | 968774 | 967467 | 968319 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| ARCIS GOLF LLC | Services: Consumer | Term Loan B (01/25) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.08% | 11/24/2028 | 493000 | 489645 | 491462 |
| Aretec Group, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.50% | 0.00% | 7.83% | 8/9/2030 | 2616340 | 2604026 | 2611579 |
| Ascensus Group Holdings, Inc | Banking, Finance, Insurance & Real Estate | Term Loan | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 8/2/2028 | 493458 | 490772 | 491342 |
| Aspire Bakeries Holdings, LLC | Beverage, Food & Tobacco | Term loan | Loan | 1M USD SOFR+ | 4.25% | 0.00% | 8.58% | 12/23/2030 | 891000 | 883903 | 891740 |
| Assuredpartners Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B5 (02/24) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.83% | 2/14/2031 | 1287000 | 1286060 | 1288673 |
| Asurion, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B10 | Loan | 1M USD SOFR+ | 4.00% | 0.00% | 8.43% | 8/19/2028 | 1950000 | 1890600 | 1938632 |
| Asurion, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B12 | Loan | 1M USD SOFR+ | 4.25% | 0.00% | 8.58% | 9/19/2030 | 2904880 | 2902007 | 2869034 |
| ATHENAHEALTH GROUP INC. | Healthcare & Pharmaceuticals | Term Loan B (2/22) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.33% | 2/15/2029 | 1303799 | 1301116 | 1297515 |
| Avolon TLB Borrower 1 (US) LLC | Capital Equipment | Term Loan B6 | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 6/22/2030 | 1468940 | 1429604 | 1468514 |
| Axalta Coating Systems US Holdings | Chemicals, Plastics, & Rubber | Term Loan B (11/24) | Loan | 3M USD SOFR+ | 1.75% | 0.50% | 6.05% | 12/20/2029 | 848920 | 843161 | 850338 |
| B&G Foods, Inc. | Beverage, Food & Tobacco | Term Loan B | Loan | 1M USD SOFR+ | 3.50% | 0.00% | 7.83% | 10/10/2029 | 530953 | 529509 | 485822 |
| Baldwin Insurance Group Holdings, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B-1 (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 5/27/2031 | 1636178 | 1626904 | 1636865 |
| Belfor Holdings Inc. | Services: Consumer | Term Loan 4/23 | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.33% | 11/1/2030 | 1458445 | 1446966 | 1457541 |
| Bengal Debt Merger Sub LLC | Beverage, Food & Tobacco | Second Out Term Loan | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.56% | 1/24/2029 | 1167000 | 714962 | 826901 |
| Bengal Debt Merger Sub LLC | Beverage, Food & Tobacco | Third Out Term Loan | Loan | 3M USD SOFR+ | 6.00% | 0.50% | 10.31% | 1/24/2030 | 389000 | 134283 | 136150 |
| Blackstone Mortgage Trust, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.69% | 4/23/2026 | 342601 | 342129 | 341745 |
| Bombardier Recreational Products, Inc. | Consumer goods: Durable | Term Loan | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.08% | 1/22/2031 | 1422142 | 1419348 | 1407693 |
| Bombardier Recreational Products, Inc. | Consumer goods: Durable | Term Loan B3 | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.08% | 12/13/2029 | 487566 | 478922 | 485840 |
| Boost Newco Borrower, LLC (Worldpay) | Banking, Finance, Insurance & Real Estate | Term Loan B (01/25) | Loan | 3M USD SOFR+ | 2.00% | 0.00% | 6.30% | 1/31/2031 | 498750 | 496749 | 499064 |
| Boxer Parent Company, Inc. | High Tech Industries | Term Loan | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.33% | 7/30/2031 | 1007194 | 1003310 | 999478 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| BroadStreet Partners, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B-4 | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 6/16/2031 | 2889052 | 2887470 | 2891132 |
| Brookfield WEC Holdings Inc. | Energy: Electricity | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 1/27/2031 | 1436831 | 1436831 | 1433454 |
| BROWN GROUP HOLDING, LLC | Aerospace & Defense | Term Loan B-2 | Loan | 3M USD SOFR+ | 2.50% | 0.00% | 6.78% | 7/1/2031 | 490053 | 480899 | 488284 |
| Buckeye Partners, L.P. | Utilities: Oil & Gas | Term Loan B (01/25) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 11/22/2030 | 663337 | 661550 | 663039 |
| Buckeye Partners, L.P. | Utilities: Oil & Gas | Term Loan B5 (09/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 11/2/2026 | 480759 | 479940 | 480869 |
| BW Gas & Convenience Holdings LLC | Beverage, Food & Tobacco | Term Loan B | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.94% | 3/31/2028 | 2406250 | 2395539 | 2388203 |
| Callaway Golf Company | Retail | Term Loan B | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 3/16/2030 | 470000 | 466490 | 458133 |
| Calpine Corporation | Utilities: Electric | Term Loan B10 (01/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 1/31/2031 | 1990000 | 1981864 | 1986876 |
| Camping World, Inc. | Retail | Term Loan B (5/21) | Loan | 1M USD SOFR+ | 2.50% | 0.75% | 6.94% | 6/5/2028 | 2430380 | 2294352 | 2324707 |
| CAPSTONE BORROWER INC | Services: Business | Term Loan B | Loan | 3M USD SOFR+ | 2.75% | 0.00% | 7.05% | 6/17/2030 | 870487 | 860448 | 870052 |
| CareerBuilder, LLC (c) | Services: Business | Term Loan B3 | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.94% | 7/31/2026 | 4133751 | 4124925 | 165350 |
| Castle US Holding Corporation | Media: Advertising, Printing & Publishing | Term Loan B (USD) | Loan | 3M USD SOFR+ | 3.75% | 0.00% | 8.32% | 1/27/2027 | 1925708 | 1922410 | 1268560 |
| Castle US Holding Corporation | Media: Advertising, Printing & Publishing | Term Loan (4/25) | Loan | 3M USD SOFR+ | 5.00% | 2.00% | 9.33% | 4/29/2030 | 219360 | 213064 | 217989 |
| CBL & Associates Limited Partnership | Retail | Term Loan 11/21 | Loan | 1M USD SOFR+ | 2.75% | 1.00% | 7.19% | 11/1/2025 | 2063753 | 1995539 | 1916711 |
| CCC Intelligent Solutions Inc. | Services: Business | Term Loan B | Loan | 1M USD SOFR+ | 2.00% | 0.50% | 6.33% | 1/23/2032 | 241894 | 241729 | 241894 |
| CCRR Parent, Inc. | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 4.25% | 0.50% | 8.66% | 3/6/2028 | 977500 | 948617 | 429123 |
| CCRR Parent, Inc. | Healthcare & Pharmaceuticals | Term Loan B | Loan | 3M USD SOFR+ | 4.25% | 0.75% | 8.84% | 3/6/2028 | 960000 | 958242 | 428803 |
| CDK GLOBAL, INC. | High Tech Industries | Term Loan B (05/24) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.55% | 7/6/2029 | 987538 | 967621 | 877318 |
| CENTURI GROUP, INC. | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.94% | 8/28/2028 | 616921 | 613914 | 617181 |
| Charlotte Buyer, Inc. | Services: Business | Term Loan B (01/25) | Loan | 1M USD SOFR+ | 4.25% | 0.50% | 8.58% | 2/11/2028 | 1470122 | 1412229 | 1468549 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Chemours Company, (The) | Chemicals, Plastics, & Rubber | Term Loan B3 (08/23) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.33% | 8/18/2028 | 2363720 | 2335631 | 2318408 |
| Churchill Downs Incorporated | Hotel, Gaming & Leisure | Term Loan B1 (3/21) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 3/17/2028 | 480000 | 479679 | 480000 |
| CIMPRESS PUBLIC LIMITED COMPANY | Media: Advertising, Printing & Publishing | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.83% | 5/17/2028 | 1935324 | 1884301 | 1915971 |
| CITADEL SECURITIES LP | Banking, Finance, Insurance & Real Estate | Term Loan (10/24) | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.33% | 10/31/2031 | 4814822 | 4814822 | 4829267 |
| Citco Funding LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (06/24) | Loan | 6M USD SOFR+ | 2.75% | 0.50% | 6.93% | 4/27/2028 | 985050 | 982126 | 987719 |
| Clarios Global LP | Automotive | Term Loan B (07/24) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.83% | 5/6/2030 | 1194008 | 1189857 | 1186246 |
| CLYDESDALE ACQUISITION HOLDINGS, INC. | Containers, Packaging & Glass | Term Loan B | Loan | 1M USD SOFR+ | 3.18% | 0.50% | 7.50% | 4/13/2029 | 1220000 | 1200923 | 1214315 |
| Columbus McKinnon Corporation | Capital Equipment | Term Loan (03/24) | Loan | 3M USD SOFR+ | 2.50% | 0.50% | 6.80% | 5/14/2028 | 357877 | 357541 | 356535 |
| Connect Finco SARL | Telecommunications | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 4.50% | 0.50% | 8.83% | 9/27/2029 | 2858625 | 2797410 | 2603150 |
| Corelogic, Inc. | Services: Business | Term Loan (4/21) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.94% | 6/2/2028 | 2412500 | 2407700 | 2375709 |
| Cortes NP Acquisition Corp (Vertiv) | Capital Equipment | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 3/2/2027 | 1915971 | 1915971 | 1913518 |
| Creative Artists Agency, LLC | Media: Diversified & Production | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.08% | 10/1/2031 | 1572154 | 1564361 | 1571179 |
| CROCS INC | Consumer goods: Durable | Term Loan B (01/24) | Loan | 3M USD SOFR+ | 2.25% | 0.50% | 6.55% | 2/19/2029 | 750000 | 731565 | 752190 |
| Cross Financial Corp | Banking, Finance, Insurance & Real Estate | Term Loan B2 (10/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.58% | 10/24/2031 | 483850 | 482849 | 486874 |
| Crown Subsea Communications Holding, Inc. | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 4.00% | 0.75% | 8.32% | 1/30/2031 | 2382000 | 2362687 | 2390194 |
| Dave & Buster's Inc. | Hotel, Gaming & Leisure | Term Loan B (1/24) | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.56% | 6/29/2029 | 762038 | 736667 | 722115 |
| DCert Buyer, Inc. | High Tech Industries | Term Loan | Loan | 1M USD SOFR+ | 4.00% | 0.00% | 8.33% | 10/16/2026 | 1435768 | 1435768 | 1415352 |
| Delek US Holdings, Inc. | Utilities: Oil & Gas | Term Loan B (11/22) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.93% | 11/16/2029 | 5278500 | 5198117 | 5133341 |
| Derby Buyer LLC | Chemicals, Plastics, & Rubber | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.34% | 11/1/2030 | 618766 | 611284 | 609794 |
| DexKo Global, Inc. (Dragon Merger) | Automotive | Term Loan (9/21) | Loan | 1M USD SOFR+ | 3.75% | 0.50% | 8.19% | 10/4/2028 | 970000 | 968084 | 924808 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Diamond Sports Group, LLC | Media: Broadcasting & Subscription | 1st Priority Term Loan | Loan | 1M USD SOFR+ | 10.00% | 1.00% | 14.43% | 5/25/2026 | 29734 | 29479 | 26612 |
| DIRECTV FINANCING, LLC | Media: Broadcasting & Subscription | Term Loan (1/24) | Loan | 3M USD SOFR+ | 5.25% | 0.75% | 9.79% | 8/2/2029 | 2831125 | 2817448 | 2783364 |
| DISCOVERY PURCHASER CORPORATION | Chemicals, Plastics, & Rubber | Term Loan | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.02% | 10/4/2029 | 1470233 | 1387948 | 1466249 |
| Dispatch Acquisition Holdings, LLC | Environmental Industries | Term Loan B (3/21) | Loan | 3M USD SOFR+ | 4.25% | 0.75% | 8.70% | 3/25/2028 | 481250 | 479197 | 469734 |
| DOMTAR CORPORATION | Forest Products & Paper | Term Loan 9/21 | Loan | 1M USD SOFR+ | 5.50% | 0.75% | 9.94% | 11/30/2028 | 3028279 | 2988105 | 2821356 |
| DOTDASH MEREDITH, INC. | Media: Advertising, Printing & Publishing | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.82% | 12/1/2028 | 1911111 | 1785818 | 1907537 |
| DRI HOLDING INC. | Media: Advertising, Printing & Publishing | Term Loan (12/21) | Loan | 1M USD SOFR+ | 5.25% | 0.50% | 9.68% | 12/15/2028 | 3882431 | 3787136 | 3807228 |
| DRW Holdings, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (06/24) | Loan | 1M USD SOFR+ | 3.50% | 0.00% | 7.83% | 6/17/2031 | 6305000 | 6281907 | 6305000 |
| DTZ U.S. Borrower, LLC | Construction & Building | Term Loan B1 (01/25) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.08% | 1/31/2030 | 2014107 | 2013733 | 2019143 |
| DTZ U.S. Borrower, LLC | Construction & Building | 2024-3 Term Loan (09/24) | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.58% | 1/31/2030 | 1069750 | 1049122 | 1075548 |
| Dye & Durham Corporation | Services: Business | Term Loan B (04/24) | Loan | 3M USD SOFR+ | 4.25% | 1.00% | 8.65% | 4/11/2031 | 1428214 | 1409607 | 1435355 |
| EAB Global, Inc. | Services: Business | Term Loan (08/21) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.33% | 8/16/2030 | 967725 | 965896 | 946435 |
| Echo Global Logistics, Inc. | Services: Business | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.50% | 8.18% | 11/23/2028 | 1940000 | 1939082 | 1795412 |
| Edelman Financial Group Inc., The | Banking, Finance, Insurance & Real Estate | Term Loan (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 4/7/2028 | 2149983 | 2147499 | 2147059 |
| ELECTRON BIDCO INC. | Healthcare & Pharmaceuticals | Term Loan | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.08% | 11/1/2028 | 487500 | 486600 | 487944 |
| Embecta Corp | Healthcare & Pharmaceuticals | Term Loan B | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.33% | 3/30/2029 | 2794742 | 2755721 | 2783982 |
| Emrld Borrower LP | Capital Equipment | Term Loan B (04/23) | Loan | 6M USD SOFR+ | 2.50% | 0.00% | 6.83% | 5/31/2030 | 987500 | 983956 | 981901 |
| Endo Finance Holdings, Inc. | Healthcare & Pharmaceuticals | Term Loan B | Loan | 1M USD SOFR+ | 4.00% | 0.50% | 8.33% | 4/23/2031 | 1990000 | 1973150 | 1941504 |
| Endure Digital, Inc. | High Tech Industries | Term Loan B | Loan | 1M USD SOFR+ | 3.50% | 0.75% | 7.96% | 2/10/2028 | 2406250 | 2402196 | 1291362 |
| Entain Holdings (Gibraltar) Limited | Hotel, Gaming & Leisure | Term Loan B3 (5/24) | Loan | 3M USD SOFR+ | 2.75% | 0.50% | 7.05% | 10/31/2029 | 1472615 | 1461262 | 1476754 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| EOS U.S. FINCO LLC | Transportation: Cargo | Term Loan | Loan | 6M USD SOFR+ | 6.00% | 0.50% | 10.28% | 10/9/2029 | 937500 | 884118 | 288281 |
| Equiniti Group PLC | Services: Business | Term Loan (03/25) | Loan | 3M USD SOFR+ | 3.75% | 0.00% | 8.03% | 12/11/2028 | 967638 | 962171 | 972476 |
| Evertec Group LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (09/23) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.08% | 10/30/2030 | 1125000 | 1111371 | 1125000 |
| Fiesta Purchaser, Inc. | Beverage, Food & Tobacco | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.58% | 2/12/2031 | 496256 | 492228 | 495968 |
| Finco I LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (9/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 6/27/2029 | 2788574 | 2787053 | 2792645 |
| First Brands Group, LLC | Automotive | 1st Lien Term Loan (3/21) | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.54% | 3/30/2027 | 4800000 | 4772940 | 4631232 |
| First Eagle Investment Management | Banking, Finance, Insurance & Real Estate | Term Loan B (02/24) | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.30% | 3/5/2029 | 5040736 | 5034263 | 5035090 |
| First Student Bidco Inc. | Transportation: Consumer | Term Loan B (12/24) | Loan | 3M USD SOFR+ | 2.50% | 0.50% | 6.80% | 7/21/2028 | 709476 | 706990 | 709278 |
| First Student Bidco Inc. | Transportation: Consumer | Term Loan C | Loan | 3M USD SOFR+ | 2.50% | 0.50% | 6.80% | 7/21/2028 | 216966 | 216232 | 216905 |
| Fitness International, LLC (LA Fitness) | Services: Consumer | Term Loan B (1/24) | Loan | 1M USD SOFR+ | 5.25% | 1.00% | 9.58% | 2/5/2029 | 1188000 | 1160704 | 1187263 |
| Flutter Financing B.V. | Hotel, Gaming & Leisure | Term Loan | Loan | 3M USD SOFR+ | 1.75% | 0.50% | 6.05% | 11/29/2030 | 3703125 | 3695424 | 3688090 |
| Franchise Group, Inc. (b)(d) | Services: Consumer | New Money Term Commitments | Loan | 1M USD SOFR+ | 9.00% | 1.00% | 13.44% | 5/6/2025 | 514450 | 514305 | 205780 |
| Franchise Group, Inc. (c) | Services: Consumer | First Out Term Loan | Loan | 6M USD SOFR+ | 4.75% | 0.75% | 9.25% | 3/10/2026 | 827674 | 826177 | 331483 |
| Franchise Group, Inc. (c) | Services: Consumer | Term Loan B | Loan | 3M USD SOFR+ | 4.75% | 0.75% | 9.30% | 3/10/2026 | 3041686 | 3000891 | 1218195 |
| Franchise Group, Inc. (b)(c) | Services: Consumer | Term Loan DIP New Money | Loan | 1M USD SOFR+ | 9.00% | 1.00% | 13.45% | 5/6/2025 | 355828 | 354956 | 354938 |
| Franklin Square Holdings, L.P. | Banking, Finance, Insurance & Real Estate | Term Loan B (04/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 4/25/2031 | 4220578 | 4216436 | 4199475 |
| Froneri International (R&R Ice Cream) | Beverage, Food & Tobacco | Term Loan B4 (10/24) | Loan | 6M USD SOFR+ | 2.00% | 0.00% | 6.24% | 9/16/2031 | 1915000 | 1914756 | 1909523 |
| Garrett LX III S.a r.l. | Automotive | Term Loan (1/25) | Loan | 3M USD SOFR+ | 2.25% | 0.50% | 6.53% | 1/20/2032 | 1451250 | 1448149 | 1454878 |
| Genesee & Wyoming, Inc. | Transportation: Cargo | Term Loan B (03/24) | Loan | 3M USD SOFR+ | 1.75% | 0.00% | 6.05% | 4/10/2031 | 1492500 | 1486172 | 1484754 |
| GGP Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 1M USD LIBOR+ | 2.50% | 0.00% | 2.96% | 8/27/2025 | 1739305 | 1773219 | 1721912 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| GIP Pilot Acquisition Partners, L.P. | Energy: Oil & Gas | Term Loan B | Loan | 3M USD SOFR+ | 2.00% | 0.00% | 6.28% | 10/4/2030 | 407641 | 406109 | 406793 |
| Global Tel\*Link Corporation | Telecommunications | Term Loan (6/24) | Loan | 1M USD SOFR+ | 7.50% | 3.00% | 11.83% | 7/31/2029 | 4796995 | 4733018 | 4657067 |
| Go Daddy Operating Company, LLC | High Tech Industries | Term Loan B7 | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 5/30/2031 | 937869 | 937869 | 937100 |
| GOLDEN WEST PACKAGING GROUP LLC | Forest Products & Paper | Term Loan (11/21) | Loan | 6M USD SOFR+ | 5.25% | 0.75% | 9.79% | 12/1/2027 | 1750000 | 1743790 | 1233750 |
| GOTO GROUP, INC. | High Tech Industries | First Lien Term Loan | Loan | 1M USD SOFR+ | 4.75% | 0.00% | 9.18% | 4/30/2028 | 1242244 | 826469 | 1086193 |
| GOTO GROUP, INC. | High Tech Industries | Second-Out Term Loan (02/24) | Loan | 1M USD SOFR+ | 4.75% | 0.00% | 9.18% | 4/30/2028 | 1715480 | 1652660 | 625087 |
| Graham Packaging Co Inc | Containers, Packaging & Glass | Term Loan B (07/24) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.83% | 8/4/2027 | 817017 | 815023 | 816796 |
| Great Outdoors Group, LLC | Retail | Term Loan (1/25) | Loan | 1M USD SOFR+ | 3.25% | 0.75% | 7.58% | 1/20/2032 | 957843 | 956032 | 948744 |
| Griffon Corporation | Consumer goods: Durable | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 1/24/2029 | 141563 | 141445 | 141252 |
| Grosvenor Capital Management Holdings, LLLP | Banking, Finance, Insurance & Real Estate | Term Loan B (5/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 2/25/2030 | 2779708 | 2779679 | 2785489 |
| Groupe Solmax Inc. | Environmental Industries | Term Loan (6/21) | Loan | 1M USD SOFR+ | 4.75% | 0.75% | 9.19% | 5/27/2028 | 2405762 | 2146993 | 2029356 |
| GYP HOLDINGS III CORP. | Construction & Building | Term Loan (1/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 5/12/2030 | 246258 | 245373 | 245950 |
| Hertz Corporation (The) | Transportation: Consumer | Term Loan B | Loan | 3M USD SOFR+ | 3.75% | 0.00% | 8.03% | 6/30/2028 | 2077710 | 2033553 | 1699837 |
| Hillman Group Inc. (The) (New) | Consumer goods: Durable | Term Loan B-1 (2/21) | Loan | 1M USD SOFR+ | 2.00% | 0.50% | 6.33% | 7/14/2028 | 2705549 | 2705053 | 2699921 |
| Hilton Domestic Operating Company Inc. | Hotel, Gaming & Leisure | Term Loan B 4 | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 11/8/2030 | 1500000 | 1497504 | 1504470 |
| HLF Financing SARL (Herbalife) | Consumer goods: Non-durable | Term Loan | Loan | 1M USD SOFR+ | 6.75% | 0.50% | 11.08% | 4/12/2029 | 2999535 | 2998985 | 3009523 |
| Holley Purchaser, Inc | Automotive | Term Loan (11/21) | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.19% | 11/17/2028 | 2182913 | 2178800 | 2030109 |
| Hudson River Trading LLC | Banking, Finance, Insurance & Real Estate | Term Loan (10/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 3/29/2030 | 5761050 | 5681962 | 5773436 |
| Hunter Douglas Inc | Consumer goods: Durable | Term Loan B (1/25) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.55% | 1/19/2032 | 2227067 | 2038972 | 2190877 |
| Hyperion Refinance S.a.r.l. | Banking, Finance, Insurance & Real Estate | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.33% | 2/18/2031 | 2970075 | 2959616 | 2962947 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Idera, Inc. | High Tech Industries | Term Loan (06/24) | Loan | 3M USD SOFR+ | 3.50% | 0.75% | 7.78% | 3/2/2028 | 4714277 | 4711503 | 4469747 |
| IMA Financial Group, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan (10/21) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.33% | 11/1/2028 | 2434062 | 2427937 | 2431019 |
| INDY US BIDCO, LLC | Services: Business | Term Loan (01/25) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.83% | 3/6/2028 | 2170828 | 2170397 | 2164489 |
| INEOS 226 Ltd. | Chemicals, Plastics, & Rubber | Term Loan 3/23 | Loan | 1M USD SOFR+ | 3.75% | 0.00% | 8.18% | 3/13/2030 | 491250 | 487577 | 434756 |
| Ineos US Finance LLC | Chemicals, Plastics, & Rubber | Term Loan C | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.58% | 2/18/2030 | 987538 | 980329 | 953596 |
| INEOS US PETROCHEM LLC | Chemicals, Plastics, & Rubber | Term Loan B | Loan | 1M USD SOFR+ | 4.25% | 0.00% | 8.68% | 4/2/2029 | 2687725 | 2643307 | 2452549 |
| Informatica Inc. | High Tech Industries | Term Loan B (06/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 10/27/2028 | 485000 | 485000 | 486363 |
| Ingram Micro Inc. | Wholesale | Term Loan B | Loan | 3M USD SOFR+ | 2.75% | 0.00% | 7.05% | 9/17/2031 | 599923 | 596713 | 602551 |
| Inmar, Inc. | Services: Business | Term Loan (06/23) | Loan | 1M USD SOFR+ | 5.00% | 1.00% | 9.33% | 10/30/2031 | 3291584 | 3239655 | 3301887 |
| Innophos, Inc. | Chemicals, Plastics, & Rubber | Term Loan B | Loan | 1M USD SOFR+ | 4.25% | 0.00% | 8.69% | 3/16/2029 | 475000 | 471904 | 474763 |
| IRB Holding Corporation | Beverage, Food & Tobacco | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.75% | 6.83% | 12/15/2027 | 491256 | 488460 | 490544 |
| Isagenix International, LLC (c) | Beverage, Food & Tobacco | Term Loan | Loan | 6M USD SOFR+ | 2.50% | 0.00% | 2.50% | 4/13/2028 | 1407452 | 1074792 | 182969 |
| Isolved Inc. | Services: Business | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.58% | 10/15/2030 | 618770 | 613694 | 620316 |
| Jane Street Group | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 3M USD SOFR+ | 2.00% | 0.00% | 6.33% | 12/15/2031 | 3830000 | 3829989 | 3818893 |
| Journey Personal Care Corp. | Consumer goods: Non-durable | Term Loan B (11/24) | Loan | 3M USD SOFR+ | 3.75% | 0.75% | 8.05% | 3/1/2028 | 2887744 | 2853503 | 2873305 |
| JP Intermediate B, LLC (b) | Consumer goods: Non-durable | Term Loan 7/23 | Loan | Prime | 6.50% | 1.00% | 14.00% | 11/20/2027 | 3413673 | 3404567 | 102410 |
| Kleopatra Finco S.a r.l. | Containers, Packaging & Glass | Term Loan (1/21) (USD) | Loan | 6M USD SOFR+ | 4.73% | 0.50% | 9.23% | 2/12/2026 | 1440000 | 1440000 | 1305605 |
| Koppers Inc | Chemicals, Plastics, & Rubber | Term Loan | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.83% | 4/10/2030 | 982612 | 960286 | 980156 |
| Lakeland Tours, LLC (c) | Hotel, Gaming & Leisure | Holdco Fixed Term Loan | Loan | Fixed | 0.00% | 0.00% | 8.00% | 9/27/2027 | 1127568 | 711596 | 19732 |
| Latham Pool Products, Inc. | Consumer goods: Durable | Term Loan 2/22 | Loan | 1M USD SOFR+ | 4.00% | 0.50% | 8.43% | 2/23/2029 | 988812 | 977033 | 959148 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Lealand Finance Company B.V. (c) | Energy: Oil & Gas | Exit Term Loan | Loan | 1M USD SOFR+ | 1.00% | 0.00% | 5.44% | 12/31/2027 | 369512 | 369512 | 154825 |
| LHS BORROWER, LLC | Construction & Building | Term Loan (02/22) | Loan | 1M USD SOFR+ | 4.75% | 0.50% | 9.18% | 2/16/2029 | 2443764 | 2131750 | 2304274 |
| Lifetime Brands, Inc | Consumer goods: Non-durable | Term Loan | Loan | 1M USD SOFR+ | 5.50% | 1.00% | 9.94% | 8/26/2027 | 1541812 | 1538500 | 1387630 |
| Liquid Tech Solutions Holdings, LLC | Services: Business | Term Loan (12/24) | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.08% | 6/18/2029 | 965081 | 964118 | 965081 |
| LOYALTY VENTURES INC. (b) | Services: Business | Loyalty Ventures Claims | Term Loan B | Prime | 5.50% | 0.50% | 14.00% | 11/3/2027 | 2913525 | 2906099 | 211231 |
| LSF11 TRINITY BIDCO INC | Aerospace & Defense | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 6/14/2030 | 968466 | 957340 | 963624 |
| LSF9 Atlantis Holdings, LLC (A Wireless) | Retail | Term Loan | Loan | 3M USD SOFR+ | 4.25% | 0.75% | 8.55% | 3/29/2029 | 2638407 | 2581125 | 2631811 |
| Lumen Technologies Inc | Telecommunications | Term Loan B1 (3/24) | Loan | 1M USD SOFR+ | 2.35% | 2.00% | 6.79% | 4/16/2029 | 1604190 | 1602340 | 1587041 |
| Lumen Technologies Inc | Telecommunications | Term Loan B2 (3/24) | Loan | 1M USD SOFR+ | 2.35% | 2.00% | 6.79% | 4/15/2030 | 504190 | 503696 | 498659 |
| MAGNITE, INC. | Services: Business | Term Loan B | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 2/6/2031 | 3233770 | 3207215 | 3217601 |
| Marriott Ownership Resorts, Inc. | Hotel, Gaming & Leisure | Term Loan B (3/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 4/1/2031 | 1307196 | 1307196 | 1298215 |
| Max US Bidco Inc. | Beverage, Food & Tobacco | Term Loan B | Loan | 1M USD SOFR+ | 5.00% | 0.50% | 9.33% | 10/3/2030 | 1980000 | 1870077 | 1954755 |
| Mayfield Agency Borrower Inc. (FeeCo) | Banking, Finance, Insurance & Real Estate | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 12/29/2031 | 3407069 | 3343070 | 3393577 |
| McGraw-Hill Education, Inc. | Media: Advertising, Printing & Publishing | Term Loan (1/25) | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.58% | 8/6/2031 | 1189880 | 1183332 | 1192486 |
| Michaels Companies Inc | Retail | Term Loan B (Magic Mergeco) | Loan | 3M USD SOFR+ | 4.25% | 0.75% | 8.81% | 4/8/2028 | 2411087 | 2402142 | 1676308 |
| MIWD Holdco II LLC | Construction & Building | Term Loan B2 (03/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 3/21/2031 | 496250 | 494202 | 494776 |
| MKS Instruments, Inc. | High Tech Industries | Term Loan B (01/25) | Loan | 1M USD SOFR+ | 2.00% | 0.50% | 6.32% | 8/17/2029 | 1275401 | 1274025 | 1276039 |
| Momentive Performance Materials Inc. | Chemicals, Plastics, & Rubber | Term Loan (03/23) | Loan | 1M USD SOFR+ | 4.00% | 0.00% | 8.33% | 3/28/2028 | 458824 | 447267 | 456245 |
| Moneygram International, Inc. | Services: Business | Term Loan B | Loan | 3M USD SOFR+ | 4.75% | 0.50% | 9.04% | 6/1/2030 | 2956384 | 2638038 | 2641204 |
| MPH Acquisition Holdings LLC (Multiplan) | Services: Business | First-Out Term Loan (01/25) | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.03% | 12/31/2030 | 315611 | 286645 | 309955 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| MPH Acquisition Holdings LLC (Multiplan) | Services: Business | Second-Out Term Loan (01/25) | Loan | 3M USD SOFR+ | 4.60% | 0.50% | 9.14% | 12/31/2030 | 2616207 | 2466257 | 2293550 |
| NAB Holdings, LLC (North American Bancard) | Banking, Finance, Insurance & Real Estate | Term Loan B (2/25) | Loan | 3M USD SOFR+ | 2.50% | 0.50% | 6.80% | 11/24/2028 | 2903175 | 2900711 | 2878237 |
| Napa Management Services Corp | Healthcare & Pharmaceuticals | Term Loan B (02/22) | Loan | 1M USD SOFR+ | 5.25% | 0.75% | 9.68% | 2/22/2029 | 2931990 | 2512905 | 2382242 |
| Natgasoline LLC | Chemicals, Plastics, & Rubber | Term Loan (3/25) | Loan | 3M USD SOFR+ | 5.50% | 0.00% | 9.80% | 3/25/2030 | 3269852 | 3170881 | 3228979 |
| National Mentor Holdings, Inc. | Healthcare & Pharmaceuticals | Term Loan 2/21 | Loan | 3M USD SOFR+ | 3.75% | 0.75% | 8.15% | 3/2/2028 | 2673386 | 2670120 | 2588933 |
| National Mentor Holdings, Inc. | Healthcare & Pharmaceuticals | Term Loan C 2/21 | Loan | 3M USD SOFR+ | 3.75% | 0.75% | 8.15% | 3/2/2028 | 87464 | 87295 | 84701 |
| Nexstar Broadcasting, Inc. (Mission Broadcasting) | Media: Broadcasting & Subscription | Term Loan | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.94% | 9/18/2026 | 571911 | 570403 | 571710 |
| Next Level Apparel, Inc. | Retail | Term Loan | Loan | 3M USD SOFR+ | 7.50% | 1.00% | 11.88% | 8/9/2026 | 2360823 | 2353895 | 1749960 |
| NortonLifeLock Inc. | High Tech Industries | Term Loan B (05/24) | Loan | 1M USD SOFR+ | 1.75% | 0.50% | 6.08% | 9/12/2029 | 966250 | 963748 | 964801 |
| Nouryon Finance B.V. | Chemicals, Plastics, & Rubber | Term Loan B (10/24) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.51% | 4/3/2028 | 482705 | 479642 | 483511 |
| Novae LLC | Automotive | Term Loan B | Loan | 3M USD SOFR+ | 5.00% | 0.75% | 9.45% | 12/22/2028 | 1940000 | 1932037 | 1770250 |
| Olaplex, Inc. | Consumer goods: Non-durable | Term Loan (2/22) | Loan | 3M USD SOFR+ | 3.50% | 0.50% | 7.93% | 2/23/2029 | 1319846 | 1281877 | 1259714 |
| Open Text Corporation | High Tech Industries | Term Loan B (08/23) | Loan | 1M USD SOFR+ | 1.75% | 0.50% | 6.08% | 1/31/2030 | 918133 | 897845 | 916884 |
| Oxbow Carbon, LLC | Metals & Mining | Term Loan B (04/23) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.83% | 5/2/2030 | 463938 | 456780 | 457559 |
| PACIFIC DENTAL SERVICES, LLC | Healthcare & Pharmaceuticals | Term Loan B (02//24) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.07% | 3/17/2031 | 1188000 | 1187535 | 1185957 |
| Padagis LLC | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 4.75% | 0.50% | 9.27% | 7/6/2028 | 930329 | 925587 | 869858 |
| PAR PETROLEUM LLC | Energy: Oil & Gas | Term Loan B | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.01% | 2/28/2030 | 2452485 | 2433351 | 2379426 |
| PATAGONIA HOLDCO LLC | Telecommunications | Term Loan B | Loan | 3M USD SOFR+ | 5.75% | 0.50% | 10.05% | 8/1/2029 | 2939848 | 2639288 | 2505309 |
| Pathway Partners Vet Management Company LLC | Consumer goods: Non-durable | Term Loan Tranch A | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.28% | 6/30/2028 | 131927 | 127813 | 131268 |
| Pathway Partners Vet Management Company LLC | Consumer goods: Non-durable | Term Loan B (03/25) | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.28% | 6/30/2028 | 417772 | 414354 | 323773 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| PCI Gaming Authority | Hotel, Gaming & Leisure | Term Loan | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.33% | 7/18/2031 | 788531 | 787943 | 786686 |
| PEARLS (Netherlands) Bidco B.V. | Chemicals, Plastics, & Rubber | USD Term Loan (02/22) | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.53% | 2/28/2029 | 971193 | 970694 | 962996 |
| PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC | Healthcare & Pharmaceuticals | Term Loan (12/22) | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.79% | 12/29/2028 | 1455878 | 1453139 | 1317569 |
| Penn National Gaming, Inc | Hotel, Gaming & Leisure | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.83% | 5/3/2029 | 972500 | 969842 | 970069 |
| Peraton Corp. | Aerospace & Defense | Term Loan B | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.18% | 2/1/2028 | 5167574 | 5162187 | 4468092 |
| Phoenix Guarantor Inc. | Healthcare & Pharmaceuticals | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.83% | 2/21/2031 | 962799 | 962799 | 963020 |
| PHYSICIAN PARTNERS, LLC (b) | Healthcare & Pharmaceuticals | Term Loan | Loan | 1M USD SOFR+ | 4.00% | 0.50% | 8.42% | 12/22/2028 | 2928567 | 2883374 | 878570 |
| Plastipak Holdings Inc. | Containers, Packaging & Glass | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.50% | 6.57% | 12/1/2028 | 1795294 | 1791222 | 1795294 |
| Playtika Holding Corp. | High Tech Industries | Term Loan B (3/21) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.19% | 3/13/2028 | 4320000 | 4316511 | 4262069 |
| PMHC II, INC. | Chemicals, Plastics, & Rubber | Term Loan (02/22) | Loan | 3M USD SOFR+ | 4.25% | 0.50% | 8.64% | 4/21/2029 | 1950000 | 1945004 | 1712354 |
| PointClickCare Technologies, Inc. | High Tech Industries | Term Loan B (10/24) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.55% | 11/3/2031 | 481369 | 480337 | 481970 |
| Polymer Process Holdings, Inc. | Containers, Packaging & Glass | Term Loan | Loan | 1M USD SOFR+ | 4.75% | 0.75% | 9.19% | 2/12/2028 | 4020266 | 4004404 | 3666804 |
| Pre-Paid Legal Services, Inc. | Services: Consumer | Term Loan (12/21) | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.58% | 12/15/2028 | 2910206 | 2896892 | 2894287 |
| Prime Security Services Borrower, LLC (ADT) | Services: Consumer | Term Loan B | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.33% | 10/13/2030 | 1985038 | 1969281 | 1983013 |
| Primo Brands Corporation | Beverage, Food & Tobacco | Term Loan B (01/25) | Loan | 3M USD SOFR+ | 2.25% | 0.50% | 6.55% | 3/31/2028 | 1443886 | 1440702 | 1443525 |
| PRIORITY HOLDINGS, LLC | Services: Consumer | Term Loan B (5/24) | Loan | 1M USD SOFR+ | 4.75% | 0.50% | 9.08% | 5/16/2031 | 2872211 | 2857778 | 2882982 |
| PriSo Acquisition Corporation | Construction & Building | Term Loan (01/21) | Loan | 3M USD SOFR+ | 3.25% | 0.75% | 7.80% | 12/28/2027 | 479988 | 479131 | 460952 |
| Project Leopard Holdings, Inc. (NEW) | High Tech Industries | Term Loan B (06/22) | Loan | 3M USD SOFR+ | 5.25% | 0.50% | 9.63% | 7/20/2029 | 977500 | 931122 | 847981 |
| Propulsion (BC) Finco | Aerospace & Defense | Term Loan B (10/24) | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.55% | 9/14/2029 | 740597 | 734635 | 742048 |
| PUG LLC | Services: Consumer | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 4.75% | 0.00% | 9.08% | 3/15/2030 | 464578 | 463950 | 452382 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Quartz AcquireCo, LLC | High Tech Industries | Term Loan (2/25) | Loan | 3M USD SOFR+ | 2.25% | 0.00% | 6.55% | 6/28/2030 | 1231867 | 1224342 | 1231103 |
| Quikrete Holdings, Inc. | Construction & Building | Term Loan (2/25) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 4/14/2031 | 990019 | 988219 | 984841 |
| Rackspace Technology Global, Inc. | High Tech Industries | Term Loan (3/24) | Loan | 1M USD SOFR+ | 2.75% | 0.75% | 7.20% | 5/15/2028 | 2034813 | 1186116 | 907751 |
| Rackspace Technology Global, Inc. | High Tech Industries | Super-Priority Term Loan (03/24) | Loan | 1M USD SOFR+ | 6.25% | 0.75% | 10.70% | 5/15/2028 | 545532 | 541417 | 543780 |
| RAND PARENT LLC | Transportation: Cargo | Term Loan B (01/25) | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.30% | 3/18/2030 | 2450265 | 2384217 | 2392684 |
| RealPage, Inc. | High Tech Industries | Term Loan (04/21) | Loan | 3M USD SOFR+ | 3.00% | 0.50% | 7.56% | 4/24/2028 | 965000 | 964614 | 956778 |
| Rent-A-Center, Inc. | Retail | Term Loan B2 (9/21) | Loan | 3M USD SOFR+ | 2.75% | 0.50% | 7.03% | 2/17/2028 | 1835107 | 1812832 | 1837401 |
| Research Now Group, Inc | Media: Advertising, Printing & Publishing | Term Loan (07/24) | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.58% | 7/15/2028 | 337886 | 334033 | 336761 |
| Research Now Group, Inc | Media: Advertising, Printing & Publishing | Second-Out Term Loan | Loan | 3M USD SOFR+ | 5.50% | 1.00% | 10.08% | 7/15/2028 | 2880173 | 2768310 | 2512951 |
| Resideo Funding Inc. | Services: Consumer | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 2/14/2028 | 674488 | 674464 | 674070 |
| Resolute Investment Managers (American Beacon), Inc. | Banking, Finance, Insurance & Real Estate | Term Loan (12/23) | Loan | 3M USD SOFR+ | 6.50% | 1.00% | 11.06% | 4/30/2027 | 1943552 | 1943552 | 1916343 |
| Restoration Hardware, Inc. | Retail | Term Loan (9/21) | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.94% | 10/20/2028 | 3383546 | 3381337 | 3215215 |
| Reynolds Consumer Products LLC | Containers, Packaging & Glass | Term Loan B (2/25) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 3/4/2032 | 996705 | 996705 | 1001269 |
| Russell Investments US Inst'l Holdco, Inc. (c) | Banking, Finance, Insurance & Real Estate | Term Loan B PIK (3/24) | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.28% | 5/30/2027 | 5770982 | 5762890 | 5377112 |
| RV Retailer LLC | Automotive | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.18% | 2/8/2028 | 2890412 | 2864807 | 2659179 |
| Ryan Specialty Group LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 9/15/2031 | 1452294 | 1445326 | 1446848 |
| S&S HOLDINGS LLC | Services: Business | Term Loan | Loan | 1M USD SOFR+ | 5.00% | 0.50% | 9.42% | 3/10/2028 | 2402412 | 2373412 | 2343865 |
| Sally Holdings LLC | Retail | Term Loan B | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 2/28/2030 | 396250 | 394107 | 395259 |
| Schweitzer-Mauduit International, Inc. | High Tech Industries | Term Loan B | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.19% | 4/20/2028 | 939236 | 937492 | 929843 |
| Scientific Games Holdings LP | Hotel, Gaming & Leisure | Term Loan B | Loan | 3M USD SOFR+ | 3.00% | 0.50% | 7.28% | 4/4/2029 | 490038 | 489534 | 487038 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Sedgwick Claims Management Services, Inc. | Services: Business | Term Loan B 2/23 | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.33% | 7/31/2031 | 982563 | 976875 | 983240 |
| SETANTA AIRCRAFT LEASING DAC | Aerospace & Defense | Term Loan B (05/24) | Loan | 3M USD SOFR+ | 1.75% | 0.00% | 6.05% | 11/5/2028 | 500000 | 499476 | 502320 |
| Sitel Worldwide Corporation | Services: Business | USD Term Loan (7/21) | Loan | 1M USD SOFR+ | 3.75% | 0.50% | 8.19% | 8/28/2028 | 1930000 | 1926200 | 1080800 |
| SiteOne Landscape Supply, LLC | Services: Business | Term Loan B (06/24) | Loan | 1M USD SOFR+ | 1.75% | 0.50% | 6.09% | 3/23/2030 | 1254557 | 1250528 | 1256916 |
| Smyrna Ready Mix Concrete, LLC | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 4/2/2029 | 509075 | 506748 | 508760 |
| Sparta U.S. HoldCo LLC | Chemicals, Plastics, & Rubber | Term Loan | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 8/2/2030 | 1935000 | 1931086 | 1912825 |
| Specialty Pharma III Inc. | Services: Business | Term Loan | Loan | 1M USD SOFR+ | 4.25% | 0.75% | 8.68% | 3/31/2028 | 1930044 | 1921933 | 1905919 |
| Spin Holdco, Inc. | Services: Consumer | Term Loan 3/21 | Loan | 3M USD SOFR+ | 4.00% | 0.75% | 8.56% | 3/4/2028 | 2880000 | 2873627 | 2452205 |
| SRAM, LLC | Consumer goods: Durable | Term Loan (02/25) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 2/23/2032 | 2263418 | 2262540 | 2252101 |
| STANDARD INDUSTRIES INC. | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 1.75% | 0.50% | 6.08% | 9/22/2028 | 207750 | 206899 | 207906 |
| Staples, Inc. | Wholesale | Term Loan B | Loan | 3M USD SOFR+ | 5.75% | 0.50% | 10.03% | 9/4/2029 | 4252838 | 4202769 | 3796424 |
| Star Parent, Inc. | Services: Business | Term Loan B (09/23) | Loan | 3M USD SOFR+ | 4.00% | 0.00% | 8.30% | 9/27/2030 | 1237500 | 1222691 | 1215225 |
| Storable, Inc | High Tech Industries | Term Loan B (3/25) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.58% | 4/16/2031 | 485000 | 484862 | 484481 |
| Superannuation & Investments US LLC | Banking, Finance, Insurance & Real Estate | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.50% | 8.19% | 12/1/2028 | 967500 | 962490 | 970722 |
| SupplyOne, Inc | Wholesale | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 3.75% | 0.00% | 8.08% | 3/27/2031 | 495000 | 490727 | 496134 |
| Sweetwater Borrower, LLC | Retail | Term Loan (8/21) | Loan | 1M USD SOFR+ | 4.25% | 0.75% | 8.69% | 8/2/2028 | 2083452 | 2026740 | 2057409 |
| Syncsort Incorporated | High Tech Industries | Term Loan B (10/21) | Loan | 3M USD SOFR+ | 4.00% | 0.75% | 8.54% | 4/24/2028 | 2413709 | 2413394 | 2256818 |
| Ta TT Buyer LLC | Media: Broadcasting & Subscription | Term Loan B (6/24) | Loan | 3M USD SOFR+ | 4.75% | 0.50% | 9.05% | 4/2/2029 | 977570 | 971326 | 938467 |
| Tenable Holdings, Inc. | Services: Business | Term Loan B (6/21) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.19% | 7/7/2028 | 967500 | 966880 | 965081 |
| Teneo Holdings LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 4.75% | 1.00% | 9.08% | 3/13/2031 | 3465000 | 3434970 | 3488112 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Thor Industries, Inc. | Automotive | Term Loan B (06/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 11/15/2030 | 188283 | 186817 | 187813 |
| TIBCO Software Inc | High Tech Industries | Term Loan (Cov-Lite) (10/24) | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.05% | 3/21/2031 | 497500 | 497114 | 496022 |
| Torrid LLC | Wholesale | Term Loan 5/21 | Loan | 6M USD SOFR+ | 5.50% | 0.75% | 10.18% | 6/14/2028 | 3061375 | 2773489 | 2816465 |
| TORY BURCH LLC | Retail | Term Loan | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.69% | 4/17/2028 | 2278492 | 2180961 | 2236182 |
| Tosca Services, LLC (c) | Containers, Packaging & Glass | Term Loan A (08/24) | Loan | 1M USD SOFR+ | 5.50% | 1.50% | 9.82% | 11/30/2028 | 80509 | 79712 | 80811 |
| Trans Union LLC | Banking, Finance, Insurance & Real Estate | Term Loan B9 (11/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 6/24/2031 | 604472 | 604028 | 603801 |
| Tronox Finance LLC | Chemicals, Plastics, & Rubber | Term Loan (09/24) | Loan | 3M USD SOFR+ | 2.25% | 0.00% | 6.55% | 4/4/2029 | 1995000 | 1980884 | 1945883 |
| Tronox Finance LLC | Chemicals, Plastics, & Rubber | Term Loan B (09/24) | Loan | 3M USD SOFR+ | 2.50% | 0.00% | 6.80% | 9/30/2031 | 346056 | 345860 | 337366 |
| TruGreen Limited Partnership | Services: Consumer | Term Loan | Loan | 1M USD SOFR+ | 4.00% | 0.75% | 8.43% | 11/2/2027 | 932586 | 930163 | 891786 |
| Ultra Clean Holdings, Inc. | High Tech Industries | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.58% | 2/25/2028 | 1225996 | 1223841 | 1229061 |
| Univision Communications Inc. | Media: Broadcasting & Subscription | Term Loan B (05/24) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.94% | 1/31/2029 | 2397483 | 2396601 | 2321554 |
| Univision Communications Inc. | Media: Broadcasting & Subscription | Term Loan B (6/22) | Loan | 3M USD SOFR+ | 4.25% | 0.50% | 8.55% | 6/25/2029 | 243125 | 238350 | 240694 |
| Vaco Holdings, LLC | Services: Business | Term Loan (01/22) | Loan | 3M USD SOFR+ | 5.00% | 0.75% | 9.45% | 1/19/2029 | 2288978 | 2244371 | 2048636 |
| Vericast Corp. (c) | Media: Advertising, Printing & Publishing | Extended Term Loan (07/24) | Loan | 6M USD SOFR+ | 7.75% | 1.00% | 12.03% | 6/16/2026 | 1288093 | 1287985 | 1224977 |
| Verifone Systems, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan (03/25) | Loan | 3M USD SOFR+ | 5.50% | 0.00% | 10.21% | 8/21/2028 | 1197757 | 1197332 | 1090953 |
| Vertex Aerospace Services Corp | Aerospace & Defense | Term Loan (10/21) | Loan | 1M USD SOFR+ | 2.25% | 0.75% | 6.58% | 12/6/2030 | 970293 | 968411 | 966353 |
| Viasat Inc | Telecommunications | Term Loan (2/22) | Loan | 1M USD SOFR+ | 4.50% | 0.50% | 8.94% | 3/5/2029 | 2929724 | 2884572 | 2763257 |
| Virtus Investment Partners, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B (9/21) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.69% | 9/28/2028 | 2567727 | 2564301 | 2558098 |
| Vistra Operations Company LLC | Energy: Electricity | 2018 Incremental Term Loan | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 12/20/2030 | 1865775 | 1863018 | 1867119 |
| VM Consolidated, Inc. | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.58% | 3/24/2028 | 1811912 | 1811688 | 1819848 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**May 31, 2025**

**(unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset<br> Name** | **Asset<br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current<br> Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Warner Music Group Corp. (WMG Acquisition Corp.) | Hotel, Gaming & Leisure | Term Loan J | Loan | 3M USD SOFR+ | 1.75% | 0.00% | 6.08% | 1/24/2031 | 1250000 | 1250000 | 1248438 |
| Watlow Electric Manufacturing Company | High Tech Industries | Term Loan B (03/21) | Loan | 3M USD SOFR+ | 3.00% | 0.50% | 7.28% | 3/2/2028 | 2654117 | 2648858 | 2654117 |
| WeddingWire, Inc. | Services: Consumer | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.75% | 0.00% | 8.08% | 1/31/2028 | 4760954 | 4760760 | 4737150 |
| Wellpath Recovery Solutions | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 6.93% | 2.00% | 11.23% | 1/27/2030 | 693228 | 693228 | 681097 |
| Wellpath Correct Care | Healthcare & Pharmaceuticals | Term Loan | Loan | 1M USD SOFR+ | 9.50% | 1.00% | 13.84% | 5/9/2030 | 580094 | 580094 | 527885 |
| WEX Inc. | Services: Business | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 3/31/2028 | 2888398 | 2884894 | 2877566 |
| Windsor Holdings III, LLC | Chemicals, Plastics, & Rubber | Term Loan B (02/25) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.07% | 8/1/2030 | 493775 | 493775 | 491617 |
| Wyndham Hotels & Resorts, Inc. | Hotel, Gaming & Leisure | Term Loan (05/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.08% | 5/24/2030 | 985056 | 981574 | 987164 |
| Xperi Corporation | High Tech Industries | Term Loan (1/25) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.83% | 6/8/2028 | 1631585 | 1630908 | 1627506 |
| Zayo Group, LLC | Telecommunications | Term Loan 4/22 | Loan | 1M USD SOFR+ | 4.25% | 0.50% | 8.58% | 3/9/2027 | 970000 | 959651 | 926903 |
| ZEBRA BUYER (Allspring) LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (12/24) | Loan | 3M USD SOFR+ | 3.00% | 0.50% | 7.31% | 11/1/2030 | 1852261 | 1845947 | 1853706 |
| Zekelman Industries, Inc. | Metals & Mining | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.59% | 1/24/2031 | 1439488 | 1438697 | 1432896 |
| Zest Acquisition Corp. | Healthcare & Pharmaceuticals | Term Loan (1/23) | Loan | 3M USD SOFR+ | 5.25% | 0.00% | 9.53% | 2/8/2028 | 1955000 | 1897165 | 1957444 |
| Zodiac Pool Solutions | Consumer goods: Durable | Term Loan (1/22) | Loan | 1M USD SOFR+ | 1.93% | 0.50% | 6.35% | 1/29/2029 | 483750 | 483365 | 483145 |
| TOTAL INVESTMENTS |  |  |  |  |  |  |  |  |  | $**498283887** | $**465120764** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of<br> Shares** | **Cost** | **Fair Value** |
| **Cash and cash equivalents** | | | |
| U.S. Bank Money Market (a) | 17490859 | $17490859 | $17490859 |
| **Total cash and cash equivalents** | **17490859** | $**17490859** | $**17490859** |

---

(a) Included within cash and cash equivalents in Saratoga CLO's
Statements of Assets and Liabilities as of May 31, 2025.

(b) As of May 31, 2025, the investment was in default and on non-accrual
status.

(c) Investments include Payment-in-Kind Interest.

(d) All or a portion of this investment has an unfunded commitment
as of May 31, 2025.

SOFR - Secured Overnight Financing Rate

1M SOFR - The 1-month SOFR rate as of May 31, 2025 was 4.32%.

3M SOFR - The 3-month SOFR rate as of May 31, 2025 was 4.32%.

6M SOFR - The 6-month SOFR rate as of May 31, 2025 was 4.26%.

Prime - The Prime Rate as of May 31, 2025 was 7.50%.

See accompanying notes to financial statements.

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| ALTISOURCE PORTFOLIO SOL | Banking, Finance, Insurance & Real Estate | Common Stock | Equity |  |  |  |  |  | 296227 | $216246 | $204397 |
| Altisource Portfolio Solutions - CS Warrant | Banking, Finance, Insurance & Real Estate | Warrants | Equity |  |  |  |  |  | 7917 | 3736 | 2895 |
| Altisource Portfolio Solutions - NS Warrant | Banking, Finance, Insurance & Real Estate | Warrants | Equity |  |  |  |  |  | 7917 | 3129 | 2883 |
| Endo Finance Holdings, Inc. | Healthcare & Pharmaceuticals | Common Stock | Equity |  |  |  |  |  | 24148 | 670107 | 682181 |
| Envision Parent Inc | Healthcare & Pharmaceuticals | Common Stock | Equity |  |  |  |  |  | 4410 | 175000 | 50715 |
| Envision Parent Inc | Healthcare & Pharmaceuticals | Warrants | Equity |  |  |  |  |  | 92837 |  | 4642 |
| Instant Brands Litigation Trust | Consumer goods: Durable | Equity Interests | Equity |  |  |  |  |  | 51095 | 35250 | 151056 |
| Isagenix International, LLC | Beverage, Food & Tobacco | Common Stock | Equity |  |  |  |  |  | 86398 |  |  |
| Resolute Investment Managers (American Beacon), Inc. | Banking, Finance, Insurance & Real Estate | Common Stock | Equity |  |  |  |  |  | 24320 | 1034581 | 231040 |
| URS TOPCO, LLC | Transportation: Cargo | Common Stock | Equity |  |  |  |  |  | 25330 | 440405 | 354620 |
| Wellpath Holdings LLC | Healthcare & Pharmaceuticals | Common Stock | Equity |  |  |  |  |  | 41758 |  | **-** |
| 1011778 B.C Unltd Liability Co | Beverage, Food & Tobacco | Term Loan B6 | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 9/20/2030 | $1436662 | 1419292 | 1429076 |
| 19TH HOLDINGS GOLF, LLC | Consumer goods: Durable | Term Loan | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.66% | 2/7/2029 | 2448533 | 2374623 | 2398044 |
| 888 Acquisitions Limited | Hotel, Gaming & Leisure | Term Loan B | Loan | 6M USD SOFR+ | 5.25% | 0.00% | 9.50% | 7/8/2028 | 3036695 | 2797339 | 2936484 |
| Adtalem Global Education Inc. | Services: Business | Term Loan B (08/24) | Loan | 1M USD SOFR+ | 2.75% | 0.75% | 7.07% | 8/12/2028 | 352462 | 350628 | 352902 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Aegis Sciences Corporation | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 5.50% | 1.00% | 10.28% | 5/9/2025 | 2267140 | 2265721 | 1271865 |
| Agiliti Health Inc. | Healthcare & Pharmaceuticals | Term Loan B (03/23) | Loan | 6M USD SOFR+ | 3.00% | 0.00% | 7.26% | 5/1/2030 | 2154146 | 2140760 | 2093119 |
| AHEAD DB Holdings, LLC | Services: Business | Term Loan B3 (07/24) | Loan | 1M USD SOFR+ | 3.00% | 0.75% | 7.30% | 2/1/2031 | 2895655 | 2838488 | 2902228 |
| Air Canada | Transportation: Consumer | Term Loan B (03/24) | Loan | 3M USD SOFR+ | 2.00% | 0.00% | 6.34% | 3/21/2031 | 992500 | 990413 | 995607 |
| AIT Worldwide Logistics Holdings, Inc. | Transportation: Cargo | Term Loan B (01/25) | Loan | 3M USD SOFR+ | 4.00% | 0.75% | 8.30% | 4/8/2030 | 2455696 | 2341381 | 2458250 |
| AlixPartners, LLP | Banking, Finance, Insurance & Real Estate | Term Loan B (01/21) | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.94% | 2/4/2028 | 240624 | 240582 | 241166 |
| Allen Media, LLC | Media: Diversified & Production | Term Loan (7/21) | Loan | 3M USD SOFR+ | 5.50% | 0.00% | 9.98% | 2/10/2027 | 4303877 | 4290645 | 2571566 |
| Alliant Holdings Intermediate, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B6 (09/24) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.07% | 9/19/2031 | 797021 | 797021 | 795579 |
| Allied Universal Holdco LLC | Services: Business | Term Loan 4/21 | Loan | 1M USD SOFR+ | 3.75% | 0.50% | 8.17% | 5/12/2028 | 1935000 | 1930761 | 1936529 |
| Alterra Mountain Company (Intrawest Resort Holdings) | Hotel, Gaming & Leisure | First Lien Term Loan | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 5/31/2030 | 249375 | 249375 | 249532 |
| Altisource Solutions S.a r.l. | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 3M USD SOFR+ | 6.50% | 3.50% | 10.92% | 2/20/2029 | 500000 | 487543 | 500000 |
| Altisource Solutions S.a r.l. | Banking, Finance, Insurance & Real Estate | Term Loan B (02/25) | Loan | 3M USD SOFR+ | 6.50% | 3.50% | 10.92% | 4/30/2030 | 545284 | 545284 | 539831 |
| Altium Packaging LLC | Containers, Packaging & Glass | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.82% | 6/11/2031 | 482575 | 481544 | 477547 |
| American Axle & Manufacturing Inc. | Automotive | Term Loan (12/22) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.32% | 12/13/2029 | 480000 | 469318 | 478200 |
| American Greetings Corporation | Media: Advertising, Printing & Publishing | Term Loan B (04/24) | Loan | 1M USD SOFR+ | 5.75% | 0.00% | 10.07% | 10/30/2029 | 2926807 | 2925603 | 2945099 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| American Trailer World Corp | Automotive | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.17% | 3/3/2028 | 1357439 | 1356879 | 1140588 |
| Anastasia Parent LLC | Consumer goods: Non-durable | Term Loan | Loan | 3M USD SOFR+ | 3.75% | 0.00% | 8.34% | 8/11/2025 | 937500 | 937084 | 765084 |
| Anchor Packaging, LLC | Containers, Packaging & Glass | Term Loan (12/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.57% | 7/18/2029 | 1944396 | 1928125 | 1945408 |
| AP Core Holdings II LLC | High Tech Industries | Term Loan B1 | Loan | 1M USD SOFR+ | 5.50% | 0.75% | 9.94% | 9/1/2027 | 1674963 | 1662638 | 1576559 |
| AP Core Holdings II LLC | High Tech Industries | Term Loan B2 | Loan | 1M USD SOFR+ | 5.50% | 0.75% | 9.94% | 9/1/2027 | 500000 | 496326 | 467625 |
| APEX GROUP TREASURY LLC | Banking, Finance, Insurance & Real Estate | Term Loan (2/25) | Loan | 3M USD SOFR+ | 4.00% | 0.00% | 8.29% | 7/27/2028 | 490038 | 468587 | 491875 |
| Apollo Commercial Real Estate Finance, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.19% | 5/15/2026 | 2878173 | 2868237 | 2874575 |
| Apollo Commercial Real Estate Finance, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B1 (2/21) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.94% | 3/6/2028 | 962500 | 957781 | 957688 |
| Aramark Services, Inc. | Services: Consumer | Term Loan B7 (03/24) | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.32% | 4/6/2028 | 1753715 | 1750058 | 1758538 |
| Aramark Services, Inc. | Services: Consumer | Term Loan B8 (03/24) | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.32% | 6/22/2030 | 2331250 | 2305337 | 2337078 |
| ARC FALCON I INC. | Chemicals, Plastics, & Rubber | Term Loan | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.92% | 9/23/2028 | 971274 | 969846 | 971711 |
| ARCIS GOLF LLC | Services: Consumer | Term Loan B (01/25) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.07% | 11/24/2028 | 493000 | 489289 | 494543 |
| Aretec Group, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.50% | 0.00% | 7.82% | 8/9/2030 | 2622898 | 2610006 | 2616891 |
| Ascensus Group Holdings, Inc | Banking, Finance, Insurance & Real Estate | Term Loan | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 8/2/2028 | 494767 | 491912 | 493035 |
| Aspire Bakeries Holdings, LLC | Beverage, Food & Tobacco | Term loan | Loan | 1M USD SOFR+ | 4.25% | 0.00% | 8.57% | 12/23/2030 | 893250 | 885649 | 895483 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Assuredpartners Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B5 (02/24) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.82% | 2/14/2031 | 1290250 | 1289103 | 1290082 |
| Asurion, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B10 | Loan | 1M USD SOFR+ | 4.00% | 0.00% | 8.42% | 8/19/2028 | 1955000 | 1890928 | 1949780 |
| Asurion, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B12 | Loan | 1M USD SOFR+ | 4.25% | 0.00% | 8.56% | 9/19/2030 | 2912179 | 2908959 | 2898521 |
| ATHENAHEALTH GROUP INC. | Healthcare & Pharmaceuticals | Term Loan B (2/22) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.32% | 2/15/2029 | 1303799 | 1300749 | 1300070 |
| Avolon TLB Borrower 1 (US) LLC | Capital Equipment | Term Loan B6 | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 6/22/2030 | 1472622 | 1429929 | 1472136 |
| Axalta Coating Systems US Holdings | Chemicals, Plastics, & Rubber | Term Loan B (11/24) | Loan | 3M USD SOFR+ | 1.75% | 0.50% | 6.08% | 12/20/2029 | 851048 | 844987 | 852546 |
| AZURITY PHARMACEUTICALS, INC. | Healthcare & Pharmaceuticals | Term Loan B | Loan | 1M USD SOFR+ | 6.62% | 0.75% | 11.05% | 9/20/2027 | 425000 | 418550 | 422344 |
| B&G Foods, Inc. | Beverage, Food & Tobacco | Term Loan B | Loan | 1M USD SOFR+ | 3.50% | 0.00% | 7.82% | 10/10/2029 | 532287 | 530730 | 528849 |
| Baldwin Insurance Group Holdings, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B-1 (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.31% | 5/27/2031 | 1640279 | 1630478 | 1642329 |
| Belfor Holdings Inc. | Services: Consumer | Term Loan 4/23 | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.32% | 11/1/2030 | 1490834 | 1478738 | 1498288 |
| Bengal Debt Merger Sub LLC | Beverage, Food & Tobacco | Term Loan | Loan | 3M USD SOFR+ | 3.00% | 0.50% | 7.43% | 1/24/2029 | 1950000 | 1949473 | 1175753 |
| Blackstone Mortgage Trust, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.69% | 4/23/2026 | 342601 | 341898 | 341317 |
| Bombardier Recreational Products, Inc. | Consumer goods: Durable | Term Loan | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.07% | 1/22/2031 | 1425751 | 1422525 | 1423712 |
| Bombardier Recreational Products, Inc. | Consumer goods: Durable | Term Loan B3 | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.06% | 12/13/2029 | 488806 | 479686 | 488669 |
| Boost Newco Borrower, LLC (Worldpay) | Banking, Finance, Insurance & Real Estate | Term Loan B (01/25) | Loan | 3M USD SOFR+ | 2.00% | 0.00% | 6.29% | 1/31/2031 | 498750 | 496603 | 498127 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Boxer Parent Company, Inc. | High Tech Industries | Term Loan | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.29% | 7/30/2031 | 1007194 | 1003006 | 1004766 |
| BroadStreet Partners, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B-4 | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.31% | 6/16/2031 | 2896329 | 2894596 | 2894794 |
| Brookfield WEC Holdings Inc. | Energy: Electricity | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.56% | 1/27/2031 | 1440450 | 1440450 | 1437396 |
| BROWN GROUP HOLDING, LLC | Aerospace & Defense | Term Loan B-2 | Loan | 3M USD SOFR+ | 2.50% | 0.00% | 6.81% | 7/1/2031 | 491284 | 481764 | 490464 |
| Buckeye Partners, L.P. | Utilities: Oil & Gas | Term Loan B (01/25) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 11/22/2030 | 663337 | 661343 | 663430 |
| Buckeye Partners, L.P. | Utilities: Oil & Gas | Term Loan B5 (09/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 11/2/2026 | 483028 | 482076 | 482897 |
| BW Gas & Convenience Holdings LLC | Beverage, Food & Tobacco | Term Loan B | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.94% | 3/31/2028 | 2412500 | 2400434 | 2418531 |
| Callaway Golf Company | Retail | Term Loan B | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 3/16/2030 | 471250 | 467499 | 465458 |
| Calpine Corporation | Utilities: Electric | Term Loan B10 (01/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 1/31/2031 | 1990000 | 1981632 | 1987513 |
| Camping World, Inc. | Retail | Term Loan B (5/21) | Loan | 1M USD SOFR+ | 2.50% | 0.75% | 6.94% | 6/5/2028 | 2436709 | 2289886 | 2386586 |
| CAPSTONE BORROWER INC | Services: Business | Term Loan B (05/24) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.58% | 6/17/2030 | 872669 | 862196 | 874851 |
| CareerBuilder, LLC | Services: Business | Term Loan B3 | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.94% | 7/31/2026 | 4089659 | 4079749 | 204483 |
| Castle US Holding Corporation | Media: Advertising, Printing & Publishing | Term Loan B (USD) | Loan | 3M USD SOFR+ | 3.75% | 0.00% | 8.32% | 1/27/2027 | 1929894 | 1925694 | 1192520 |
| CBL & Associates Limited Partnership | Retail | Term Loan 11/21 | Loan | 1M USD SOFR+ | 2.75% | 1.00% | 7.17% | 11/1/2025 | 2085112 | 1976819 | 1978250 |
| CCC Intelligent Solutions Inc. | Services: Business | Term Loan (01/25) | Loan | 1M USD SOFR+ | 2.00% | 0.50% | 6.32% | 9/16/2028 | 242500 | 242288 | 241894 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| CCI Buyer, Inc | Telecommunications | Term Loan | Loan | 3M USD SOFR+ | 4.00% | 0.75% | 8.33% | 12/17/2027 | 240625 | 239544 | 241426 |
| CCRR Parent, Inc. | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 4.25% | 0.50% | 8.66% | 3/6/2028 | 980000 | 948779 | 395263 |
| CCRR Parent, Inc. | Healthcare & Pharmaceuticals | Term Loan B | Loan | 3M USD SOFR+ | 4.25% | 0.75% | 8.82% | 3/6/2028 | 962500 | 960608 | 399438 |
| CCS-CMGC Holdings, Inc. | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 5.50% | 0.00% | 10.28% | 9/25/2025 | 1140869 | 1139841 | 386047 |
| CDK GLOBAL, INC. | High Tech Industries | Term Loan B (05/24) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.58% | 7/6/2029 | 990019 | 968890 | 903640 |
| CENTURI GROUP, INC. | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.94% | 8/28/2028 | 616921 | 613611 | 617470 |
| Charlotte Buyer, Inc. | Services: Business | Term Loan B (01/25) | Loan | 1M USD SOFR+ | 4.25% | 0.50% | 8.57% | 2/11/2028 | 1473806 | 1410924 | 1469886 |
| Chemours Company, (The) | Chemicals, Plastics, & Rubber | Term Loan B3 (08/23) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.32% | 8/18/2028 | 2369720 | 2339142 | 2358866 |
| Churchill Downs Incorporated | Hotel, Gaming & Leisure | Term Loan B1 (3/21) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 3/17/2028 | 481250 | 480828 | 480047 |
| CIMPRESS PUBLIC LIMITED COMPANY | Media: Advertising, Printing & Publishing | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.82% | 5/17/2028 | 1940187 | 1883647 | 1930486 |
| CITADEL SECURITIES LP | Banking, Finance, Insurance & Real Estate | Term Loan (10/24) | Loan | 3M USD SOFR+ | 2.00% | 0.00% | 6.33% | 10/31/2031 | 4826890 | 4826890 | 4832344 |
| Citco Funding LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (06/24) | Loan | 6M USD SOFR+ | 2.75% | 0.50% | 7.31% | 4/27/2028 | 987538 | 984246 | 994529 |
| Clarios Global LP | Automotive | Term Loan B (07/24) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.82% | 5/6/2030 | 1197000 | 1192661 | 1191015 |
| Claros Mortgage Trust, Inc | Banking, Finance, Insurance & Real Estate | Term Loan B-1 (11/21) | Loan | 1M USD SOFR+ | 4.50% | 0.50% | 8.92% | 8/10/2026 | 3368637 | 3360331 | 3099146 |
| CLYDESDALE ACQUISITION HOLDINGS, INC. | Containers, Packaging & Glass | Term Loan B | Loan | 1M USD SOFR+ | 3.18% | 0.50% | 7.50% | 4/13/2029 | 1220000 | 1199733 | 1219244 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Columbus McKinnon Corporation | Capital Equipment | Term Loan (03/24) | Loan | 3M USD SOFR+ | 2.50% | 0.50% | 6.83% | 5/14/2028 | 361967 | 361543 | 361062 |
| Connect Finco SARL | Telecommunications | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 4.50% | 0.50% | 8.82% | 9/27/2029 | 2865844 | 2801249 | 2491679 |
| Consolidated Communications, Inc. | Telecommunications | Term Loan B | Loan | 1M USD SOFR+ | 3.50% | 0.75% | 7.94% | 10/2/2027 | 2714005 | 2592779 | 2700788 |
| Corelogic, Inc. | Services: Business | Term Loan (4/21) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.94% | 6/2/2028 | 2418750 | 2413203 | 2406656 |
| Cortes NP Acquisition Corp (Vertiv) | Capital Equipment | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.06% | 3/2/2027 | 1920785 | 1920785 | 1918921 |
| Creative Artists Agency, LLC | Media: Diversified & Production | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.07% | 10/1/2031 | 1576094 | 1568099 | 1576536 |
| CROCS INC | Consumer goods: Durable | Term Loan B (01/24) | Loan | 3M USD SOFR+ | 2.25% | 0.50% | 6.58% | 2/19/2029 | 750000 | 730356 | 752723 |
| Cross Financial Corp | Banking, Finance, Insurance & Real Estate | Term Loan B2 (10/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.57% | 10/24/2031 | 485063 | 483905 | 485974 |
| Crown Subsea Communications Holding, Inc. | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 4.00% | 0.75% | 8.31% | 1/30/2031 | 2388000 | 2367977 | 2397695 |
| CTS Midco, LLC | High Tech Industries | Term Loan B | Loan | 3M USD SOFR+ | 6.00% | 1.00% | 10.55% | 11/2/2027 | 1919403 | 1894257 | 1919403 |
| Dave & Buster's Inc. | Hotel, Gaming & Leisure | Term Loan B (1/24) | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.56% | 6/29/2029 | 762038 | 735302 | 721079 |
| DCert Buyer, Inc. | High Tech Industries | Term Loan | Loan | 1M USD SOFR+ | 4.00% | 0.00% | 8.32% | 10/16/2026 | 1439547 | 1439547 | 1394748 |
| Delek US Holdings, Inc. | Utilities: Oil & Gas | Term Loan B (11/22) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.92% | 11/16/2029 | 5292000 | 5206553 | 5270514 |
| Derby Buyer LLC | Chemicals, Plastics, & Rubber | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.31% | 11/1/2030 | 620320 | 612532 | 620475 |
| DexKo Global, Inc. (Dragon Merger) | Automotive | Term Loan (9/21) | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.34% | 10/4/2028 | 972500 | 970335 | 916251 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Diamond Sports Group, LLC | Media: Broadcasting & Subscription | 1st Priority Term Loan | Loan | 1M USD SOFR+ | 10.00% | 1.00% | 14.41% | 5/25/2026 | 29734 | 29407 | 26463 |
| DIRECTV FINANCING, LLC | Media: Broadcasting & Subscription | Term Loan (1/24) | Loan | 3M USD SOFR+ | 5.25% | 0.75% | 9.80% | 8/2/2029 | 2902900 | 2887032 | 2882115 |
| DISCOVERY PURCHASER CORPORATION | Chemicals, Plastics, & Rubber | Term Loan | Loan | 3M USD SOFR+ | 4.00% | 0.50% | 8.29% | 10/4/2029 | 1470233 | 1383873 | 1465749 |
| Dispatch Acquisition Holdings, LLC | Environmental Industries | Term Loan B (3/21) | Loan | 3M USD SOFR+ | 4.25% | 0.75% | 8.73% | 3/25/2028 | 482500 | 480166 | 454496 |
| DOMTAR CORPORATION | Forest Products & Paper | Term Loan 9/21 | Loan | 1M USD SOFR+ | 5.50% | 0.75% | 9.94% | 11/30/2028 | 3071416 | 3028380 | 2973530 |
| DOTDASH MEREDITH, INC. | Media: Advertising, Printing & Publishing | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.81% | 12/1/2028 | 1911111 | 1778613 | 1920667 |
| DRI HOLDING INC. | Media: Advertising, Printing & Publishing | Term Loan (12/21) | Loan | 1M USD SOFR+ | 5.25% | 0.50% | 9.67% | 12/15/2028 | 3892437 | 3790333 | 3773718 |
| DRW Holdings, LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (06/24) | Loan | 3M USD SOFR+ | 3.50% | 0.00% | 7.79% | 6/17/2031 | 6305000 | 6280258 | 6283311 |
| DTZ U.S. Borrower, LLC | Construction & Building | Term Loan B1 (01/25) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.07% | 1/31/2030 | 2014107 | 2013573 | 2009072 |
| DTZ U.S. Borrower, LLC | Construction & Building | 2024-3 Term Loan (09/24) | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.57% | 1/31/2030 | 1097250 | 1075232 | 1098161 |
| Dye & Durham Corporation | Services: Business | Term Loan B (04/24) | Loan | 3M USD SOFR+ | 4.25% | 1.00% | 8.68% | 4/11/2031 | 1431964 | 1412492 | 1443148 |
| EAB Global, Inc. | Services: Business | Term Loan (08/21) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.32% | 8/16/2028 | 970169 | 967824 | 967336 |
| Echo Global Logistics, Inc. | Services: Business | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.50% | 8.16% | 11/23/2028 | 1945000 | 1943317 | 1923663 |
| Edelman Financial Group Inc., The | Banking, Finance, Insurance & Real Estate | Term Loan (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 4/7/2028 | 2155371 | 2152592 | 2158281 |
| ELECTRON BIDCO INC. | Healthcare & Pharmaceuticals | Term Loan | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.07% | 11/1/2028 | 487500 | 486541 | 486769 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| ELO Touch Solutions, Inc. | Media: Diversified & Production | Term Loan (12/18) | Loan | 1M USD SOFR+ | 6.50% | 0.00% | 10.94% | 12/15/2025 | 2137656 | 2124478 | 2137656 |
| Embecta Corp | Healthcare & Pharmaceuticals | Term Loan B | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.31% | 3/30/2029 | 2885658 | 2843183 | 2880262 |
| Emrld Borrower LP | Capital Equipment | Term Loan B (04/23) | Loan | 6M USD SOFR+ | 2.50% | 0.00% | 6.93% | 5/31/2030 | 990000 | 986329 | 986594 |
| Endo Finance Holdings, Inc. | Healthcare & Pharmaceuticals | Term Loan B | Loan | 1M USD SOFR+ | 4.00% | 0.50% | 8.32% | 4/23/2031 | 1995000 | 1977056 | 1995000 |
| Endure Digital, Inc. | High Tech Industries | Term Loan B | Loan | 1M USD SOFR+ | 3.50% | 0.75% | 7.92% | 2/10/2028 | 2412500 | 2407887 | 1668654 |
| Entain Holdings (Gibraltar) Limited | Hotel, Gaming & Leisure | Term Loan B3 (5/24) | Loan | 3M USD SOFR+ | 2.75% | 0.50% | 7.08% | 10/31/2029 | 1476325 | 1464198 | 1477476 |
| EOS U.S. FINCO LLC | Transportation: Cargo | Term Loan | Loan | 6M USD SOFR+ | 6.00% | 0.50% | 10.28% | 10/9/2029 | 950000 | 893353 | 397813 |
| Equiniti Group PLC | Services: Business | Term Loan (12/24) | Loan | 6M USD SOFR+ | 3.75% | 0.50% | 8.03% | 12/11/2028 | 970069 | 964262 | 976937 |
| Evertec Group LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (09/23) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.07% | 10/30/2030 | 1125000 | 1110800 | 1130625 |
| Fiesta Purchaser, Inc. | Beverage, Food & Tobacco | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.57% | 2/12/2031 | 497503 | 493271 | 497011 |
| Finco I LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (9/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 6/27/2029 | 2795563 | 2793344 | 2794389 |
| First Brands Group, LLC | Automotive | 1st Lien Term Loan (3/21) | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.55% | 3/30/2027 | 4812500 | 4781859 | 4607969 |
| First Eagle Investment Management | Banking, Finance, Insurance & Real Estate | Term Loan B (02/24) | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.33% | 3/5/2029 | 5053465 | 5046585 | 5052454 |
| First Student Bidco Inc. | Transportation: Consumer | Term Loan B (12/24) | Loan | 3M USD SOFR+ | 2.50% | 0.50% | 6.89% | 7/21/2028 | 709476 | 706708 | 707603 |
| First Student Bidco Inc. | Transportation: Consumer | Term Loan C | Loan | 3M USD SOFR+ | 2.50% | 0.50% | 6.89% | 7/21/2028 | 216966 | 216137 | 216393 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Fitness International, LLC (LA Fitness) | Services: Consumer | Term Loan B (1/24) | Loan | 1M USD SOFR+ | 5.25% | 1.00% | 9.57% | 2/5/2029 | 1191000 | 1161999 | 1204030 |
| Flutter Financing B.V. | Hotel, Gaming & Leisure | Term Loan | Loan | 3M USD SOFR+ | 1.75% | 0.50% | 6.08% | 11/29/2030 | 3712500 | 3704077 | 3699729 |
| Franchise Group, Inc. | Services: Consumer | New Money Term Commitments | Loan | 1M USD SOFR+ | 9.00% | 1.00% | 13.43% | 5/6/2025 | 257225 | 254175 | 257225 |
| Franchise Group, Inc. | Services: Consumer | First Out Term Loan | Loan | 6M USD SOFR+ | 4.75% | 0.75% | 9.30% | 3/10/2026 | 827674 | 825735 | 412802 |
| Franchise Group, Inc. | Services: Consumer | Term Loan B | Loan | 3M USD SOFR+ | 4.75% | 0.75% | 9.30% | 3/10/2026 | 3041686 | 2988228 | 1517041 |
| Franchise Group, Inc. | Services: Consumer | Term Loan DIP New Money | Loan | 1M USD SOFR+ | 9.00% | 1.00% | 13.43% | 5/6/2025 | 355828 | 353546 | 355828 |
| Franklin Square Holdings, L.P. | Banking, Finance, Insurance & Real Estate | Term Loan B (04/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 4/25/2031 | 4231210 | 4225781 | 4231210 |
| Froneri International (R&R Ice Cream) | Beverage, Food & Tobacco | Term Loan B4 (10/24) | Loan | 6M USD SOFR+ | 2.00% | 0.00% | 6.24% | 9/16/2031 | 1915000 | 1914701 | 1905751 |
| Garrett LX III S.a r.l. | Automotive | Term Loan (1/25) | Loan | 3M USD SOFR+ | 2.25% | 0.50% | 6.54% | 1/20/2032 | 1451250 | 1447746 | 1438552 |
| Genesee & Wyoming, Inc. | Transportation: Cargo | Term Loan B (03/24) | Loan | 3M USD SOFR+ | 1.75% | 0.00% | 6.08% | 4/10/2031 | 1496250 | 1489525 | 1489711 |
| GGP Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 2.96% | 8/27/2025 | 2323401 | 2300582 | 2318312 |
| GIP Pilot Acquisition Partners, L.P. | Energy: Oil & Gas | Term Loan B | Loan | 3M USD SOFR+ | 2.00% | 0.00% | 6.30% | 10/4/2030 | 415684 | 414006 | 414387 |
| Global Tel\*Link Corporation | Telecommunications | Term Loan (6/24) | Loan | 1M USD SOFR+ | 7.50% | 3.00% | 11.82% | 7/31/2029 | 4809048 | 4741980 | 4798757 |
| Go Daddy Operating Company, LLC | High Tech Industries | Term Loan B7 | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 5/30/2031 | 940231 | 940231 | 938473 |
| GOLDEN WEST PACKAGING GROUP LLC | Forest Products & Paper | Term Loan (11/21) | Loan | 6M USD SOFR+ | 5.25% | 0.75% | 9.92% | 12/1/2027 | 1775000 | 1767298 | 1434786 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| ALTISOURCE PORTFOLIO SOL | Banking, Finance, Insurance & Real Estate | Common Stock | Equity |  |  |  |  |  | 296227 | $216246 | $204397 |
| GOTO GROUP, INC. | High Tech Industries | First Lien Term Loan | Loan | 3M USD SOFR+ | 4.75% | 0.00% | 9.19% | 4/30/2028 | 1245381 | 804484 | 1151043 |
| GOTO GROUP, INC. | High Tech Industries | Second-Out Term Loan (02/24) | Loan | 3M USD SOFR+ | 4.75% | 0.00% | 9.19% | 4/30/2028 | 1719812 | 1651916 | 832389 |
| Graham Packaging Co Inc | Containers, Packaging & Glass | Term Loan B (07/24) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.82% | 8/4/2027 | 830576 | 828359 | 830161 |
| Great Outdoors Group, LLC | Retail | Term Loan (1/25) | Loan | 1M USD SOFR+ | 3.25% | 0.75% | 7.55% | 1/20/2032 | 960244 | 958144 | 962049 |
| Griffon Corporation | Consumer goods: Durable | Term Loan B | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.31% | 1/24/2029 | 142188 | 142044 | 142898 |
| Grosvenor Capital Management Holdings, LLLP | Banking, Finance, Insurance & Real Estate | Term Loan B (5/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 2/25/2030 | 2786709 | 2786614 | 2791057 |
| Groupe Solmax Inc. | Environmental Industries | Term Loan (6/21) | Loan | 1M USD SOFR+ | 4.75% | 0.75% | 9.19% | 5/27/2028 | 2412086 | 2134984 | 2133827 |
| GYP HOLDINGS III CORP. | Construction & Building | Term Loan (1/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 5/12/2030 | 246881 | 245937 | 247037 |
| Hertz Corporation (The) | Transportation: Consumer | Term Loan B | Loan | 1M USD SOFR+ | 3.75% | 0.00% | 8.07% | 6/30/2028 | 2082970 | 2035333 | 1807726 |
| Hillman Group Inc. (The) (New) | Consumer goods: Durable | Term Loan B-1 (2/21) | Loan | 1M USD SOFR+ | 2.00% | 0.50% | 6.31% | 7/14/2028 | 2714525 | 2713474 | 2704780 |
| Hilton Domestic Operating Company Inc. | Hotel, Gaming & Leisure | Term Loan B 4 | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 11/8/2030 | 1500000 | 1497236 | 1505160 |
| HLF Financing SARL (Herbalife) | Consumer goods: Non-durable | Term Loan | Loan | 1M USD SOFR+ | 6.75% | 0.50% | 11.07% | 4/12/2029 | 3038490 | 3037561 | 3036606 |
| Holley Purchaser, Inc | Automotive | Term Loan (11/21) | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.19% | 11/17/2028 | 2189325 | 2184763 | 2130935 |
| Hudson River Trading LLC | Banking, Finance, Insurance & Real Estate | Term Loan (10/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.31% | 3/29/2030 | 5775525 | 5692371 | 5770327 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Hunter Douglas Inc | Consumer goods: Durable | Term Loan B (1/25) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.55% | 1/19/2032 | 2232648 | 2038638 | 2215904 |
| Hyperion Refinance S.a.r.l. | Banking, Finance, Insurance & Real Estate | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.32% | 2/18/2031 | 2977538 | 2966717 | 2968992 |
| Idera, Inc. | High Tech Industries | Term Loan (06/24) | Loan | 3M USD SOFR+ | 3.50% | 0.75% | 7.79% | 3/2/2028 | 4726151 | 4723056 | 4447167 |
| IMA Financial Group, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan (10/21) | Loan | 1M USD SOFR+ | 3.00% | 0.50% | 7.32% | 11/1/2028 | 2440193 | 2433243 | 2440193 |
| INDY US BIDCO, LLC | Services: Business | Term Loan (01/25) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.82% | 3/6/2028 | 2170828 | 2170359 | 2166313 |
| INEOS 226 Ltd. | Chemicals, Plastics, & Rubber | Term Loan 3/23 | Loan | 1M USD SOFR+ | 3.75% | 0.00% | 8.17% | 3/13/2030 | 492500 | 488601 | 474031 |
| Ineos US Finance LLC | Chemicals, Plastics, & Rubber | Term Loan C | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.57% | 2/18/2030 | 990019 | 982264 | 973931 |
| INEOS US PETROCHEM LLC | Chemicals, Plastics, & Rubber | Term Loan B | Loan | 1M USD SOFR+ | 4.25% | 0.00% | 8.67% | 4/2/2029 | 2694512 | 2647631 | 2627149 |
| Informatica Inc. | High Tech Industries | Term Loan B (06/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 10/27/2028 | 486250 | 486237 | 485642 |
| Ingram Micro Inc. | Wholesale | Term Loan B | Loan | 3M USD SOFR+ | 2.75% | 0.00% | 7.08% | 9/17/2031 | 693439 | 689636 | 697343 |
| Inmar, Inc. | Services: Business | Term Loan (06/23) | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.31% | 10/30/2031 | 3299855 | 3234272 | 3303980 |
| Innophos, Inc. | Chemicals, Plastics, & Rubber | Term Loan B | Loan | 1M USD SOFR+ | 4.25% | 0.00% | 8.69% | 3/16/2029 | 476250 | 472714 | 475826 |
| IRB Holding Corporation | Beverage, Food & Tobacco | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.75% | 6.82% | 12/15/2027 | 492487 | 489357 | 491935 |
| Isagenix International, LLC | Beverage, Food & Tobacco | Term Loan | Loan | 6M USD SOFR+ | 2.50% | 0.00% | 2.50% | 4/13/2028 | 1378403 | 1025602 | 186084 |
| Isolved Inc. | Services: Business | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.57% | 10/15/2030 | 620324 | 614960 | 624394 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Jane Street Group | Banking, Finance, Insurance & Real Estate | Term Loan B | Loan | 3M USD SOFR+ | 2.00% | 0.00% | 6.30% | 12/15/2031 | 3840000 | 3839989 | 3790810 |
| Journey Personal Care Corp. | Consumer goods: Non-durable | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.07% | 3/1/2028 | 2895000 | 2858590 | 2872072 |
| JP Intermediate B, LLC | Consumer goods: Non-durable | Term Loan 7/23 | Loan | Prime | 6.50% | 1.00% | 14.00% | 11/20/2027 | 3370462 | 3360549 | 134818 |
| Kleopatra Finco S.a r.l. | Containers, Packaging & Glass | Term Loan (1/21) (USD) | Loan | 6M USD SOFR+ | 4.73% | 0.50% | 9.23% | 2/12/2026 | 1443750 | 1443745 | 1348304 |
| Koppers Inc | Chemicals, Plastics, & Rubber | Term Loan | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.82% | 4/10/2030 | 985081 | 961555 | 988775 |
| KREF Holdings X LLC | Banking, Finance, Insurance & Real Estate | Term Loan (11/21) | Loan | 3M USD SOFR+ | 3.50% | 0.50% | 8.06% | 9/1/2027 | 481363 | 476486 | 481363 |
| Lakeland Tours, LLC | Hotel, Gaming & Leisure | Holdco Fixed Term Loan | Loan | Fixed | 0.00% | 0.00% | 8.00% | 9/27/2027 | 1127568 | 680756 | 28189 |
| Latham Pool Products, Inc. | Consumer goods: Durable | Term Loan 2/22 | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.19% | 2/23/2029 | 991609 | 978723 | 970954 |
| Lealand Finance Company B.V. | Energy: Oil & Gas | Exit Term Loan | Loan | 1M USD SOFR+ | 1.00% | 0.00% | 5.43% | 12/31/2027 | 366724 | 366724 | 149257 |
| LHS BORROWER, LLC | Construction & Building | Term Loan (02/22) | Loan | 1M USD SOFR+ | 4.75% | 0.50% | 9.17% | 2/16/2029 | 2450166 | 2120597 | 2266403 |
| Lifetime Brands, Inc | Consumer goods: Non-durable | Term Loan | Loan | 1M USD SOFR+ | 5.50% | 1.00% | 9.93% | 8/26/2027 | 1576347 | 1572295 | 1500163 |
| Liquid Tech Solutions Holdings, LLC | Services: Business | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.18% | 3/17/2028 | 967500 | 966360 | 969919 |
| LOYALTY VENTURES INC. | Services: Business | Loyalty Ventures Claims | Term Loan B | Prime | 5.50% | 0.50% | 14.00% | 11/3/2027 | 2913525 | 2905305 | 211231 |
| LSF11 A5 HOLDCO LLC | Chemicals, Plastics, & Rubber | Term Loan B (06/24) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.93% | 10/15/2028 | 1622206 | 1607812 | 1621622 |
| LSF11 TRINITY BIDCO INC | Aerospace & Defense | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 6/14/2030 | 970924 | 959085 | 970924 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| LSF9 Atlantis Holdings, LLC (A Wireless) | Retail | Term Loan Extended | Loan | 1M USD SOFR+ | 5.25% | 0.75% | 9.57% | 3/29/2029 | 2671805 | 2610533 | 2680167 |
| Lumen Technologies Inc | Telecommunications | Term Loan B1 (3/24) | Loan | 1M USD SOFR+ | 2.35% | 2.00% | 6.79% | 4/16/2029 | 1608268 | 1607707 | 1512785 |
| Lumen Technologies Inc | Telecommunications | Term Loan B2 (3/24) | Loan | 1M USD SOFR+ | 2.35% | 2.00% | 6.79% | 4/15/2030 | 1608268 | 1607702 | 1507767 |
| MAGNITE, INC. | Services: Business | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 3.75% | 0.00% | 8.07% | 2/6/2031 | 3233770 | 3205941 | 3278235 |
| Marriott Ownership Resorts, Inc. | Hotel, Gaming & Leisure | Term Loan B (3/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 4/1/2031 | 1310489 | 1310489 | 1310489 |
| Max US Bidco Inc. | Beverage, Food & Tobacco | Term Loan B | Loan | 3M USD SOFR+ | 5.00% | 0.50% | 9.31% | 10/3/2030 | 1985000 | 1870513 | 1942819 |
| Mayfield Agency Borrower Inc. (FeeCo) | Banking, Finance, Insurance & Real Estate | Term Loan B (12/24) | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.29% | 12/29/2031 | 3415608 | 3349332 | 3405634 |
| McGraw-Hill Education, Inc. | Media: Advertising, Printing & Publishing | Term Loan (1/25) | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.55% | 8/6/2031 | 1244525 | 1236501 | 1251134 |
| Michaels Companies Inc | Retail | Term Loan B (Magic Mergeco) | Loan | 3M USD SOFR+ | 4.25% | 0.75% | 8.84% | 4/8/2028 | 2417349 | 2407248 | 1957038 |
| MIWD Holdco II LLC | Construction & Building | Term Loan B2 (03/24) | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 3/21/2031 | 497500 | 495226 | 498067 |
| MKS Instruments, Inc. | High Tech Industries | Term Loan B (01/25) | Loan | 1M USD SOFR+ | 2.00% | 0.50% | 6.32% | 8/17/2029 | 1280586 | 1278776 | 1281227 |
| Momentive Performance Materials Inc. | Chemicals, Plastics, & Rubber | Term Loan (03/23) | Loan | 1M USD SOFR+ | 4.00% | 0.00% | 8.32% | 3/28/2028 | 491250 | 477801 | 490331 |
| Moneygram International, Inc. | Services: Business | Term Loan B | Loan | 3M USD SOFR+ | 4.75% | 0.50% | 9.15% | 6/1/2030 | 2963850 | 2633472 | 2846363 |
| Mosel Bidco SE | High Tech Industries | Term Loan B | Loan | 3M USD SOFR+ | 4.50% | 0.50% | 8.83% | 9/28/2030 | 500000 | 495844 | 501250 |
| MPH Acquisition Holdings LLC (Multiplan) | Services: Business | First-Out Term Loan (01/25) | Loan | 3M USD SOFR+ | 3.75% | 0.00% | 8.04% | 12/31/2030 | 315611 | 285615 | 313638 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| MPH Acquisition Holdings LLC (Multiplan) | Services: Business | Second-Out Term Loan (01/25) | Loan | 3M USD SOFR+ | 4.60% | 0.00% | 9.15% | 12/31/2030 | 2616207 | 2460718 | 2198556 |
| NAB Holdings, LLC (North American Bancard) | Banking, Finance, Insurance & Real Estate | Term Loan B (2/25) | Loan | 3M USD SOFR+ | 2.50% | 0.50% | 6.82% | 11/24/2028 | 2910506 | 2906771 | 2886873 |
| Napa Management Services Corp | Healthcare & Pharmaceuticals | Term Loan B (02/22) | Loan | 1M USD SOFR+ | 5.25% | 0.75% | 9.67% | 2/22/2029 | 2939547 | 2497131 | 2712966 |
| Natgasoline LLC | Chemicals, Plastics, & Rubber | Term Loan | Loan | 6M USD SOFR+ | 3.50% | 0.00% | 8.17% | 11/14/2025 | 3269852 | 3265583 | 3253503 |
| National Mentor Holdings, Inc. | Healthcare & Pharmaceuticals | Term Loan 2/21 | Loan | 3M USD SOFR+ | 3.75% | 0.75% | 8.48% | 3/2/2028 | 2680348 | 2676078 | 2623658 |
| National Mentor Holdings, Inc. | Healthcare & Pharmaceuticals | Term Loan C 2/21 | Loan | 3M USD SOFR+ | 3.75% | 0.75% | 8.18% | 3/2/2028 | 87464 | 87262 | 85614 |
| Nexstar Broadcasting, Inc. (Mission Broadcasting) | Media: Broadcasting & Subscription | Term Loan | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.94% | 9/18/2026 | 571911 | 570138 | 571356 |
| Next Level Apparel, Inc. | Retail | Term Loan | Loan | 3M USD SOFR+ | 7.50% | 1.00% | 11.90% | 8/9/2026 | 2382698 | 2373272 | 1894245 |
| NorthPole Newco S.a.r.l | Aerospace & Defense | Term Loan | Loan | Prime | 7.00% | 0.00% | 14.50% | 3/3/2025 |  |  |  |
| NortonLifeLock Inc. | High Tech Industries | Term Loan B (05/24) | Loan | 1M USD SOFR+ | 1.75% | 0.50% | 6.07% | 9/12/2029 | 970000 | 967278 | 967507 |
| Nouryon Finance B.V. | Chemicals, Plastics, & Rubber | Term Loan B (10/24) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.55% | 4/3/2028 | 483926 | 480497 | 485591 |
| Novae LLC | Automotive | Term Loan B | Loan | 1M USD SOFR+ | 5.00% | 0.75% | 9.42% | 12/22/2028 | 1945000 | 1935728 | 1819800 |
| Olaplex, Inc. | Consumer goods: Non-durable | Term Loan (2/22) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.92% | 2/23/2029 | 2442273 | 2367591 | 2262498 |
| Open Text Corporation | High Tech Industries | Term Loan B (08/23) | Loan | 1M USD SOFR+ | 1.75% | 0.50% | 6.07% | 1/31/2030 | 921883 | 900638 | 920731 |
| Oxbow Carbon, LLC | Metals & Mining | Term Loan B (04/23) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.82% | 5/2/2030 | 492500 | 484592 | 491269 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| PACIFIC DENTAL SERVICES, LLC | Healthcare & Pharmaceuticals | Term Loan B (02//24) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.07% | 3/17/2031 | 1191000 | 1190157 | 1194347 |
| PACTIV EVERGREEN GROUP HOLDINGS INC. | Containers, Packaging & Glass | Term Loan B4 (05/24) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.82% | 9/24/2028 | 921247 | 919105 | 920841 |
| Padagis LLC | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 4.75% | 0.50% | 9.30% | 7/6/2028 | 941176 | 935900 | 876866 |
| PAR PETROLEUM LLC | Energy: Oil & Gas | Term Loan B | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.04% | 2/28/2030 | 2458727 | 2438711 | 2448474 |
| PATAGONIA HOLDCO LLC | Telecommunications | Term Loan B | Loan | 3M USD SOFR+ | 5.75% | 0.50% | 10.05% | 8/1/2029 | 2947386 | 2631038 | 2597384 |
| Pathway Partners Vet Management Company LLC | Services: Business | Term Loan | Loan | 3M USD SOFR+ | 3.75% | 0.00% | 8.34% | 3/31/2027 | 476580 | 472582 | 387545 |
| PCI Gaming Authority | Hotel, Gaming & Leisure | Term Loan | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.32% | 7/18/2031 | 790518 | 789679 | 788834 |
| PEARLS (Netherlands) Bidco B.V. | Chemicals, Plastics, & Rubber | USD Term Loan (02/22) | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.57% | 2/28/2029 | 973627 | 972968 | 969246 |
| PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC | Healthcare & Pharmaceuticals | Term Loan (12/22) | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.80% | 12/29/2028 | 1459630 | 1456242 | 1379350 |
| Penn National Gaming, Inc | Hotel, Gaming & Leisure | Term Loan B | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.82% | 5/3/2029 | 975000 | 971989 | 976463 |
| Peraton Corp. | Aerospace & Defense | Term Loan B | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.17% | 2/1/2028 | 5181328 | 5175310 | 4677754 |
| Phoenix Guarantor Inc. | Healthcare & Pharmaceuticals | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.82% | 2/21/2031 | 965218 | 965218 | 961444 |
| PHYSICIAN PARTNERS, LLC | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 4.00% | 0.50% | 8.74% | 12/22/2028 | 2928567 | 2881253 | 1156784 |
| Plastipak Holdings Inc. | Containers, Packaging & Glass | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.50% | 6.57% | 12/1/2028 | 1795294 | 1791011 | 1796892 |
| Playtika Holding Corp. | High Tech Industries | Term Loan B (3/21) | Loan | 1M USD SOFR+ | 2.75% | 0.00% | 7.19% | 3/13/2028 | 4331250 | 4327202 | 4316351 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| PMHC II, INC. | Chemicals, Plastics, & Rubber | Term Loan (02/22) | Loan | 3M USD SOFR+ | 4.25% | 0.50% | 8.69% | 4/21/2029 | 1955000 | 1949220 | 1890368 |
| PointClickCare Technologies, Inc. | High Tech Industries | Term Loan B (10/24) | Loan | 3M USD SOFR+ | 3.25% | 0.00% | 7.58% | 11/3/2031 | 482575 | 481443 | 483178 |
| Polymer Process Holdings, Inc. | Containers, Packaging & Glass | Term Loan | Loan | 1M USD SOFR+ | 4.75% | 0.75% | 9.19% | 2/12/2028 | 4020266 | 4001931 | 3897648 |
| Pre-Paid Legal Services, Inc. | Services: Consumer | Term Loan (12/21) | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.69% | 12/15/2028 | 2917500 | 2903248 | 2917500 |
| Prime Security Services Borrower, LLC (ADT) | Services: Consumer | Term Loan B | Loan | 1M USD SOFR+ | 2.00% | 0.00% | 6.31% | 10/13/2030 | 1990013 | 1973564 | 1985834 |
| Primo Brands Corporation | Beverage, Food & Tobacco | Term Loan B (01/25) | Loan | 3M USD SOFR+ | 2.25% | 0.50% | 6.56% | 3/31/2028 | 1447505 | 1443799 | 1448620 |
| PRIORITY HOLDINGS, LLC | Services: Consumer | Term Loan B (5/24) | Loan | 1M USD SOFR+ | 4.75% | 0.50% | 9.07% | 5/16/2031 | 2872211 | 2857095 | 2875802 |
| PriSo Acquisition Corporation | Construction & Building | Term Loan (01/21) | Loan | 3M USD SOFR+ | 3.25% | 0.75% | 7.82% | 12/28/2027 | 481239 | 480294 | 466152 |
| Project Leopard Holdings, Inc. (NEW) | High Tech Industries | Term Loan B (06/22) | Loan | 3M USD SOFR+ | 5.25% | 0.50% | 9.64% | 7/20/2029 | 980000 | 930969 | 871387 |
| Propulsion (BC) Finco | Aerospace & Defense | Term Loan B (10/24) | Loan | 3M USD SOFR+ | 3.25% | 0.50% | 7.58% | 9/14/2029 | 742457 | 736171 | 745509 |
| PUG LLC | Services: Consumer | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 4.75% | 0.00% | 9.07% | 3/15/2030 | 465765 | 465063 | 465570 |
| Quartz AcquireCo, LLC | High Tech Industries | Term Loan (2/25) | Loan | 3M USD SOFR+ | 2.25% | 0.00% | 6.57% | 6/28/2030 | 1234994 | 1226841 | 1233450 |
| Quikrete Holdings, Inc. | Construction & Building | Term Loan (2/25) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 4/14/2031 | 992500 | 990531 | 990981 |
| Rackspace Technology Global, Inc. | High Tech Industries | Term Loan (3/24) | Loan | 1M USD SOFR+ | 2.75% | 0.75% | 7.17% | 5/15/2028 | 2040103 | 1143598 | 1165409 |
| Rackspace Technology Global, Inc. | High Tech Industries | Super-Priority Term Loan (03/24) | Loan | 1M USD SOFR+ | 6.25% | 0.75% | 10.67% | 5/15/2028 | 546909 | 542424 | 563705 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| RAND PARENT LLC | Transportation: Cargo | Term Loan B (01/25) | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.30% | 3/18/2030 | 2456406 | 2386949 | 2452108 |
| RealPage, Inc. | High Tech Industries | Term Loan (04/21) | Loan | 3M USD SOFR+ | 3.00% | 0.50% | 7.59% | 4/24/2028 | 967500 | 966881 | 960747 |
| Rent-A-Center, Inc. | Retail | Term Loan B2 (9/21) | Loan | 3M USD SOFR+ | 2.75% | 0.50% | 7.04% | 2/17/2028 | 1840124 | 1815493 | 1839351 |
| Research Now Group, Inc | Media: Advertising, Printing & Publishing | Term Loan (07/24) | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.58% | 7/15/2028 | 338737 | 334497 | 339018 |
| Research Now Group, Inc | Media: Advertising, Printing & Publishing | Second-Out Term Loan | Loan | 3M USD SOFR+ | 5.50% | 1.00% | 10.08% | 7/15/2028 | 2887427 | 2767310 | 2721400 |
| Resideo Funding Inc. | Services: Consumer | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.06% | 2/14/2028 | 674488 | 674302 | 675756 |
| Resolute Investment Managers (American Beacon), Inc. | Banking, Finance, Insurance & Real Estate | Term Loan (12/23) | Loan | 3M USD SOFR+ | 6.50% | 1.00% | 11.09% | 4/30/2027 | 1948473 | 1948473 | 1930449 |
| Restoration Hardware, Inc. | Retail | Term Loan (9/21) | Loan | 1M USD SOFR+ | 2.50% | 0.50% | 6.94% | 10/20/2028 | 3392312 | 3389647 | 3339595 |
| Reynolds Consumer Products LLC | Containers, Packaging & Glass | Term Loan | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.17% | 2/4/2027 | 996705 | 996705 | 996944 |
| Russell Investments US Inst'l Holdco, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B PIK (3/24) | Loan | 3M USD SOFR+ | 5.00% | 1.00% | 9.29% | 5/30/2027 | 5764065 | 5754497 | 5539266 |
| RV Retailer LLC | Automotive | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.17% | 2/8/2028 | 2897881 | 2869896 | 2714039 |
| Ryan Specialty Group LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 9/15/2031 | 1455934 | 1448552 | 1453750 |
| S&S HOLDINGS LLC | Services: Business | Term Loan | Loan | 1M USD SOFR+ | 5.00% | 0.50% | 9.42% | 3/10/2028 | 2408668 | 2376694 | 2403996 |
| Sally Holdings LLC | Retail | Term Loan B | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 2/28/2030 | 441250 | 438790 | 440147 |
| Schweitzer-Mauduit International, Inc. | High Tech Industries | Term Loan B | Loan | 1M USD SOFR+ | 3.75% | 0.75% | 8.19% | 4/20/2028 | 939236 | 936933 | 933365 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Scientific Games Holdings LP | Hotel, Gaming & Leisure | Term Loan B | Loan | 3M USD SOFR+ | 3.00% | 0.50% | 7.30% | 4/4/2029 | 491269 | 490668 | 491087 |
| Sedgwick Claims Management Services, Inc. | Services: Business | Term Loan B 2/23 | Loan | 3M USD SOFR+ | 3.00% | 0.00% | 7.31% | 7/31/2031 | 985031 | 978594 | 985297 |
| SETANTA AIRCRAFT LEASING DAC | Aerospace & Defense | Term Loan B (05/24) | Loan | 3M USD SOFR+ | 1.75% | 0.00% | 6.08% | 11/5/2028 | 500000 | 499374 | 501500 |
| Sitel Worldwide Corporation | Services: Business | USD Term Loan (7/21) | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.18% | 8/28/2028 | 1935000 | 1930481 | 1248733 |
| SiteOne Landscape Supply, LLC | Services: Business | Term Loan B (06/24) | Loan | 1M USD SOFR+ | 1.75% | 0.50% | 6.06% | 3/23/2030 | 1257709 | 1253356 | 1257709 |
| Smyrna Ready Mix Concrete, LLC | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.32% | 4/2/2029 | 509075 | 506578 | 510984 |
| Sparta U.S. HoldCo LLC | Chemicals, Plastics, & Rubber | Term Loan | Loan | 1M USD SOFR+ | 3.00% | 0.00% | 7.31% | 8/2/2030 | 1940000 | 1935791 | 1945820 |
| Specialty Pharma III Inc. | Services: Business | Term Loan | Loan | 1M USD SOFR+ | 4.25% | 0.75% | 8.67% | 3/31/2028 | 1935000 | 1925487 | 1847925 |
| Spin Holdco, Inc. | Services: Consumer | Term Loan 3/21 | Loan | 3M USD SOFR+ | 4.00% | 0.75% | 8.71% | 3/4/2028 | 2887500 | 2880793 | 2496128 |
| SRAM, LLC | Consumer goods: Durable | Term Loan (02/25) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.94% | 5/12/2028 | 2269091 | 2267559 | 2274764 |
| STANDARD INDUSTRIES INC. | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 1.75% | 0.50% | 6.07% | 9/22/2028 | 210250 | 209230 | 210250 |
| Staples, Inc. | Wholesale | Term Loan B | Loan | 3M USD SOFR+ | 5.75% | 0.50% | 10.04% | 9/4/2029 | 4263551 | 4210817 | 4001726 |
| Star Parent, Inc. | Services: Business | Term Loan B (09/23) | Loan | 3M USD SOFR+ | 4.00% | 0.00% | 8.33% | 9/27/2030 | 1240625 | 1225176 | 1214088 |
| Storable, Inc | High Tech Industries | Term Loan B | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.82% | 4/17/2028 | 485000 | 484751 | 484913 |
| Superannuation & Investments US LLC | Banking, Finance, Insurance & Real Estate | Term Loan | Loan | 1M USD SOFR+ | 3.75% | 0.50% | 8.19% | 12/1/2028 | 970000 | 964328 | 974608 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| SupplyOne, Inc | Wholesale | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 3.75% | 0.00% | 8.07% | 3/27/2031 | 496250 | 491740 | 498811 |
| Sweetwater Borrower, LLC | Retail | Term Loan (8/21) | Loan | 1M USD SOFR+ | 4.25% | 0.75% | 8.69% | 8/2/2028 | 2083452 | 2022885 | 2083452 |
| Syncsort Incorporated | High Tech Industries | Term Loan B (10/21) | Loan | 3M USD SOFR+ | 4.00% | 0.75% | 8.55% | 4/24/2028 | 2419962 | 2419490 | 2377105 |
| Ta TT Buyer LLC | Media: Broadcasting & Subscription | Term Loan B (6/24) | Loan | 3M USD SOFR+ | 4.75% | 0.50% | 9.08% | 4/2/2029 | 980032 | 973273 | 969624 |
| Tenable Holdings, Inc. | Services: Business | Term Loan B (6/21) | Loan | 1M USD SOFR+ | 2.75% | 0.50% | 7.19% | 7/7/2028 | 970000 | 969283 | 971213 |
| Teneo Holdings LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 4.75% | 1.00% | 9.07% | 3/13/2031 | 3473750 | 3442264 | 3500880 |
| Ten-X, LLC | Banking, Finance, Insurance & Real Estate | Term Loan 5/23 | Loan | 6M USD SOFR+ | 6.00% | 0.00% | 10.25% | 5/25/2028 | 1860000 | 1860000 | 1616340 |
| Thor Industries, Inc. | Automotive | Term Loan B (06/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 11/15/2030 | 291839 | 289445 | 292569 |
| TIBCO Software Inc | High Tech Industries | Term Loan (Cov-Lite) (10/24) | Loan | 3M USD SOFR+ | 3.75% | 0.50% | 8.08% | 3/21/2031 | 498750 | 498297 | 500137 |
| Torrid LLC | Wholesale | Term Loan 5/21 | Loan | 3M USD SOFR+ | 5.50% | 0.75% | 10.07% | 6/14/2028 | 3107759 | 2794667 | 2863582 |
| TORY BURCH LLC | Retail | Term Loan | Loan | 1M USD SOFR+ | 3.25% | 0.50% | 7.69% | 4/17/2028 | 2284411 | 2178846 | 2279773 |
| Tosca Services, LLC | Containers, Packaging & Glass | Term Loan A (08/24) | Loan | 1M USD SOFR+ | 5.50% | 1.50% | 9.82% | 11/30/2028 | 80509 | 79712 | 82925 |
| Tosca Services, LLC | Containers, Packaging & Glass | Superpriority Second-Out Term Loan B | Loan | 1M USD SOFR+ | 1.50% | 0.00% | 5.92% | 11/30/2028 | 6878 | 10704 | 5932 |
| Trans Union LLC | Banking, Finance, Insurance & Real Estate | Term Loan B9 (11/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 6/24/2031 | 605987 | 605382 | 604878 |
| Tronox Finance LLC | Chemicals, Plastics, & Rubber | Term Loan (09/24) | Loan | 3M USD SOFR+ | 2.25% | 0.00% | 6.60% | 4/4/2029 | 1995000 | 1979840 | 1967070 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Tronox Finance LLC | Chemicals, Plastics, & Rubber | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.82% | 9/30/2031 | 346923 | 346684 | 342458 |
| TruGreen Limited Partnership | Services: Consumer | Term Loan | Loan | 1M USD SOFR+ | 4.00% | 0.75% | 8.42% | 11/2/2027 | 935021 | 932096 | 885933 |
| Ultra Clean Holdings, Inc. | High Tech Industries | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 3.25% | 0.00% | 7.57% | 2/25/2028 | 1233755 | 1230873 | 1237358 |
| Univision Communications Inc. | Media: Broadcasting & Subscription | Term Loan B (05/24) | Loan | 1M USD SOFR+ | 3.50% | 0.50% | 7.94% | 1/31/2029 | 2403522 | 2402406 | 2379486 |
| Univision Communications Inc. | Media: Broadcasting & Subscription | Term Loan B (6/22) | Loan | 3M USD SOFR+ | 4.25% | 0.50% | 8.58% | 6/25/2029 | 243750 | 238712 | 240094 |
| Vaco Holdings, LLC | Services: Business | Term Loan (01/22) | Loan | 3M USD SOFR+ | 5.00% | 0.75% | 9.48% | 1/19/2029 | 2294893 | 2247090 | 2098680 |
| Vericast Corp. | Media: Advertising, Printing & Publishing | Extended Term Loan (07/24) | Loan | 6M USD SOFR+ | 7.75% | 1.00% | 12.03% | 6/16/2026 | 1297729 | 1297560 | 1235438 |
| Verifone Systems, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan (7/18) | Loan | 3M USD SOFR+ | 4.00% | 0.00% | 8.58% | 8/20/2025 | 1339456 | 1338547 | 1272175 |
| Vertex Aerospace Services Corp | Aerospace & Defense | Term Loan (10/21) | Loan | 1M USD SOFR+ | 2.25% | 0.75% | 6.57% | 12/6/2030 | 972724 | 970725 | 966509 |
| Viasat Inc | Telecommunications | Term Loan (2/22) | Loan | 1M USD SOFR+ | 4.50% | 0.50% | 8.94% | 3/5/2029 | 2937255 | 2888468 | 2689057 |
| Virtus Investment Partners, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan B (9/21) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.69% | 9/28/2028 | 2575227 | 2570947 | 2575227 |
| Vistra Operations Company LLC | Energy: Electricity | 2018 Incremental Term Loan | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 12/20/2030 | 1870499 | 1866269 | 1868554 |
| VM Consolidated, Inc. | Construction & Building | Term Loan B | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.57% | 3/24/2028 | 1817804 | 1817479 | 1816895 |
| Walker & Dunlop, Inc. | Banking, Finance, Insurance & Real Estate | Term Loan | Loan | 1M USD SOFR+ | 2.25% | 0.50% | 6.67% | 12/15/2028 | 491202 | 484449 | 491816 |
| Warner Music Group Corp. (WMG Acquisition Corp.) | Hotel, Gaming & Leisure | Term Loan J | Loan | 3M USD SOFR+ | 1.75% | 0.00% | 6.04% | 1/24/2031 | 1250000 | 1250000 | 1248050 |

---

**Saratoga Investment Corp. CLO 2013-1, Ltd.**

**Schedule of Investments**

**February 28, 2025**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Issuer Name** | **Industry** | **Asset Name** | **Asset <br> Type** | **Reference<br> Rate/Spread** | **Reference<br> Rate/Spread** | **SOFR/LIBOR Floor** | **Current Rate<br> (All In)** | **Maturity<br> Date** | **Principal/<br> Number of Shares** | **Cost** | **Fair<br> Value** |
| Watlow Electric Manufacturing Company | High Tech Industries | Term Loan B (03/21) | Loan | 3M USD SOFR+ | 3.50% | 0.50% | 7.79% | 3/2/2028 | 2661649 | 2655782 | 2671072 |
| WeddingWire, Inc. | Services: Consumer | Term Loan B (12/24) | Loan | 1M USD SOFR+ | 3.75% | 0.00% | 8.07% | 1/31/2028 | 4772917 | 4772450 | 4784849 |
| Wellpath Holdings LLC | Healthcare & Pharmaceuticals | Term Loan | Loan | 3M USD SOFR+ | 6.93% | 2.00% | 11.23% | 1/27/2030 | 693228 | 693228 | 693228 |
| WEX Inc. | Services: Business | Term Loan B (11/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 3/31/2028 | 2895655 | 2891840 | 2886621 |
| Windsor Holdings III, LLC | Chemicals, Plastics, & Rubber | Term Loan B (09/24) | Loan | 1M USD SOFR+ | 3.50% | 0.00% | 7.82% | 8/1/2030 | 495013 | 495013 | 493156 |
| Wyndham Hotels & Resorts, Inc. | Hotel, Gaming & Leisure | Term Loan (05/24) | Loan | 1M USD SOFR+ | 1.75% | 0.00% | 6.07% | 5/24/2030 | 987538 | 983680 | 987814 |
| Xperi Corporation | High Tech Industries | Term Loan (1/25) | Loan | 1M USD SOFR+ | 2.50% | 0.00% | 6.82% | 6/8/2028 | 1690908 | 1690037 | 1690908 |
| Zayo Group, LLC | Telecommunications | Term Loan 4/22 | Loan | 1M USD SOFR+ | 4.25% | 0.50% | 8.57% | 3/9/2027 | 972500 | 960739 | 935185 |
| ZEBRA BUYER (Allspring) LLC | Banking, Finance, Insurance & Real Estate | Term Loan B (12/24) | Loan | 3M USD SOFR+ | 3.00% | 0.50% | 7.38% | 11/1/2030 | 1852261 | 1845463 | 1852261 |
| Zekelman Industries, Inc. | Metals & Mining | Term Loan B (03/24) | Loan | 1M USD SOFR+ | 2.25% | 0.00% | 6.56% | 1/24/2031 | 1443124 | 1442200 | 1444812 |
| Zest Acquisition Corp. | Healthcare & Pharmaceuticals | Term Loan (1/23) | Loan | 3M USD SOFR+ | 5.25% | 0.00% | 9.54% | 2/8/2028 | 1960000 | 1896443 | 1979600 |
| Zodiac Pool Solutions | Consumer goods: Durable | Term Loan (1/22) | Loan | 1M USD SOFR+ | 1.93% | 0.50% | 6.35% | 1/29/2029 | 485000 | 484495 | 484267 |
|  |  |  |  |  |  |  |  |  |  | $**520335803** | $**492195089** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of Shares** | **Cost** | **Fair Value** |
| **Cash and cash equivalents** | | | |
| U.S. Bank Money Market (a) | 21272327 | $21272327 | $21272327 |
| **Total cash and cash equivalents** | **21272327** | $**21272327** | $**21272327** |

---

(a) Included within cash and cash equivalents in Saratoga CLO's Statements of Assets and Liabilities as of February 28, 2025.

(b) As
 of February 28, 2025, the investment was in default and on non-accrual status.

(c) Investments
 include Payment-in-Kind Interest.

(d) All
 or a portion of this investment has an unfunded commitment as of February 28, 2025.

SOFR - Secured Overnight Financing Rate

1M SOFR - The 1-month SOFR rate as of February 28, 2025 was 4.32%.

3M SOFR - The 3-month SOFR rate as of February 28, 2025 was 4.32%.

6M SOFR - The 6-month SOFR rate as of February 28, 2025 was 4.26%.

Prime - The Prime Rate as of February 28, 2025 was 7.50%.

See accompanying notes to financial statements.

**Note 5. Investment in SLF JV**

On October 26, 2021, the Company and TJHA entered into the LLC Agreement to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd ("SLF 2021"), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. ("SLF 2022").

The Company and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

The Company and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, with the Company providing $43.75 million and TJHA providing $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured loan and equity. The unsecured loan pays a fixed-rate of 10% per annum and is due and payable in full on October 20, 2033. As of May 31, 2025, the Company and TJHA's investment in SLF JV consisted of an unsecured loan of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 28, 2025, the Company and TJHA's investment in SLF JV consisted of an unsecured loan of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of May 31, 2025, and February 28, 2025, the Company's investment in the unsecured note of SLF JV had a fair value of $16.6 million and $16.5 million, respectively, and the Company's investment in the membership interests of SLF JV had a fair value of $3.1 million and $3.1 million, respectively.

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, ASC 810 concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate SLF JV.

For the three months ended May 31, 2025 and May 31, 2024, the Company earned $0.4 million and $0.4 million, respectively, of interest income related to SLF JV, which is included in interest income. As of May 31, 2025 and February 28, 2025, $0.2 million and $0.2 million, respectively, of interest income related to SLF JV was included in interest receivable on the Statements of Assets and Liabilities.

For the three months ended May 31, 2025 and May 31, 2024, the Company earned $0.4 million and $1.3 million, respectively, of dividend related to SLF JV, which is included in dividend income on control investments. As of May 31, 2025 and February 28, 2025, $0.0 million and $0.0 million, respectively, of dividend income related to SLF JV was included in dividend receivable on the Statements of Assets and Liabilities.

SLF JV's initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00% per annum and was paid in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing.

On October 28, 2022, SLF 2022 issued $402.1 million of the 2022 JV CLO Notes through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, the Company purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million. As of February 28, 2025 and February 29, 2024, the fair value of these Class E Notes were $12.3 million and $12.3 million, respectively.

**Note 6. Income Taxes**

SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc.,, SIA-MDP, Inc., SIA-PP Inc., SIA-SIQ, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., and SIA-Vector, Inc. each 100% owned by the Company, are each filing standalone C Corporation tax returns for U.S. federal and state tax purposes. As separately regarded entities for tax purposes, these entities are subject to U.S. federal income tax at corporate rates. For tax purposes, any distributions by the entities to the parent company would generally need to be distributed to the Company's shareholders. Generally, such distributions of the entities' income to the Company's shareholders will be considered as qualified dividends for tax purposes. The entities' taxable net income will differ from U.S. GAAP net income because of deferred tax temporary differences arising from net operating losses and unrealized appreciation and deprecation of securities held. Deferred tax assets and liabilities are measured using enacted corporate federal and state tax rates expected to apply to taxable income in the years in which those net operating losses are utilized and the unrealized gains and losses are realized. Deferred tax assets and deferred tax liabilities are netted off by entity, as allowed. The recoverability of deferred tax assets is assessed and a valuation allowance is recorded to the extent that it is more likely than not that any portion of the deferred tax asset will not be realized on the basis of a history of operating losses combined with insufficient projected taxable income or other taxable events in the Corporate Blockers.

The Company may distribute a portion of its realized net long term capital gains in excess of realized net short term capital losses to its stockholders, but may also decide to retain a portion, or all, of its net capital gains and elect to pay the 21% U.S. federal tax on the net capital gain, potentially in the form of a "deemed distribution" to its stockholders. Income tax (provision) relating to an election to retain its net capital gains, including in the form of a deemed distribution, is included as a component of income tax (provision) benefit from realized gains on investments, depending on the character of the underlying taxable income (ordinary or capital gains), on the consolidated statements of operations.

Deferred tax assets and liabilities, and related valuation allowance as of May 31, 2025 and February 28, 2025 were as follows:

---

| | | |
|:---|:---|:---|
|  | **May 31,<br> 2025** | **February 28, <br> 2025** |
| Total deferred tax assets | $1799606 | $1786943 |
| Total deferred tax liabilities | (5025381) | (4968693) |
| Valuation allowance on net deferred tax assets | (1768642) | (1707579) |
| Net deferred tax liability | $(4994417) | $(4889329) |

---

As of May 31, 2025, the valuation allowance on deferred tax assets was $1.8 million, which represents the federal and state tax effect of net operating losses and unrealized losses that the Company does not believe will be realized through future taxable income. Any adjustments to the Company's valuation allowance will depend on estimates of future taxable income and will be made in the period such determination is made.

Net income tax expense for the three months ended May 31, 2025 includes $(0.1) million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, and $0.1 million income tax provision/benefit from realized gain/(loss) on investments and $0.0 million net change in total operating expense in the consolidated statement of operations, respectively. Net income tax expense for the three months ended May 31, 2024 includes $0.5 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, and $0.0 million income tax provision/benefit from realized gain/(loss) on investments and ($0.06) million net change in total operating expense, in the consolidated statement of operations, respectively.

Deferred tax temporary differences may include differences for state taxes and joint venture interests.

Federal and state income tax (provisions) benefit on investments for three months ended May 31, 2025 and May 31, 2024:

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31,<br> 2025** | **May 31,<br> 2024** |
| Current |  |  |
| &nbsp;&nbsp;&nbsp;Federal | $- | $- |
| &nbsp;&nbsp;&nbsp;State | - | - |
| Net current expense | - | - |
| Deferred |  |  |
| &nbsp;&nbsp;&nbsp;Federal | 98776 | 322466 |
| &nbsp;&nbsp;&nbsp;State | 6312 | 23156 |
| Net deferred expense | 105088 | 345622 |
| Net tax provision | $105088 | $345622 |

---

**Note 7. Agreements and Related Party Transactions**

**Investment Advisory and Management Agreement**

On July 30, 2010, the Company entered into the Management Agreement with the Manager. The initial term of the Management Agreement was two years from its effective date, with one-year renewals thereafter subject to certain approvals by the Company's board of directors and/or the Company's stockholders. Most recently, on July 7, 2025, the Company's board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, the Manager implements the Company's business strategy on a day-to-day basis and performs certain services for the Company, subject to oversight by the board of directors. The Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, the Company pays the Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive management fee.

 

*Base Management Fee and Incentive Management Fee*

The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters. The base management fee is paid quarterly following the filing of the most recent quarterly report on Form 10-Q.

The incentive management fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20% of the Company's pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a "catch-up" provision. Under this provision, in any fiscal quarter, the Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. The Manager will receive 100% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of the Company's "incentive fee capital gains," which equals the Company's realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis on each investment in the Company's portfolio, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and the Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the "incentive fee capital gains" calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended May 31, 2025 and May 31, 2024, the Company incurred $4.3 million and $5.0 million in base management fees, respectively. For the three months ended May 31, 2025 and May 31, 2024, the Company incurred $2.5 million and $3.6 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended May 31, 2025 and May 31, 2024, the Company accrued an expense (benefit) of ($0.4) million and ($0.0) million in incentive fees related to capital gains.

The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of May 31, 2025, the base management fees accrual was $4.3 million and the incentive fees accrual was $2.5 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2025, the base management fees accrual was $4.2 million and the incentive fees accrual was $2.0 million and are included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

**Administration Agreement**

On July 30, 2010, the Company entered into a separate administration agreement (the "Administration Agreement") with the Manager, pursuant to which the Manager, as the Company's administrator, has agreed to furnish the Company with the facilities and administrative services necessary to conduct day-to-day operations and provide managerial assistance on the Company's behalf to those portfolio companies to which the Company is required to provide such assistance. The initial term of the Administration Agreement was two years from its effective date, with one-year renewals thereafter subject to certain approvals by the Company's board of directors and/or the Company's stockholders Since its inception the amount of expenses payable or reimbursable by the Company under the Administration Agreement has been subject to a cap that is reviewed annually in connection with the renewal of the Administration Agreement. Most recently, on July 7, 2025, the Company's board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to keep the cap on the payment or reimbursement of expenses by the Company unchanged at $5.0 million, while continuing to assess whether to increase this within the foreseeable future, with any increase to be effective August 1, 2025.

For the three months ended May 31, 2025 and May 31, 2024, the Company recognized $1.3 million and $1.1 million in administrator expenses, respectively, pertaining to bookkeeping, recordkeeping and other administrative services provided to the Company in addition to the Company's allocable portion of rent and other overhead related expenses. As of May 31, 2025 and February 28, 2025, $0.6 million and $0.3 million, respectively, of administrator expenses were accrued and included in due to the Manager in the accompanying consolidated statements of assets and liabilities.

**Saratoga CLO**

See Note 4. *Investment in Saratoga CLO* for more information regarding Saratoga CLO.

For the three months ended May 31, 2025 and May 31, 2024, the Company recognized management fee income of $0.7 million and $0.8 million, respectively, related to the Saratoga CLO.

For the three months ended May 31, 2025 and May 31, 2024, the Company neither bought nor sold any investments from the Saratoga CLO.

**SLF JV** 

See Note 5 for more information about SLF JV.

As of May 31, 2025, the Company's investment in the SLF JV had a fair value of $19.7 million, consisting of an unsecured loan of $16.6 million and membership interest of $3.1 million. For the three months ended May 31, 2025, the Company had $0.4 million of interest income related to SLF JV, of which $0.2 million was included in interest receivable as of May 31, 2025. For the three months ended May 31, 2024, the Company had $0.4 million of interest income related to SLF JV, of which $0.2 million was included in interest receivable on the Statements of Assets and Liabilities as of May 31, 2024.

As part of the JV CLO trust transaction, the Company purchased 87.50% of the Class E Notes from SLF 2022 with a principal value of $12.3 million and fair value of $12.3 million, respectively.

**Note 8. Borrowings**

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200% after giving effect to such leverage, or, 150% if certain requirements under the 1940 Act are met. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our directors who are not "interested persons" (as defined in Section 2(a)(19) of the 1940 Act") of the Company ("independent directors"), approved a minimum asset coverage ratio of 150%, which became effective on April 16, 2019. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing. Our asset coverage ratio, as defined in the 1940 Act, was 163.8% as of May 31, 2025 and 162.9% as of February 28, 2025.

***Encina Credit Facility***

 ****

On October 4, 2021, the Company entered into the Credit and Security Agreement (the "Encina Credit Agreement") relating to a $50.0 million senior secured revolving credit facility with Encina, supported by loans held by SIF II and pledged to the Encina Credit Facility. The terms of the Encina Credit Facility required a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increased to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. Advances under the Encina Credit Facility originally bore interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to the selection by Encina and the Company of a replacement benchmark rate.

On January 27, 2023, we entered into the first amendment to the Encina Credit Agreement to, among other things:

● increased the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

● changed the underlying benchmark used to compute interest under the Encina Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

● increased the applicable effective margin rate on borrowings from 4.00% to 4.25%;

● extended the revolving period from October 4, 2024 to January 27, 2026;

● extended the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a "Facility Increase") from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to the Encina Facility Increase from $75.0 million to $150.0 million;

● revised the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

● amended the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Encina Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

In addition to any fees or other amounts payable under the terms of the Encina Credit Facility, an administrative agent fee per annum equal to $0.1 million is payable in equal monthly installments in arrears.

As of May 31, 2025 and February 28, 2025, there were $32.5 million and $32.5 million outstanding borrowings under the Encina Credit Facility. During the applicable periods, the Company was in compliance with all of the limitations and requirements under the Encina Credit Agreement. Financing costs of $2.0 million related to the Encina Credit Facility have been capitalized and are being amortized over the term of the facility, with all existing financing costs amortized through January 27, 2026 from the date of the amendment and extension.

For the three months ended May 31, 2025 and May 31, 2024, we recorded $0.8 million and $0.9 million of interest expense related to the Encina Credit Facility, respectively, which includes commitment and administrative agent fees. For the three months ended May 31, 2025 and May 31, 2024, we recorded $0.1 million and $0.1 million of deferred financing costs related to the Encina Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024, the weighted average interest rate on the outstanding borrowings under the Encina Credit Facility was 8.9% and 9.9%, respectively, and the average dollar amount of outstanding borrowings under the Encina Credit Facility was $32.5 million and $34.8 million, respectively.

The Encina Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Encina Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. Availability on the Encina Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain "eligible" loan assets included as part of the borrowing base. Funds may be borrowed at the greater of the prevailing one-month SOFR rate, plus an applicable effective margin of 4.25%. In addition, the Company will pay the lender a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility.

Our borrowing base under the Encina Credit Facility was $79.5 million subject to the Encina Credit Facility cap of $65.0 million at May 31, 2025. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission ("SEC"). Accordingly, the May 31, 2025 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the period ended February 28, 2025. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

***Live Oak Credit Facility***

 ****

On March 27, 2024, the Company and its wholly owned special purpose subsidiary, SIF III, entered into a credit and security agreement (the "Live Oak Credit Agreement"), by and among SIF III, as borrower, the Company, as collateral manager and equity holder, the lenders from time to time parties thereto, Live Oak, as administrative agent and collateral agent, U.S. Bank National Association, as custodian, and U.S. Bank Trust Company, National Association, as collateral administrator, relating to Live Oak Credit Facility.

The Live Oak Credit Facility originally provided for borrowings in U.S. dollars in an aggregate amount of up to $50.0 million. During the first two years following the closing date, SIF III may request one or more increases in the commitment amount from $50.0 million to an amount not to exceed $150.0 million, subject to certain terms and conditions and a customary fee. The terms of the Live Oak Credit Agreement required a minimum drawn amount of $12.5 million at all times during the period ended March 27, 2025 and, thereafter, the greater of: (i) $25.0 million and (ii) 50% of the facility amount in effect at such time. The Live Oak Credit Facility matures on March 27, 2027. Advances are available during the term of the Live Oak Credit Facility and must be repaid in full at maturity. SIF III may request an extension of the maturity date by an additional one year, subject to the agreement of the lenders and an extension fee.

On June 14, 2024, the Company entered into the first amendment to the Live Oak Credit Agreement (the "Amendment"). The Amendment, among other things:

● increased the borrowings available under the Live Oak Credit Facility from up to $50.0 million to up to $75.0 million, subject to a borrowing base requirement;

● replaced administrative agent approval with "Required Lender" (as defined in the Live Oak Credit Agreement) approval with respect to certain matters;

● replaced Required Lender approval with 100% lender approval with respect to certain matters; and

● added new lenders (as identified in the Amendment) to the Live Oak Credit Agreement;

● changed the definition of Required Lender to require the approval of at least two unaffiliated lenders.

Advances under the Live Oak Credit Facility are subject to a borrowing base calculation, and the Live Oak Credit Facility has various eligibility criteria for loans to be included in the borrowing base. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to Adjusted Term SOFR plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility's utilization. The Live Oak Credit Agreement also provides for an unused fee of 0.50% on the unused commitments. SIF III's obligations to the lenders under the Live Oak Credit Facility are secured by a first priority security interest in substantially all of SIF III's assets. In addition, SIF III's obligations to the lenders under the Live Oak Credit Facility are secured by a pledge by the Company of its equity interests in SIF III, which is evidenced by the equity pledge agreement, dated as of March 27, 2024, by and between the Company, as pledgor, and Live Oak, as collateral agent for the benefit of the secured parties.

In connection with the Live Oak Credit Agreement, the Company entered into a loan sale and contribution agreement with SIF III, dated as of March 27, 2024, by and between the Company, as seller, and SIF III, as purchaser, pursuant to which the Company will sell or contribute certain loans held by the Company to SIF III to be used to support the borrowing base under the Live Oak Credit Facility. The Live Oak Credit Facility permits loan proceeds and excess cash in SIF III's collection accounts to be distributed to us at any time based on three business days advance notice, subject to compliance with various conditions, including the absence of a default or event of default, the absence of an over-advance against the borrowing base and the absence of a violation of the financial covenant.

As of May 31, 2025 and February 28, 2025, there were $37.5 million and $20.0 million in outstanding borrowings under the Live Oak Credit Facility. During the applicable period, the Company was in compliance with all of the limitations and requirements under the Live Oak Credit Agreement.

For the three months ended May 31, 2025 and May 31, 2024, we recorded $0.8 million and $0.3 million of interest expense related to the Live Oak Credit Facility, which includes commitment and administrative agent fees. For the three months ended May 31, 2025 and May 31, 2024, we recorded $0.1 million and $0.05 million of deferred financing costs related to the Live Oak Credit Facility. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024, the weighted average interest rate on the outstanding borrowings under the Live Oak Credit Facility was 8.5% and 9.5% respectively, and the average dollar amount of outstanding borrowings under the Live Oak Credit Facility was $32.4 million and $12.9 million, respectively.

Our borrowing base under the Live Oak Credit Facility was $86.8 million subject to the Live Oak Credit Facility cap of $75.0 million at May 31, 2025. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the May 31, 2025 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the period ended February 28, 2025. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

***SBA Debentures***

The Company's wholly owned subsidiaries, SBIC II LP and SBIC III LP, received SBIC licenses from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provide up to $175.0 million in long-term capital in the form of debentures guaranteed by the SBA. The Company's wholly owned subsidiary, SBIC LP, repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $24.0 million and have average annual fully taxed net income not exceeding $8.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to "smaller enterprises" as defined by the SBA. A smaller enterprise is one that has a net worth not exceeding $6.0 million and has an average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

The SBIC Subsidiaries are able to borrow funds from the SBA against each SBIC's regulatory capital (which generally approximates equity capital in the respective SBIC). The SBIC Subsidiaries are subject to customary regulatory requirements including but not limited to, a periodic examination by the SBA and requirements to maintain certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that the SBIC Subsidiaries will receive SBA-guaranteed debenture funding, which is dependent upon the SBIC Subsidiaries complying with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to each SBIC Subsidiary's assets over the Company's stockholders and debtholders in the event that the Company liquidates such SBIC Subsidiary or the SBA exercises its remedies under the SBA-guaranteed debentures issued by the SBIC Subsidiary upon an event of default.

The Company received exemptive relief from the SEC to permit it to exclude the debentures guaranteed by the SBA of the SBIC Subsidiaries from the definition of senior securities in the asset coverage test under the 1940 Act. This allows the Company increased flexibility under the asset coverage requirement by permitting it to borrow up to $350.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of May 31, 2025, we have funded SBIC II LP and SBIC III LP with an aggregate total of equity capital of $87.5 million and $87.5 million, respectively, and have $170.0 million in SBA-guaranteed debentures outstanding, of which $131.0 million was held by SBIC II LP and $39.0 million held in SBIC III LP.

As noted above, as of May 31, 2025, there was $170.0 million of SBA debentures outstanding and as of February 28, 2025, there was $170.0 million of SBA debentures outstanding. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy. Financing costs of $6.0 million, and $0.4 million related to the SBA debentures issued by SBIC II LP and SBIC III LP, respectively, have been capitalized and are being amortized over the term of the commitment and drawdown.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $1.3 million and $1.8 million of interest expense related to the SBA debentures, respectively. For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $0.2 million and $0.2 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the three months ended May 31, 2025 and May 31, 2024 on the outstanding borrowings of the SBA debentures was 3.04% and 3.36%, respectively. During the three months ended May 31, 2025 and May 31, 2024, the average dollar amount of SBA debentures outstanding was $170 million and $214.0 million, respectively.

 ****

***Notes***

*7.75% 2025 Notes*

On July 9, 2020, the Company issued $5.0 million in aggregate principal amount of 7.75% fixed-rate notes due in 2025 (the "7.75% 2025 Notes") for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the 7.75% 2025 Notes.

As of May 31, 2025, the total amount of 7.75% 2025 Notes outstanding was $5.0 million. The 7.75% 2025 Notes are not listed and have a par value of $25.00 per note. The carrying amount of the outstanding 7.75% 2025 Notes had a fair value of $5.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 7.75% 2025 Notes was $5.0 million and $5.0 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $0.1 million and $0.1 million, respectively, of interest expense and $0.01 million and $0.01 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024, the average dollar amount of 7.75% 2025 Notes outstanding was $5.0 million and $5.0 million respectively.

 

*6.25% 2027 Notes*

 

On December 29, 2020, the Company issued $5.0 million in aggregate principal amount of 6.25% fixed-rate notes due in 2027 (the "6.25% 2027 Notes"). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

On January 28, 2021, the Company issued an additional $10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million (the "Additional 6.25% 2027 Notes"). Offering costs incurred were approximately $0.1 million. The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at the Company's option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.

As of May 31, 2025, the total amount of 6.25% 2027 Notes outstanding was $15.0 million. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note. The carrying amount of the outstanding 6.25% 2027 Notes had a fair value of $14.6 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 6.25% 2027 Notes was $15.0 million and $14.2 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $0.2 million and $0.2 million, respectively, of interest expense and $0.02 million and $0.02 million, respectively, of amortization of deferred financing costs related to the 6.25% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024 the average dollar amount of 6.25% 2027 Notes outstanding was $15.0 million and $15.0 million respectively.

 

*4.375% 2026 Notes*

On March 10, 2021, the Company issued $50.0 million in aggregate principal amount of 4.375% fixed-rate notes due 2026 (the "4.375% 2026 Notes") for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a "make-whole" premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $1.3 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

On July 15, 2021, the Company issued an additional $125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the "Additional 4.375% 2026 Notes") for net proceeds for approximately $123.8 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting commissions of $2.5 million. Offering costs incurred were approximately $0.2 million. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes. The net proceeds from the offering were used to redeem all of the outstanding 6.25% 2025 Notes (as described above), and for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $2.7 million have been capitalized and are being amortized over the term of the additional 4.375% 2026 Notes.

As of May 31, 2025, the total amount of 4.375% 2026 Notes outstanding was $175.0 million. The 4.375% 2026 Notes are not listed and are issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. The carrying amount of the outstanding 4.375% 2026 Notes had a fair value of $170.7 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 4.375% 2026 Notes was $175.0 million and $163.4 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $1.9 million and $1.9 million, respectively, of interest expense, $0.2 million and $0.2 million, respectively, of amortization of deferred financing costs and $0.06 million and $0.06 million, respectively, of amortization of premium on issuance of 4.375% Notes due 2026 (inclusive of the issuance of the Additional 4.375% 2026 Notes). Interest expense, amortization of deferred financing costs and amortization of premium on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024, the average dollar amount of 4.375% 2026 Notes outstanding was $175.0 million and $175.0 million, respectively.

 

*4.35% 2027 Notes*

On January 19, 2022, the Company issued $75.0 million in aggregate principal amount of 4.35% fixed-rate notes due in 2027 (the "4.35% 2027 Notes") for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at the Company's option at any time prior to November 28, 2026, at par plus a "make-whole" premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes

As of May 31, 2025, the total amount of 4.35% 2027 Notes outstanding was $75.0 million. The 4.35% 2027 Notes are not listed. The carrying amount of the outstanding 4.35% 2027 Notes had a fair value of $70.9 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 4.35% 2027 Notes was $75.0 million and $64.5 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $0.8 million and $0.8 million, respectively, of interest expense, $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs and $0.03 million and $0.02 million, respectively, of amortization of on issuance of the 4.35% Notes due 2027 (inclusive of the issuance of the Additional 4.35% 2027 Notes). Interest expense, amortization of deferred financing costs, and amortization of discount on issuance of notes and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2024 and May 31, 2023, the average dollar amount of 4.35% 2027 Notes outstanding was $75.0 million and $75.0 million, respectively.

*6.00% 2027 Notes*

On April 27, 2022, the Company issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the "6.00% 2027 Notes") for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds to the Company were $9.7 million after deducting underwriting commissions of approximately $0.3 million. Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company's option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol "SAT" with a par value of $25.00 per note.

On August 15, 2022, the Company issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the "Additional 6.00% 2027 Notes") for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. Additional offering costs incurred were approximately $0.2 million. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Additional financing costs of $0.03 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.

As of May 31, 2025, the carrying amount and fair value of the 6.00% 2027 Notes was $105.5 million and $103.1 million, respectively. The fair value of the 6.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 6.00% 2027 Notes was $105.5 million and $100.7 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $1.6 million and $1.6 million, respectively, of interest expense, $0.2 million and $0.2 million, respectively, of amortization of deferred financial costs and $0.01 million and $0.01 million, respectively, of amortization of discount on issuance of 6.00% Notes due 2027. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024, the average dollar amount of 6.00% 2027 Notes outstanding was $105.5 million and $105.5 million, respectively.

*7.00% 2025 Notes*

On September 8, 2022, the Company issued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the "7.00% 2025 Notes") for net proceeds of $11.6 million after deducting underwriting discounts of approximately $0.4 million. Additional offering costs incurred were approximately $0.05 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at the Company's option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $0.04 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

As of May 31, 2025, the total amount of 7.00% 2025 Notes outstanding was $12.0 million. The 7.00% 2025 Notes are not listed. The carrying amount of the outstanding 7.00% 2025 Notes had a fair value of $12.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 7.00% 2025 Notes was $12.0 million and $11.8 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $0.2 million and $0.2 million, respectively, of interest expense, $0.04 million and $0.03 million, respectively, of amortization of deferred financial costs and $0.03 million and $0.03 million, respectively, of amortization of discount on issuance of 7.00% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024, the average dollar amount of 7.00% 2025 Notes outstanding was $12.0 million and $12.0 million, respectively.

*8.00% 2027 Notes*

On October 27, 2022, the Company issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the "8.00% 2027 Notes") for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.2 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds to the Company were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company's option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company's investment objective and strategies. Financing costs of $1.7 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol "SAJ" with a par value of $25.00 per note.

As of May <u>31, 2025, the carrying amount and fair value of the 8.00% 2027 Notes was $46.0 million and $46.9 million, respectively</u>. The fair value of the 8.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 8.00% 2027 Notes was $46.0 million and $46.2 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $0.9 million and $0.9 million, respectively, of interest expense and $0.09 million and $0.09 million, respectively, of amortization of deferred financing costs related to the 8.00% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024, the average dollar amount of 8.00% 2027 Notes outstanding was $46.0 million and $46.0 million, respectively.

*8.125% 2027 Notes*

On December 13, 2022, the Company issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the "8.125% 2027 Notes") for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.9 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds to the Company were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at the Company's option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company's investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol "SAY" with a par value of $25.00 per note

As of May 31, 2025, the carrying amount and fair value of the 8.125% 2027 Notes was $60.4 million and $60.8 million, respectively. The fair value of the 8.125% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 8.125% 2027 Notes was $60.4 million and $61.0 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $1.2 million and $1.2 million, respectively, of interest expense and $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 8.125% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024 the average dollar amount of 8.125% 2027 Notes outstanding was $60.4 million and $60.4 million respectively.

*8.75% 2025 Notes*

On March 31, 2023, the Company issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the "8.75% 2025 Notes") for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, the Company issued an additional $10.0 million in aggregate principal amount of the 8.75% 2025 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year. On February 2, 2024, pursuant to the terms of the indenture governing the 8.75% 2025 Notes, the Company elected to exercise its option to extend the maturity date of the 8.75% 2025 Notes from March 31, 2024 to March 31, 2025. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through the SBIC Subsidiaries) in accordance with the Company's investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2025 Notes have been capitalized and are being amortized over the term of the 8.75% 2025 Notes.

On March 31, 2025, $20.0 million in aggregate principal amount of the issued and outstanding 8.75% 2025 Notes was repaid in full.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $0.1 million and $0.4 million, respectively, of interest expense, $0.1 million and $0.03 million, respectively, of amortization of deferred financial costs and $0.01 million and $0.03 million, respectively, of amortization of discount related to the 8.75% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024 the average dollar amount of 8.75% 2025 Notes outstanding was $6.5 million and $20.0 million respectively.

*8.50% 2028 Notes*

On April 14, 2023, the Company issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the "8.50% 2028 Notes") for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds to the Company were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year. The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at the Company's option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company's investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes.

As of May 31, 2025, the total amount of 8.50% 2028 Notes outstanding was $57.5 million. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol "SAZ" with a par value of $25.00 per note. As of May 31, 2025, the carrying amount and fair value of the 8.50% 2028 Notes was $57.5 million and $57.8 million, respectively. The fair value of the 8.50% 2028 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2025, the carrying amount and fair value of the 8.50% 2028 Notes was $57.5 million and $58.3 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, the Company recorded $1.2 million and $1.2 million, respectively, of interest expense and $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 8.50% 2028 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended May 31, 2025 and May 31, 2024 the average dollar amount of 8.50% 2028 Notes outstanding was $57.5 million and $57.5 million respectively.

**SENIOR SECURITIES**

**(dollar amounts in thousands, except per share data)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Class and Year** (1)(2) | **Total Amount<br> Outstanding<br> Exclusive of<br> Treasury<br> Securities**(3) | **Asset<br> Coverage<br> per Unit**(4) | **Involuntary<br> Liquidating<br> Preference<br> per Share**(5) | **Average<br> Market<br> Value per<br> Share**(6) |  |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |  |
| **Credit Facility with Encina Lender Finance, LLC** | | | | |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $32500 | $1638 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $32500 | $1629 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $35000 | $1610 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | $32500 | $1659 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2022 (as of February 28, 2022) | $12500 | $2093 |  | N/A |  |
| **Credit Facility with Live Oak Banking Company** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $20000 | $1638 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $20000 | $1629 |  | N/A |  |
| **Credit Facility with Madison Capital Funding**(14) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2021 (as of February 28, 2021) | - | $3471 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2020 (as of February 29, 2020) | - | $6071 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2019 (as of February 28, 2019) | - | $2345 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2018 (as of February 28, 2018) | - | $2930 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2017 (as of February 28, 2017) | - | $2710 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2016 (as of February 29, 2016) | - | $3025 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2015 (as of February 28, 2015) | $9600 | $3117 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2014 (as of February 28, 2014) | - | $3348 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2013 (as of February 28, 2013) | $24300 | $5421 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2012 (as of February 29, 2012) | $20000 | $5834 |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2011 (as of February 28, 2011) | $4500 | $20077 |  | N/A |  |
| **7.50% Notes due 2020**(7) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2017 (as of February 28, 2017) | $- | $- |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2016 (as of February 29, 2016) | $61793 | $3025 |  | $25.24 | (8) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2015 (as of February 28, 2015) | $48300 | $3117 |  | $25.46 | (8) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2014 (as of February 28, 2014) | $48300 | $3348 |  | $25.18 | (8) |
| **6.75% Notes due 2023**(9) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2020 (as of February 29, 2020) | $- | $- |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2019 (as of February 28, 2019) | $74451 | $2345 |  | $25.74 | (10) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2018 (as of February 28, 2018) | $74451 | $2930 |  | $26.05 | (10) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2017 (as of February 28, 2017) | $74451 | $2710 |  | $25.89 | (10) |
| **8.75% Notes due 2025** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $20000 | $1629 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $20000 | $1610 |  | $25.00 | (12) |
| **6.25% Notes due 2025**(13) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2022 (as of February 28, 2022) | - | - |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2021 (as of February 28, 2021) | $60000 | $3471 |  | $24.24 | (11) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2020 (as of February 29, 2020) | $60000 | $6071 |  | $25.75 | (11) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2019 (as of February 28, 2019) | $60000 | $2345 |  | $24.97 | (11) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Class and Year** (1)(2) | **Total Amount<br> Outstanding<br> Exclusive of<br> Treasury<br> Securities**(3) | **Asset<br> Coverage<br> per Unit**(4) | **Involuntary<br> Liquidating<br> Preference<br> per Share**(5) | **Average<br> Market<br> Value per<br> Share**(6) |  |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |  |
| **7.00% Notes due 2025** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $12000 | $1638 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $12000 | $1629 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $12000 | $1610 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | $12000 | $1659 |  | $25.00 | (12) |
| **7.25% Notes due 2025**(17) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | - | - |  | N/A |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2022 (as of February 28, 2022) | $43125 | $2093 |  | $25.46 | (11) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2021 (as of February 28, 2021) | $43125 | $3471 |  | $25.77 | (11) |
| **7.75% Notes due 2025** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $5000 | $1638 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $5000 | $1629 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $5000 | $1610 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | $5000 | $1659 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2022 (as of February 28, 2022) | $5000 | $2093 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2021 (as of February 28, 2021) | $5000 | $3471 |  | $25.00 | (12) |
| **4.375% Notes due 2026** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $175000 | $1638 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $175000 | $1629 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $175000 | $1610 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | $175000 | $1659 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2022 (as of February 28, 2022) | $175000 | $2093 |  | $25.00 | (12) |
| **4.35% Notes due 2027** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $75000 | $1638 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $75000 | $1629 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $75000 | $1610 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | $75000 | $1659 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2022 (as of February 28, 2022) | $75000 | $2093 |  | $25.00 | (12) |
| **6.00% Notes due 2027** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $105500 | $1638 |  | $24.52 | (15) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $105500 | $- |  | $24.36 | (15) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $105500 | $1610 |  | $23.51 | (15) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | $105500 | $1659 |  | $23.97 | (15) |
| **6.25% Notes due 2027** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $15000 | $1638 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $15000 | $1629 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $15000 | $1610 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | $15000 | $1659 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2022 (as of February 28, 2022) | $15000 | $2093 |  | $25.00 | (12) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2021 (as of February 28, 2021) | $15000 | $3471 |  | $25.00 | (12) |
| **8.00% Notes due 2027** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $46000 | $1638 |  | $25.36 | (15) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $46000 | $1629 |  | $25.21 | (15) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $46000 | $1610 |  | $25.00 | (15) |
| **8.125% Notes due 2027** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fiscal year 2026 (as of May 31, 2025) | $60375 | $1638 |  | $25.33 | (15) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $60375 | $1629 |  | $25.27 | (15) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $60375 | $1610 |  | $25.05 | (15) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2023 (as of February 28, 2023) | $60375 | $1659 |  | $25.10 | (15) |
| **8.50% Notes due 2028** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Fiscal year 2026 (as of May 31, 2025)** | $57500 | $1638 |  | $25.32 | (17) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2025 (as of February 28, 2025) | $57500 | $1629 |  | $25.47 | (17) |
| &nbsp;&nbsp;&nbsp;Fiscal year 2024 (as of February 29, 2024) | $57500 | $1610 |  | $25.17 | (17) |

---

(1) We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the 150% asset coverage ratio we are required to maintain under the 1940 Act.

(2) This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.

(3) Total amount of senior securities outstanding at the end of the period presented.

(4) Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness, calculated on a total basis.

(5) The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The "—" indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.

(6) Not applicable for credit facility because not registered for public trading.

(7) On January 13, 2017, the Company redeemed in full its 2020 Notes. The Company used a portion of the net proceeds from the 2023 Notes offering, which was completed in December 2016, to redeem the 2020 Notes in full.

(8) Based on the average daily trading price of the 2020 Notes on the NYSE.&nbsp;&nbsp;&nbsp;&nbsp;

(9) On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.45 million, respectively, in aggregate principal amount of the $74.45 million in aggregate principal amount of issued and outstanding 2023 Notes.

(10) Based on the average daily trading price of the 2023 Notes on the NYSE.&nbsp;&nbsp;&nbsp;&nbsp;

(11) Based on the average daily trading price of the 2025 Notes on the NYSE.&nbsp;&nbsp;&nbsp;&nbsp;

(12) The carrying value of this unlisted security approximates its fair value, based on a waterfall analysis showing adequate collateral coverage.

(13) On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes. The Company used a portion of the net proceeds from the 4.375% 2026 Notes offering, which was completed in July 2021, to redeem the 6.25% 2025 Notes in full.

(14) On October 4, 2021, the Company repaid all remaining amounts outstanding under the Madison Credit Facility and the credit agreement relating to the Madison Credit Facility was terminated.

(15) Based on the average daily trading price of the 2027 Notes on the NYSE.&nbsp;&nbsp;&nbsp;&nbsp;

(16) Based on the average daily trading price of the 2028 Notes on the NYSE.&nbsp;&nbsp;&nbsp;&nbsp;

(17) On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes.

**Note 9. Commitments and Contingencies**

**Contractual Obligations**

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** |
| <br>**Long-Term Debt Obligations** | <br>**Total** | **Less Than <br> 1 Year** | **1 - 3<br> Years** | **3 - 5<br> Years** | **More Than<br> 5 Years** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| &nbsp;&nbsp;&nbsp;Encina Credit Facility | $32500 | $32500 | $- | $- | $- |
| &nbsp;&nbsp;&nbsp;Live Oak Credit Facility | $37500 | $- | $37500 | $- | $- |
| &nbsp;&nbsp;&nbsp;SBA debentures | 170000 | - | - | 20000 | 150000 |
| &nbsp;&nbsp;&nbsp;6.25% 2025 Notes | - | - | - | - | - |
| &nbsp;&nbsp;&nbsp;8.75% 2025 Notes | - | - | - | - | - |
| &nbsp;&nbsp;&nbsp;7.75% 2025 Notes | 5000 | 5000 | - | - | - |
| &nbsp;&nbsp;&nbsp;4.375% 2026 Notes | 175000 | 175000 | - | - | - |
| &nbsp;&nbsp;&nbsp;4.35% 2027 Notes | 75000 | - | 75000 | - | - |
| &nbsp;&nbsp;&nbsp;6.25% 2027 Notes | 15000 | - | 15000 | - | - |
| &nbsp;&nbsp;&nbsp;6.00% 2027 Notes | 105500 | - | 105500 | - | - |
| &nbsp;&nbsp;&nbsp;8.00% 2027 Notes | 46000 | - | 46000 | - | - |
| &nbsp;&nbsp;&nbsp;8.125% 2027 Notes | 60375 | - | 60375 | - | - |
| &nbsp;&nbsp;&nbsp;8.5% 2028 Notes | 57500 | - | 57500 | - | - |
| &nbsp;&nbsp;&nbsp;7.00% 2025 Notes | 12000 | 12000 | - | - | - |
| Total Long-Term Debt Obligations | $791375 | $224500 | $396875 | $20000 | $150000 |

---

**Off-Balance Sheet Arrangements**

As of May 31, 2025 and February 28, 2025, the Company's off-balance sheet arrangements consisted of $136.4 million and $126.7 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company's discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company's consolidated statements of assets and liabilities and are not reflected in the Company's consolidated statements of assets and liabilities.

A summary of the unfunded commitments outstanding as of May 31, 2025 and February 28, 2025 is shown in the table below (dollars in thousands):

---

| | | |
|:---|:---|:---|
|  | **May 31,<br> 2025** | **February 28,<br> 2025** |
| **At Company's discretion** | | |
| &nbsp;&nbsp;&nbsp;ActiveProspect, Inc. | $10000 | $10000 |
| &nbsp;&nbsp;&nbsp;Artemis Wax Corp. | 23500 | 23500 |
| &nbsp;&nbsp;&nbsp;Ascend Software, LLC | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;C2 Educational Systems, Inc. | - | 2000 |
| &nbsp;&nbsp;&nbsp;Davisware, LLC | - | 1000 |
| &nbsp;&nbsp;&nbsp;JDXpert | 4500 | 4500 |
| &nbsp;&nbsp;&nbsp;LFR Chicken LLC | 10000 | 10000 |
| &nbsp;&nbsp;&nbsp;Pepper Palace, Inc. | 1200 | 1200 |
| &nbsp;&nbsp;&nbsp;Procurement Partners, LLC | - | - |
| &nbsp;&nbsp;&nbsp;Saratoga Senior Loan Fund I JV, LLC | 8548 | 8548 |
| &nbsp;&nbsp;&nbsp;VetnCare MSO, LLC | 10000 | 10000 |
| &nbsp;&nbsp;&nbsp;StockIQ Technologies, LLC | 5000 | - |
| &nbsp;&nbsp;&nbsp;Total | $77748 | $75748 |
| **At portfolio company's discretion - satisfaction of certain financial and nonfinancial covenants required** |  |  |
| &nbsp;&nbsp;&nbsp;Axero Holdings, LLC – Revolving Credit Facility | 500 | 500 |
| &nbsp;&nbsp;&nbsp;Axiom Medical Consulting, LLC | 1000 | 1500 |
| &nbsp;&nbsp;&nbsp;BQE Software, Inc. | 250 | 2250 |
| &nbsp;&nbsp;&nbsp;Cloudpermit Intermediate Holding Company | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;Davisware, LLC | - | 1750 |
| &nbsp;&nbsp;&nbsp;Exigo, LLC – Revolving Credit Facility | 625 | 625 |
| &nbsp;&nbsp;&nbsp;Gen4 Dental Partners Holdings, LLC | 2381 | 2857 |
| &nbsp;&nbsp;&nbsp;Granite Comfort, LP | 11637 | 11637 |
| &nbsp;&nbsp;&nbsp;Innergy, Inc. | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;Inspect Point Holding, LLC | 2000 | 1500 |
| &nbsp;&nbsp;&nbsp;Modis Dental Partners OpCo, LLC | 4500 | 8900 |
| &nbsp;&nbsp;&nbsp;Pepper Palace, Inc. – Revolving Credit Facility | - | 600 |
| &nbsp;&nbsp;&nbsp;Stretch Zone Franchising, LLC | - | 1500 |
| &nbsp;&nbsp;&nbsp;VetnCare MSO, LLC | 6709 | 7319 |
| &nbsp;&nbsp;&nbsp;StockIQ Technologies, LLC | 2000 | - |
| &nbsp;&nbsp;&nbsp;SmartAC.com, Inc. | 17000 | - |
|  | 58602 | 50938 |
| Total | $136350 | $126686 |

---

The Company believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of May 31, 2025, the Company had cash and cash equivalents of $131.6 million, $32.5 million in available borrowings under the Encina Credit Facility, and $37.5 million in available borrowings under the Live Oak Credit Facility.

**Note 10. Directors Fees**

The independent directors of the Company's board of directors each receive an annual fee of $90,000. They also receive $3,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $2,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the audit committee receives an annual fee of $15,000 and the chairman of each other committee receives an annual fee of $8,000 for their additional services in these capacities. In addition, we have purchased directors' and officers' liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors' fees in the form of our common stock issued at a price per share equal to the greater of NAV or the market price at the time of payment. No compensation is paid to directors who are "interested persons" of the Company (as defined in Section 2(a)(19) of the 1940 Act). For the three months ended May 31, 2025 and May 31, 2024, the Company incurred $0.1 million and $0.1 million for directors' fees and expenses, respectively. As of May 31, 2025 and February 28, 2025, $0.0 million and $0.00 million in directors' fees and expenses were accrued and unpaid, respectively. As of May 31, 2025, the Company had not issued any common stock to our directors as compensation for their services.

**Note 11. Stockholders' Equity**

*Share Repurchases* 

 

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that originally allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the "Share Repurchase Plan"). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 7, 2025, the Company's board of directors extended the Share Repurchase Plan for another year to January 15, 2026. As of May 31, 2025, the Company had purchased 1,035,203 shares of common stock, at an average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three months ended May 31, 2025, the Company did not purchase any shares of common stock pursuant to the Share Repurchase Plan.

*Public Equity Offering*

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.

*Equity ATM Program*

 

On March 16, 2017, the Company entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which the Company offered for sale, from time to time, up to $30.0 million of the Company's common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, the Company had sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs).

On July 30, 2021, the Company entered into an equity distribution agreement (the "Equity Distribution Agreement") with Ladenburg Thalmann & Co. Inc. ("Ladenburg") and Compass Point Research and Trading, LLC ("Compass Point"), through which the Company may offer for sale, from time to time, up to $150.0 million of the Company's common stock through the Agents (as defined below), or to them, as principal for their account (the "ATM Program").

On July 6, 2023, the Company amended the Equity Distribution Agreement to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $300.0 million from $150.0 million. On July 19, 2023, the Company amended the Equity Distribution Agreement to add an additional distribution agent, Raymond James & Associates, Inc. ("Raymond James"). On May 15, 2024, the Company amended the Equity Distribution Agreement to add an additional distribution agent, Lucid Capital Markets, LLC ("Lucid" and together with Ladenburg, Compass Point, and Raymond James, the "Agents"). The sales price per share of the Company's common stock offered under the ATM Program, less the Agents' commission, will not be less than the NAV per share of the Company's common stock at the time of such sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

As of May 31, 2025, the Company sold 8,089,547 shares for gross proceeds of $214.3 million at an average price of $26.37 for aggregate net proceeds of $212.6 million (net of transaction costs). During the three months ended May 31, 2025, the Company sold 244,831 shares for gross proceeds of $6.4 million at an average price of $26.31 for aggregate net proceeds of $6.4 million (net of transaction costs).

The Company adopted Rule 3-04/Rule 8-03(a)(5) under Regulation S-X (Note 2). Pursuant to Regulation S-X, the Company has presented a reconciliation of the changes in each significant caption of stockholders' equity as shown in the tables below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | |
|  | **Shares** | **Amount** | **Capital**<br>**in Excess**<br>**of Par Value** | **Total Distributable**<br>**Earning**<br>**(Loss)** |<br>**Net Assets** |
| **Balance at February 29, 2024** | **13653476** | $**13654** | $**371081199** | $**(870745)** | $**370224108** |
| Increase (Decrease) from Operations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income |  | - | - | 14335005 | 14335005 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) from investments |  | - | - | (21194997) | (21194997) |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on investments |  | - | - | 13931431 | 13931431 |
| &nbsp;&nbsp;&nbsp;Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments |  | - | - | (461001) | (461001) |
| Decrease from Shareholder Distributions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributions of investment income |  | - | - | (9967036) | (9967036) |
| Capital Share Transactions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock |  | - | - | - | - |
| &nbsp;&nbsp;&nbsp;Capital contribution from Manager |  | - | - | - | - |
| &nbsp;&nbsp;&nbsp;Stock dividend distribution | 45490 | 45 | 987527 | - | 987572 |
| &nbsp;&nbsp;&nbsp;Offering costs | - | - | - | - | - |
| **Balance at May 31, 2024** | **13698966** | $**13699** | $**372068726** | $**(4227343)** | $**367855082** |
| Increase (Decrease) from Operations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income |  | - | - | 18197398 | 18197398 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) from investments |  | - | - | (33448727) | (33448727) |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on investments |  | - | - | 28728155 | 28728155 |
| &nbsp;&nbsp;&nbsp;Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments |  | - | - | (159187) | (159187) |
| Decrease from Shareholder Distributions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributions of investment income |  | - | - | (10137233) | (10137233) |
| Capital Share Transactions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Stock dividend distribution | 46803 | 47 | 1018307 | - | 1018354 |
| **Balance at August 31, 2024** | $**13745769** | $**13746** | $**373087033** | $**(1046937)** | $**372053842** |
| Increase (Decrease) from Operations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income |  | - | - | 12435655 | 12435655 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) from investments |  | - | - | 5444745 | 5444745 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on investments |  | - | - | (8918583) | (8918583) |
| &nbsp;&nbsp;&nbsp;Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments |  | - | - | (126875) | (126875) |
| &nbsp;&nbsp;&nbsp;Decrease from Shareholder Distributions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributions of investment income |  | - | - | (10171868) | (10171868) |
| &nbsp;&nbsp;&nbsp;Capital Share Transactions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock | 108438 | 108 | 2777318 | - | 2777426 |
| &nbsp;&nbsp;&nbsp;Capital contribution from Manager |  | - | 199652 | - | 199652 |
| &nbsp;&nbsp;&nbsp;Stock dividend distribution | 54999 | 55 | 1214181 | - | 1214236 |
| &nbsp;&nbsp;&nbsp;Offering costs | - | - | (42575) | - | (42575) |
| **Balance at November 30, 2024** | $**13909206** | $**13909** | $**377235609** | $**(2383863)** | $**374865655** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | |
|  | **Shares** | **Amount** | **Capital**<br>**in Excess**<br>**of Par Value** | **Total<br> Distributable**<br>**Earning**<br>**(Loss)** |<br>**Net Assets** |
| Increase (Decrease) from Operations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income |  | - | - | 8034545 | 8034545 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) from investments |  | - | - | 7169655 | 7169655 |
| &nbsp;&nbsp;&nbsp;Income tax (provision) benefit from realized gain on investments |  | - | - | - | - |
| &nbsp;&nbsp;&nbsp;Realized losses on extinguishment of debt |  | - | - | (800452) | (800452) |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on investments |  | - | - | (14766637) | (14766637) |
| &nbsp;&nbsp;&nbsp;Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments |  | - | - | (313873) | (313873) |
| Decrease from Shareholder Distributions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributions of investment income |  | - | - | (15548742) | (15548742) |
| Capital Share Transactions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock | 1192400 | 1193 | 30223409 | - | 30224602 |
| &nbsp;&nbsp;&nbsp;Capital contribution from Manager |  | - | 2152115 | - | 2152115 |
| &nbsp;&nbsp;&nbsp;Stock dividend distribution | 81472 | 81 | 1857389 | - | 1857470 |
| &nbsp;&nbsp;&nbsp;Offering costs |  | - | (208870) | - | (208870) |
| Tax reclassification of stockholders' equity in accordance with generally accepted accounting principles | - | - | 1653945 | (1653945) | - |
| **Balance at February 28, 2025** | $**15183078** | $**15183** | $**412913597** | $**(20263312)** | $**392665468** |
| Increase (Decrease) from Operations: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income |  | - | - | 10142032 | 10142032 |
| &nbsp;&nbsp;&nbsp;Net realized gain (loss) from investments |  | - | - | 2901339 | 2901339 |
| &nbsp;&nbsp;&nbsp;Income tax (provision) benefit from realized gain on investments |  | - | - | - | - |
| &nbsp;&nbsp;&nbsp;Realized losses on extinguishment of debt |  | - | - | - | - |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation (depreciation) on investments |  | - | - | 943977 | 943977 |
| &nbsp;&nbsp;&nbsp;Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments |  | - | - | (55085) | (55085) |
| Decrease from Shareholder Distributions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributions of investment income |  | - | - | (18980079) | (18980079) |
| Capital Share Transactions: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock | 244831 | 245 | 6143575 | - | 6143820 |
| &nbsp;&nbsp;&nbsp;Capital contribution from Manager |  | - | 297770 | - | 297770 |
| &nbsp;&nbsp;&nbsp;Stock dividend distribution | 101482 | 101 | 2312052 | - | 2312153 |
| &nbsp;&nbsp;&nbsp;Offering costs |  | - | (2080) | - | (2080) |
| Tax reclassification of stockholders' equity in accordance with generally accepted accounting principles | - | - |  | - | - |
| **Balance at May 31, 2025** | $**15529391** | $**15529** | $**421664914** | $**(25311128)** | $**396369315** |

---

**Note 12. Earnings Per Share**

In accordance with the provisions of FASB ASC Topic 260, *Earnings per Share*, basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase (decrease) in net assets resulting from operations per share for the three months ended May 31, 2025 and May 31, 2024 (dollars in thousands except share and per share amounts):

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| <br>**Basic and Diluted** | **May 31,<br> 2025** | **May 31,<br> 2024** |
| Net increase (decrease) in net assets resulting from operations | $13932 | $6610 |
| Weighted average common shares outstanding | 15344510 | 13683314 |
| Weighted average earnings (loss) per common share | $0.91 | $0.48 |

---

**Note 13. Dividend**

The following table summarizes dividends declared for the three months ended May 31, 2025 (dollars in thousands except per share amounts):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Date Declared** | **Record Date** | **Payment Date** | **Amount<br> Per Share** | **Total<br> Amount\*** |
| March 6, 2025 | &nbsp;&nbsp;March 6, 2025 | &nbsp;&nbsp;March 25, 2025 | $0.74 | $11303 |
| April 8, 2025 | &nbsp;&nbsp;April 8, 2025 | &nbsp;&nbsp;April 24, 2025 | 0.25 | 3836 |
| May 6, 2025 | &nbsp;&nbsp;May 6, 2025 | &nbsp;&nbsp;May 22, 2025 | 0.25 | 3841 |
| Total dividends declared |  |  | $1.24 | $18980 |

---

\* Total amount is calculated based on the number of shares outstanding at the date of record.

The following table summarizes dividends declared for the three months ended May 31, 2024 (dollars in thousands except per share amounts):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Date Declared** | **Record Date** | **Payment Date** | **Amount <br> Per Share** | **Total<br> Amount\*** |
| May 23, 2024 | &nbsp;&nbsp;June 13, 2024 | &nbsp;&nbsp;June 27, 2024 | 0.74 | 10137 |
| Total dividends declared |  |  | $0.74 | $10137 |

---

\* Total amount is calculated based on the number of shares outstanding at the date of record.

**Note 14. Financial Highlights**

The following is a schedule of financial highlights as of and for the three months ended May 31, 2025 and May 31, 2024:

---

| | | |
|:---|:---|:---|
| **Per share data** | **May 31,<br> 2025** | **May 31, <br> 2024** |
| Net asset value at beginning of period | $25.86 | $27.12 |
| Net investment income(1) | 0.66 | 1.05 |
| Net realized and unrealized gain and losses on investments(1) | 0.25 | (0.57) |
| Net increase in net assets resulting from operations | 0.91 | 0.48 |
| Distributions declared from net investment income | (1.24) | (0.73) |
| Total distributions to stockholders | (1.24) | (0.73) |
| Issuance of common stock at net asset value (2) | (0.01) | - |
| Capital contribution from Manager for the issuance of common stock (14) | 0.02 | - |
| Repurchases of common stock(3) | - | - |
| Dilution(4) | (0.02) | (0.02) |
| Net asset value at end of period | $25.52 | $26.85 |
| Net assets at end of period | $396369315 | $367855082 |
| Shares outstanding at end of period | 15529391 | 13698966 |
| Per share market value at end of period | $24.78 | $23.74 |
| Total return based on market value(5)(6) | 0.58% | 3.93% |
| Total return based on net asset value(5)(7) | 4.12% | 2.33% |
| **Ratio/Supplemental data:** |  |  |
| Ratio of net investment income to average net assets(8) | 30.27% | 18.29% |
| Expenses: |  |  |
| Ratios of operating expenses and income taxes to average net assets\*(9) | 18.11% | 8.51% |
| Ratio of incentive management fees to average net assets(5) | 1.61% | 0.97% |
| Ratio of interest and debt financing expenses to average net assets(9) | 31.30% | 13.93% |
| Ratio of total expenses and income taxes to average net assets\*(8) | 51.02% | 23.41% |
| Portfolio turnover rate(5)(10) | 5.15% | 3.52% |
| Asset coverage ratio per unit(11) | 1638 | 1596 |
| **Average market value per unit** |  |  |
| Revolving Credit Facilities(12) | N/A | N/A |
| SBA Debentures Payable(12) | N/A | N/A |
| 8.75% Notes Payable 2025(12) | N/A | N/A |
| 7.00% Notes Payable 2025(12) | N/A | N/A |
| 7.25% Notes Payable 2025(13) | N/A | N/A |
| 7.75% Notes Payable 2025(12) | N/A | N/A |
| 4.375% Notes Payable 2026(12) | N/A | N/A |
| 4.35% Notes Payable 2027(12) | &nbsp;&nbsp;&nbsp;&nbsp;N/A | N/A |
| 6.00% Notes Payable 2027 | $24.52 | $24.14 |
| 6.25% Notes Payable 2027(12) | N/A | N/A |
| 8.00% Notes Payable 2027 | $25.36 | $25.09 |
| 8.125% Notes Payable 2027 | $25.33 | $25.21 |
| 8.50% Notes Payable 2028 | $25.32 | $25.35 |

---

\* Certain prior period amounts have been reclassified to conform to current period presentation.

(1) Per share amounts are calculated using the weighted average shares outstanding during the period.

(2) The continuous issuance of common stock may cause an incremental decrease in NAV per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company less than NAV per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date multiplied by (B) the differences between the net proceeds per share and the NAV per share on each share transaction date, divided by (ii) the total shares outstanding during the period.

(3) Represents the anti-dilutive impact on the NAV of the Company due to the repurchase of common shares. See Note 11. Stockholders' Equity.

(4) Represents the dilutive effect of issuing common stock below NAV per share during the period in connection with the satisfaction of the Company's annual RIC distribution requirement and may include the impact of the different share amounts used for different items (weighted average basic common shares outstanding for the corresponding year and actual common shares outstanding at the end of the year) in the per common share data calculation and rounding impacts. See Note 13. Dividend.

(5) Ratios are not annualized.

(6) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the DRIP. Total investment return does not reflect brokerage commissions.

(7) Total investment return is calculated assuming a purchase of common shares at the current NAV on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the DRIP. Total investment return does not reflect brokerage commissions.

(8) Ratios are annualized. Incentive management fees included within the ratio are not annualized.

(9) Ratios are annualized.

(10) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

(11) Asset coverage ratio per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage ratio per unit is expressed in terms of dollar amounts per $1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause us to be below the required amount of regulatory coverage.

(12) The Revolving Credit Facilities, SBA Debentures, 8.75% Notes Payable 2025, 7.00% Notes Payable 2025, 7.75% Notes Payable 2025, 4.375% Notes Payable 2026, 4.35% Notes Payable 2027 and 6.25% Notes Payable 2027 are not registered for public trading.

(13) On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the $43.1 million in aggregate principal amount of issued and outstanding 7.25% 2025 Notes and are no longer listed on the NYSE.

(14) The Manager agreed to reimburse the Company to the extent the per share
price of the shares to the public, less underwriting fees, was less than net asset value per share.

**Note 15. Subsequent Events**

On June 12, 2025, the Company declared the following dividends for the quarter ended August 31, 2025. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP.

---

| | | | |
|:---|:---|:---|:---|
| **Month** | **Amount <br> per Share** | **Record Date** | **Payment Date** |
| June 2025 | $0.25 | &nbsp;&nbsp;July 8, 2025 | &nbsp;&nbsp;July 24, 2025 |
| July 2025 | $0.25 | &nbsp;&nbsp;August 6, 2025 | &nbsp;&nbsp;August 21, 2025 |
| August 2025 | $0.25 | &nbsp;&nbsp;September 4, 2025 | &nbsp;&nbsp;September 24, 2025 |

---

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under "Note about Forward-Looking Statements" and Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended February 28, 2025.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

● our future operating results;

● the introduction, withdrawal, success and timing of business initiatives and strategies;

● changes in political, economic or industry conditions, the interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

● the relative and absolute investment performance and operations of our Manager;

● the impact of increased competition;

● our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

● the unfavorable resolution of any future legal proceedings;

● our business prospects and the operational and financial performance of our portfolio companies, including their ability to achieve our respective objectives as a result of the current economic conditions caused by, among other things, elevated levels of inflation, and an elevated interest rate environment, and the effects of the disruptions caused thereby on our ability to continue to effectively manage our business;

● interest rate volatility, including the elevated interest rate environment, could adversely affect our results, particularly if we elect to use leverage as part of our investment strategy;

● the impact of investments that we expect to make and future acquisitions and divestitures;

● our contractual arrangements and relationships with third parties;

● the dependence of our future success on the general economy and its impact on the industries in which we invest;

● the ability of our portfolio companies to achieve their objectives;

● our expected financings and investments;

● our regulatory structure and tax treatment, including our ability to operate as a business development company ("BDC"), or to operate our small business investment company ("SBIC") subsidiaries, and to continue to qualify to be taxed as a regulated investment company ("RIC");

● the adequacy of our cash resources and working capital;

● the timing of cash flows, if any, from the operations of our portfolio companies;

● the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;

● the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

● the uncertainty associated with the imposition of tariffs and trade barriers and changes in trade policy and its impact on our portfolio companies and the global economy;

● the impact of geopolitical conditions on our portfolio companies and on the industries in which we invest;

● the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;

● the impact of changes to tax legislation and, generally, our tax position;

● our ability to access capital and any future financings by us;

● the ability of our Manager to attract and retain highly talented professionals; and

● the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments.

Such forward-looking statements may include statements preceded by, followed by or that otherwise include terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "project," "should," "will" and "would" or the negative of these terms or other comparable terminology.

We have based the forward-looking statements included in this Quarterly Report on Form 10-Q on information available to us on the date of this Quarterly Report on Form 10-Q, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the U.S. Securities and Exchange Commission (the "SEC"), including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this Quarterly Report on Form 10-Q.

**OVERVIEW**

We are a Maryland corporation that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the "1940 Act"). Our investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from our investments. We invest primarily in senior and unitranche leveraged loans and mezzanine debt issued by private U.S. middle-market companies, which we define as companies having earnings before interest, tax, depreciation and amortization ("EBITDA") of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of "investment company" under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of our net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code").

***Corporate History***

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC II LP ("SBIC II LP") and Saratoga Investment Corp. SBIC III LP ("SBIC III LP", and together with SBIC II LP, the "SBIC Subsidiaries"), received SBIC licenses from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provides up to $175.0 million in long-term capital in the form of debentures guaranteed by the SBA. With all debentures repaid to the SBA, SBIC LP's license was surrendered on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital.

On June 10, 2024, we completed the fifth refinancing of the Saratoga CLO. This refinancing, among other things, did not extend the Saratoga CLO reinvestment period nor extend its legal maturity, while adjusting the interest rate of two of the existing Notes. The Issuer issued $422.5 million of notes (the "2013-1 2024 Reset CLO Notes"), consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $0.5 million of transaction costs related to the refinancing.

We have formed a wholly owned special purpose entity, Saratoga Investment Funding II LLC, a Delaware limited liability company ("SIF II"), for the purpose of entering into a senior secured revolving credit facility with Encina Lender Finance, LLC ("Encina"), supported by loans held by SIF II and pledged to Encina under the credit facility (the "Encina Credit Facility). The Encina Credit Facility closed on October 4, 2021. During the first two years following the closing date, SIF II may request an increase in the commitment amount under the Encina Credit Facility to up to $75.0 million. The terms of the Encina Credit Facility require a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increases to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. The term of the Encina Credit Facility is three years. Advances under the Encina Credit Facility bear interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to our and Encina's selection of a replacement benchmark rate. Concurrently with the closing of the Encina Credit Facility, all remaining amounts outstanding on our existing revolving credit facility with Madison Capital Funding, LLC were repaid and the facility was terminated. On January 27, 2023, among other things, the borrowings available under the Encina Credit Facility was increased from up to $50.0 million to up to $65.0 million, the underlying benchmark rate used to compute interest changed from LIBOR to Term SOFR for one-month tenor plus a 0.10% credit spread adjustment; the applicable effective margin rate on borrowings increased from 4.00% to 4.25% and the maturity date was extended from October 4, 2024 to January 27, 2026.

We have formed a wholly owned special purpose entity, Saratoga Investment Funding III LLC, a Delaware limited liability company ("SIF III"), for the purpose of entering into a $50.0 million senior secured revolving credit facility with Live Oak Banking Company ("Live Oak"), supported by loans held by SIF III and pledged to Live Oak under the credit facility (the "Live Oak Credit Facility). The Live Oak Credit Facility closed on March 27, 2024. During the first two years following the closing date, SIF III may request an increase in the commitment amount under the Live Oak Credit Facility to up to $150.0 million. The terms of the Live Oak Credit Facility required a minimum drawn amount of $12.5 million at all times during the period ended March 27, 2025, which increased to the greater of $25.0 million or 50% of the facility amount in effect at any time thereafter. The term of the Live Oak Credit Facility is three years. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to Adjusted Term SOFR plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility's utilization. On June 14, 2024, the Live Oak Credit Facility was amended to, among other things: (i) increase the borrowings available under the Live Oak Credit Facility from up to $50.0 million to up to $75.0 million, subject to a borrowing base requirement; (ii) add new lenders to the Live Oak Credit Agreement; (iii) replace administrative agent approval with "Required Lender" (as defined in the Live Oak Credit Agreement) approval with respect to certain matters; (iv) replace Required Lender approval with 100% lender approval with respect to certain matters; and (v) change the definition of Required Lender to require the approval of at least two unaffiliated lenders.

On October 26, 2021, we entered into a Limited Liability Company Agreement with TJHA JV I LLC ("TJHA") to co-manage Saratoga Senior Loan Fund I JV LLC ("SLF JV"). SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2021-1 Ltd ("SLF 2021"), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. ("SLF 2022").

We and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

We and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, where we provided $43.75 million and TJHA provided $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note will pay a fixed-rate of 10.0% per annum and is due and payable in full on October 20, 2033. As of May 31, 2025 our and TJHA's investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 28, 2025, our and TJHA's investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of May 31, 2025 and February 28, 2025, our investment in the unsecured note of SLF JV had a fair value of $16.6 million and $16.5 million, respectively, and our investment in the membership interests of SLF JV had a fair value of $3.1 million and $3.1 million, respectively.

SLF JV's initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00% per annum and was paid in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing.

We have determined that SLF JV is an investment company under ("FASB") Accounting Standards Codification ("ASC") Topic 946, *Financial Services—Investment Companies*; however, in accordance with such guidance we will generally not consolidate our investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as we and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, *Consolidation*, concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, we do not consolidate SLF JV.

On October 28, 2022, SLF 2022 issued $402.1 million of debt through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, we purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million. As of May 31, 2025 and February 28, 2025, the fair value of these Class E Notes were $12.3 million and $12.3 million, respectively.

**Critical Accounting Policies and Estimates** 

***Basis of Presentation***

The preparation of financial statements in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") requires management to make certain estimates and assumptions affecting amounts reported in our consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies and estimates follows.

***Investment Valuation***

We account for investments at fair value in accordance with the FASB ASC Topic 820, *Fair Value Measurement* ("ASC 820"). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. Under ASC 820 we are required to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisors, the audit committee of our board of directors and a third-party independent valuation firm. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which we determine a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company's ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

● each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

● an independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. We use a third-party independent valuation firm to value our investment in the subordinated notes of Saratoga CLO and the Class F-2-R-3 Notes tranche of the Saratoga CLO every quarter.

In addition, all our investments are subject to the following valuation process:

● the audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

● our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flows that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and market comparables for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by Saratoga Investment Advisors and recommended to our board of directors. Specifically, we use Intex cash flows, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Our investments in CLO BB and CLO BBB debt have been valued using recent actual market trades or an independent pricing service. The valuation methodology of the independent pricing service includes incorporating data comprised of observable market transactions, executable bids, broker quotes from dealers with two sided markets, as well as transaction activity from comparable securities to those being valued. As the independent pricing service contemplates real-time market data and no unobservable inputs or significant judgment has been used by the Manager in the valuation of the Company's investments in CLO BB and CLO BBB debt, such positions are considered level II assets.

Rule 2a-5 under the 1940 Act ("Rule 2a-5") establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are "readily available" for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act ("Rule 31a-4") provides the recordkeeping requirements associated with fair value determinations. While our board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, we have adopted certain revisions to its valuation policies and procedures in order comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

***Revenue Recognition***

*Income Recognition*

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. We stop accruing interest on our investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management's judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management's judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

*Payment-in-Kind Interest*

We hold debt and preferred equity investments in our portfolio that contain a payment-in-kind ("PIK") interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

***Revenues***

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt or preferred equity investments may provide for a portion or all of the interest to be PIK. To the extent interest is PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring, amendment, redemption or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity or common equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was refinanced in October 2013 and November 2016 with its reinvestment period extended to October 2016 and October 2018, respectively.

On December 14, 2018, we completed a third refinancing and upsize of the Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030, and added a non-call period of January 2020. Following this refinancing, the Saratoga CLO portfolio increased its aggregate principal amount from approximately $300.0 million to approximately $500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased $2.5 million in aggregate principal amount of the Class F-R-2 and $7.5 million aggregate principal amount of the Class G-R-2 notes tranches at par, with a coupon of 3M USD LIBOR plus 8.75% and 3M USD LIBOR plus 10.00%, respectively. As part of this refinancing, we also redeemed our existing $4.5 million aggregate amount of the Class F notes tranche at par and the $20.0 million CLO 2013-1 Warehouse Loan was repaid.

On February 11, 2020, we entered into an unsecured loan agreement ("CLO 2013-1 Warehouse 2 Loan") with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd ("CLO 2013-1 Warehouse 2"), a wholly owned subsidiary of Saratoga CLO, which was fully repaid during the fourth quarter ended February 28, 2021.

On February 26, 2021, we completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, we invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently with the fourth refinancing of the Saratoga CLO, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. We also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.

On August 9, 2021, we exchanged our existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, we sold our Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

On June 10, 2024, we completed our fifth refinancing of the Saratoga CLO, which adjusted the interest rate of two of the existing Notes. Saratoga CLO issued $422.5 million notes (the "2013-1 2024 Reset CLO Notes"), consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the indenture with the same trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $0.5 million of transaction costs related to the refinancing.

The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO's assets, paid quarterly to the extent of available proceeds.

Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of FASB ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

On October 26, 2021, we and TJHA entered into the LLC Agreement to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd ("SLF 2021"), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

We and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

We and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, with us providing $43.75 million and TJHA providing $6.25 million, resulting in 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note pays a fixed-rate of 10% per annum and is due and payable in full on October 20, 2033.

We record interest income from its investment in an unsecured loan with SLF JV on an accrual basis and records dividend income from its membership interest when earned. All operating decisions are shared with a 50% voting interest in SLF JV

***Expenses***

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to directors who are not "interested persons" (as defined in Section 2(a)(19) of the 1940 Act) of the Company ("independent directors") and administrator expenses, including our allocable portion of our administrator's overhead. Our investment advisory and management fees compensate our Manager for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

● organization;

● calculating our net asset value ("NAV") (including the cost and expenses of any independent valuation firm);

● expenses incurred by our Manager payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

● expenses incurred by our Manager payable for travel and due diligence on our prospective portfolio companies;

● interest payable on debt, if any, incurred to finance our investments;

● offerings of our common stock and other securities;

● investment advisory and management fees;

● fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

● transfer agent and custodial fees;

● federal and state registration fees;

● all costs of registration and listing our common stock on any securities exchange;

● U.S. federal, state and local taxes;

● independent directors' fees and expenses;

● costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

● costs of any reports, proxy statements or other notices to common stockholders including printing costs;

● our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

● direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

● administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator's overhead in performing its obligations under an Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

● The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

● Under the "catch up" provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

● We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

 **

***Capital Gains Incentive Fee***

 **

We record an expense accrual relating to the capital gains incentive fee payable by us to the Manager when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if we were to liquidate our investment portfolio at such time. The actual incentive fee payable to our Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

**Recent Accounting Pronouncements**

In December 2023, the FASB issued ASU 2023-09, *Improvements to Income Tax Disclosures*. The amendments in this update require more disaggregated information on income taxes paid. ASU 2023-09 is effective for years beginning after December 15, 2024. Early adoption is permitted, however we have not elected to adopt this provision as of the date of the financial statements contained in this report. We are still assessing the impact of the new guidance.

In November 2024, the FASB issued ASU 2024-03, "Disaggregation of Income Statement Expenses," which requires additional disclosure of the nature of expenses included in the income statement in response to requests from investors for more information about an entity's expenses. The new standard requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. The new guidance is effective for annual periods beginning after December 15, 2027. We are currently evaluating the impact of the new standard on our consolidated financial statements and related disclosures and do not believe it will have a material impact on its consolidated financial statements or its disclosures.

**Portfolio and Investment Activity**

***Investment Portfolio Overview***

---

| | | |
|:---|:---|:---|
|  | **May 31,<br> 2025** | **February 28,<br> 2025** |
|  | **($ in millions)** | **($ in millions)** |
| Number of investments(1) | 127 | 135 |
| Number of portfolio companies(2) | 46 | 48 |
| Average investment per portfolio company(2) | $20.0 | $20.1 |
| Average investment size(1) | $7.5 | $7.2 |
| Weighted average maturity(3) | 1.9 | &nbsp;&nbsp;&nbsp;&nbsp;2.2 yrs |
| Number of industries (5) | 40 | 41 |
| Non-performing or delinquent investments (fair value) | $2.9 | $2.6 |
| Fixed rate debt (% of interest earning portfolio)(3) | $9.5(1.1)% | $26.1(3.0)% |
| Fixed rate debt (weighted average current coupon)(3) | 8.2% | 7.4% |
| Floating rate debt (% of interest earning portfolio)(3) | $838.6(98.9)% | $850.5(97.0)% |
| Floating rate debt (weighted average current spread over SOFR)(3)(4) | 7.0% | 7.2% |

---

(1) Excludes our investment in the subordinated notes of
 Saratoga CLO, and our investments in BBB and BB CLO Debt

(2) Excludes our investment in the subordinated notes of Saratoga CLO and
Class F-2-R-3 Notes tranche, as well as the unsecured notes and equity interests in the SLF JV, the Class E Note tranche of the SLF 2022
and our investments in BB and BBB CLO debt.

(3) Excludes our investment in the subordinated notes of Saratoga CLO and
equity interests, as well as the unsecured notes and equity interests in SLF JV, the Class E Note tranche of the SLF 2022 and our investments
in BB and BBB CLO debt.

(4) Calculation uses either 1-month or 3-month SOFR, depending on the contractual
 terms, and after factoring in any existing SOFR floors.

(5) Our investment in the subordinated notes of Saratoga CLO and Class
 F-R-3 Note tranche, the unsecured notes and equity interests in the SLF JV, the Class E Note tranche
 of the SLF 2022 and the BB and BBB CLO debt securities are included in Structured Finance Securities
 industry.

During the three months ended May 31, 2025, we invested $50.1 million in new and existing portfolio companies and had $64.3 million in aggregate amount of exits and repayments resulting in net investments of $(14.2) million for the period. During the three months ended May 31, 2024, we invested $39.3 million in new and existing portfolio companies and had $75.7 million in aggregate amount of exits and repayments resulting in net repayments of $(36.4) million for the period.

***Portfolio Composition***

Our portfolio composition at May 31, 2025 and February 28, 2025 at fair value was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **May 31, 2025** | **May 31, 2025** | **February 28, 2025** | **February 28, 2025** |
|  | **Percentage<br> of Total<br> Portfolio** | **Weighted<br> Average<br> Current<br> Yield** | **Percentage<br> of Total<br> Portfolio** | **Weighted<br> Average<br> Current<br> Yield** |
| First lien term loans | 86.9% | 11.4% | 88.7% | 11.3% |
| Second lien term loans | 0.7 | 16.8 | 0.7 | 16.7 |
| Unsecured term loans | 1.7 | 10.6 | 1.7 | 10.7 |
| Structured finance securities | 2.8 | 15.6 | 1.5 | 19.9 |
| Equity interests | 7.9 | - | 7.4 | - |
| Total | 100.0% | 10.7% | 100.0% | 10.8% |

---

At May 31, 2025, our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of $0.2 million and constituted 0.02% of our portfolio. This investment constitutes a first loss position in a portfolio that, as of May 31, 2025 and February 28, 2025, was composed of $495.7 million and $527.1 million, respectively, in aggregate principal amount of primarily senior secured first lien term loans. In addition, as of May 31, 2025, we also own $9.4 million in aggregate principal of the F-2-R-3 Notes in the Saratoga CLO, which only rank senior to the subordinated notes.

This investment is subject to unique risks. (See Part 1. Item 1A. Risk Factors— "Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of subordinated notes representing the lowest-rated securities issued by a pool of predominantly senior secured first lien term loans and is subject to additional risks and volatility. All losses in the pool of loans will be borne by our subordinated notes and only after the value of our subordinated notes is reduced to zero will the higher-rated notes issued by the pool bear any losses" predominantly senior secured first lien term loans and is subject to additional risks and volatility" in our Annual Report on Form 10-K for the fiscal year ended February 28, 2025).

We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at May 31, 2025, $438.1 million or 98.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and 10 Saratoga CLO portfolio investments were in default with a fair value of $4.6 million. At February 28, 2025, $484.3 million or 98.4% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and eight of the Saratoga CLO portfolio investments were in default with a fair value of $4.4 million. For more information relating to the Saratoga CLO, see the audited financial statements for Saratoga in our Annual Report on Form 10-K for the fiscal year ended February 28, 2025.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system ("CMR"). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—performing credit; (Yellow)—underperforming credit; (Red)—in principal payment default and/or expected loss of principal.

***Portfolio CMR distribution***

The CMR distribution for our investments at May 31, 2025 and February 28, 2025 was as follows:

***Saratoga Investment Corp.***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **May 31, 2025** | **May 31, 2025** | **February 28, 2025** | **February 28, 2025** |
| <br>**Color Score** | **Investments<br> at <br> Fair Value** | **Percentage<br> of Total<br> Portfolio** | **Investments<br> at<br> Fair Value** | **Percentage<br> of Total<br> Portfolio** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Green | $876855 | 90.6% | $890437 | 91.0% |
| Yellow | 1079 | 0.1 | 1086 | 0.1 |
| Red | 1861 | 0.2 | 1547 | 0.2 |
| N/A(1) | 88523 | 9.1 | 85008 | 8.7 |
| Total | $968318 | 100.0% | $978078 | 100.0% |

---

(1) Comprised of our investment in the subordinated notes of Saratoga
CLO, equity interests, and BB and BBB CLO debt securities.

The CMR distribution of Saratoga CLO investments at May 31, 2025 and February 28, 2025 was as follows:

***Saratoga CLO***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **May 31, 2025** | **May 31, 2025** | **February 28, 2025** | **February 28, 2025** |
| <br>**Color Score** | **Investments<br> at <br> Fair Value** | **Percentage<br> of Total<br> Portfolio** | **Investments<br> at<br> Fair Value** | **Percentage<br> of Total<br> Portfolio** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Green | $409540 | 92.1% | $446859 | 90.8% |
| Yellow | 28577 | 6.4 | 37453 | 7.6 |
| Red | 4615 | 1 | 6198 | 1.3 |
| N/A(1) | 2306 | 0.5 | 1685 | 0.3 |
| Total | $445038 | 100.0% | $492195 | 100.0% |

---

(1) Comprised of Saratoga CLO's equity interests.

***Portfolio composition by industry grouping at fair value***

 ****

The following table shows our portfolio composition by industry grouping at fair value at May 31, 2025 and February 28, 2025:

***Saratoga Investment Corp.***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **May 31, 2025** | **May 31, 2025** | **February 28, 2025** | **February 28, 2025** |
|  | **Investments At <br> Fair Value** | **Percentage<br> of Total<br> Portfolio** | **Investments At<br> Fair Value** | **Percentage<br> of Total<br> Portfolio** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Healthcare Services | $83595 | 8.6% | $85149 | 8.5% |
| Consumer Services | $59214 | 6.1 | $59439 | 6.1 |
| HVAC Services and Sales | $53752 | 5.6 | $57458 | 5.9 |
| Real Estate Services | $51659 | 5.3 | $51750 | 5.3 |
| Healthcare Software | $45944 | 4.7 | $45986 | 4.7 |
| Mental Healthcare Services | $31925 | 3.3 | $32405 | 3.3 |
| Education Software | $31910 | 3.3 | $41595 | 4.3 |
| Custom Millwork Software | $31722 | 3.3 | $31722 | 3.2 |
| Restaurant | $31656 | 3.3 | $31600 | 3.2 |
| Dental Practice Management | $31453 | 3.2 | $35159 | 3.6 |
| Municipal Government Software | $30006 | 3.1 | $29720 | 3 |
| Education Services | $28607 | 3 | $27533 | 2.8 |
| Employee Collaboration Software | $27503 | 2.8 | $27179 | 2.8 |
| Structured Finance Securities(1) | $47109 | 4.8 | $34337 | 3.5 |
| Talent Acquisition Software | $27338 | 2.8 | $27334 | 2.8 |
| Financial Services | $26308 | 2.7 | $26302 | 2.7 |
| Research Software | $26186 | 2.7 | $26280 | 2.7 |
| Health/Fitness Franchisor | $25485 | 2.6 | $28453 | 2.9 |
| Architecture & Engineering Software | $25118 | 2.6 | $25293 | 2.6 |
| Direct Selling Software | $24166 | 2.5 | $24064 | 2.5 |
| Mentoring Software | $21838 | 2.3 | $22027 | 2.3 |
| Insurance Software | $20532 | 2.1 | $20345 | 2.1 |
| IT Services | $19058 | 2 | $18810 | 1.9 |
| Marketing Orchestration Software | $18525 | 1.9 | $18444 | 1.9 |
| Fire Inspection Business Software | $18050 | 1.9 | $10178 | 1 |
| Corporate Education Software | $17505 | 1.8 | $17346 | 1.8 |
| Non-profit Services | $16556 | 1.7 | $16470 | 1.7 |
| Alternative Investment Management Software | $14145 | 1.5 | $11576 | 1.2 |
| Veterinary Services | $13273 | 1.4 | $12667 | 1.3 |
| Lead Management Software | $11525 | 1.2 | $11641 | 1.2 |
| HVAC Monitoring Devices | $10940 | 1.1 | $- | 0 |
| Supply Chain Planning Software | $10113 | 1 | $- | 0 |
| Financial Services Software | $10025 | 1 | $9933 | 1 |
| Industrial Products | $9500 | 1 | $9404 | 1 |
| Office Supplies | $5339 | 0.6 | $5339 | 0.5 |
| Cyber Security | $3747 | 0.4 | $3517 | 0.4 |
| Staffing Services | $3542 | 0.4 | $3426 | 0.4 |
| Specialty Food Retailer | $1861 | 0.2 | $1546 | 0.2 |
| Association Management Software | $1588 | 0.2 | $24850 | 2.5 |
| Field Service Management | $- | 0 | $11751 | 1.2 |
| Total | $968318 | 100.0% | $978078 | 100.0% |

---

(1) As
 of May 31, 2025 and February 28, 2025, the foregoing comprised of our investment in the subordinated
 notes and F-2-R-3 Notes of Saratoga CLO, the unsecured notes and equity interests in the
 SLF JV, E-Notes of SLF 2022, and BB and BBB CLO debt securities.

The following table shows Saratoga CLO's portfolio composition by industry grouping at fair value at May 31, 2025 and February 28, 2025:

***Saratoga CLO***

 ****

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **May 31, 2025** | **May 31, 2025** | **February 28, 2025** | **February 28, 2025** |
|  | **Investments<br> at<br> Fair Value** | **Percentage<br> of Total<br> Portfolio** | **Investments<br> at<br> Fair Value** | **Percentage<br> of Total<br> Portfolio** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Banking, Finance, Insurance & Real Estate | $94098 | 20.2% | $101194 | 20.9% |
| Services: Business | 45847 | 9.9 | $46915 | 9.5 |
| High Tech Industries | 36195 | 7.8 | $39950 | 8.1 |
| Services: Consumer | 26244 | 5.6 | $26923 | 5.5 |
| Healthcare & Pharmaceuticals | 25204 | 5.5 | $26032 | 5.3 |
| Chemicals, Plastics, & Rubber | 23041 | 5 | $25268 | 5.1 |
| Retail | 21448 | 4.6 | $22306 | 4.5 |
| Media: Advertising, Printing & Publishing | 17287 | 3.7 | $17309 | 3.5 |
| Hotel, Gaming & Leisure | 16790 | 3.6 | $16900 | 3.3 |
| Automotive | 16434 | 3.5 | $16730 | 3.3 |
| Telecommunications | 15541 | 3.3 | $19475 | 4 |
| Consumer goods: Durable | 14239 | 3.1 | $14008 | 2.8 |
| Construction & Building | 13129 | 2.8 | $13129 | 2.7 |
| Beverage, Food & Tobacco | 12633 | 2.7 | $12920 | 2.6 |
| Containers, Packaging & Glass | 12301 | 2.7 | $13522 | 2.7 |
| Consumer goods: Non-durable | 9863 | 2.1 | $10571 | 2.1 |
| Aerospace & Defense | 8131 | 1.7 | $8353 | 1.7 |
| Wholesale | 7712 | 1.7 | $8061 | 1.6 |
| Media: Broadcasting & Subscription | 6882 | 1.5 | $7069 | 1.4 |
| Transportation: Cargo | 6604 | 1.4 | $7153 | 1.5 |
| Utilities: Oil & Gas | 6277 | 1.3 | $6417 | 1.3 |
| Capital Equipment | 4720 | 1 | $4739 | 1 |
| Media: Diversified & Production | 4211 | 0.9 | $6286 | 1.3 |
| Forest Products & Paper | 4055 | 0.9 | $4408 | 0.9 |
| Transportation: Consumer | 3617 | 0.8 | $3727 | 0.8 |
| Energy: Electricity | 3301 | 0.7 | $3306 | 0.7 |
| Energy: Oil & Gas | 2941 | 0.6 | $3012 | 0.6 |
| Environmental Industries | 2499 | 0.6 | $2588 | 0.5 |
| Utilities: Electric | 1987 | 0.4 | $1988 | 0.4 |
| Metals & Mining | 1890 | 0.4 | $1936 | 0.4 |
| Total | $465121 | 100.0% | $492195 | 100.0% |

---

***Portfolio composition by geographic location at fair value***

The following table shows our portfolio composition by geographic location at fair value at May 31, 2025 and February 28, 2025. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **May 31, 2025** | **May 31, 2025** | **February 28, 2025** | **February 28, 2025** |
|  | **Investments<br> at<br> Fair Value** | **Percentage<br> of Total<br> Portfolio** | **Investments<br> at<br> Fair Value** | **Percentage<br> of Total<br> Portfolio** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Midwest | $334274 | 34.4% | $364944 | 37.3% |
| Southeast | 225435 | 23.3 | 234144 | 23.9 |
| Northeast | 127700 | 13.2 | 128787 | 13.2 |
| West | 125762 | 13.0 | 120361 | 12.3 |
| Southwest | 75400 | 7.8 | 63278 | 6.5 |
| International/Other | 19058 | 2.0 | 18810 | 1.9 |
| Other(1) | 60689 | 6.3 | 47754 | 4.9 |
| Total | $968318 | 100.0% | $978078 | 100.0% |

---

(1) Comprised of our investments in the subordinated
 notes, F-2-R-3 Notes of Saratoga CLO, as well as the unsecured notes and equity interests
 in the SLF JV, foreign investments and the BB and BBB CLO debt securities.

**Results of operations**

Operating results for the three months ended May 31, 2025 and May 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31,<br> 2025** | **May 31,<br> 2024** |
|  | **($ in thousands)** | **($ in thousands)** |
| Total investment income | $32319 | $38678 |
| Total operating expenses | 22177 | 24343 |
| Net investment income | 10142 | 14335 |
| Net realized gain (loss) from investments | 2901 | (21195) |
| Net change in unrealized appreciation (depreciation) on investments | 944 | 13931 |
| Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments | (55) | (461) |
| Net increase (decrease) in net assets resulting from operations | $13932 | $6610 |

---

***Investment income***

The composition of our investment income for three months ended May 31, 2025 and May 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31, <br> 2025** | **May 31,<br> 2024** |
|  | **($ in thousands)** | **($ in thousands)** |
| Interest from investments | $28004 | $34306 |
| Interest from cash and cash equivalents | 2027 | 625 |
| Management fee income | 705 | 804 |
| Dividend Income | 999 | 1547 |
| Structuring and advisory fee income | 264 | 411 |
| Other income | 319 | 985 |
| Total investment income | $32318 | $38678 |

---

For the three months ended May 31, 2025, total investment income decreased $6.4 million, or 16.4%, to $32.3 million from $38.7 million for the three months ended May 31, 2024. Interest income from investments decreased $6.3 million, or 18.4%, to $28.0 million for the three months ended May 31, 2025 from $34.3 million for the three months ended May 31, 2024. Interest income from investments decreased due to the decrease of $127.3 million, or 11.6%, in total investments at May 31, 2025 from $1,095.6 million at May 31, 2024 to $968.3 million as of May 31, 2025, combined with the decrease in the weighted average current yield on investments to 10.6%, down from 11.5% at May 31, 2024, primarily due to the reduction in SOFR base rates during this period.

For the three months ended May 31, 2025 and May 31, 2024, total PIK income was $0.8 million and $0.6 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, interest from cash and cash equivalents was $2.0 million and $0.6 million, respectively. The increase of $1.4 million was due to increased cash and cash equivalents balances during this period as compared to last year, reflecting the significant levels of repayments experienced during this period.

Management fee income reflects the fee income received for managing the Saratoga CLO. For the three months ended May 31, 2025 and May 31, 2024, total management fee income was $0.7 million and $0.8 million, respectively.

For the three months ended May 31, 2025 and May 31, 2024, total dividend income was $1.0 million and $1.5 million, respectively. Dividends received is recorded in the consolidated statements of operations when earned, and the decrease primarily reflects lower dividend income of $0.4 million received on our membership interest in SLF JV during the three months ended May 31, 2025 as compared to last year.

For the three months ended May 31, 2025 and May 31, 2024, total structuring and advisory fee income was $0.3 million and $0.4 million, respectively. Structuring and advisory fee income represents fee income earned and received performing certain investment and advisory activities during the closing of new investments.

For the three months ended May 31, 2025 and May 31, 2024, other income was $0.3 million and $1.0 million, respectively. Other income includes origination fees, monitoring and amendment fees and prepayment fees and is recorded in the consolidated statements of operations when earned.

***Operating expenses***

The composition of our operating expenses for the three months ended May 31, 2025 and May 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31, <br> 2025** | **May 31,<br> 2024** |
|  | **($ in thousands)** | **($ in thousands)** |
| Interest and debt financing expenses | $12452 | $12962 |
| Base management fees | 4333 | 4983 |
| Incentive management fees expense (benefit) | 2537 | 3585 |
| Professional fees | 699 | 999 |
| Administrator expenses | 1250 | 1075 |
| Insurance | 74 | 78 |
| Directors fees and expenses | 132 | 113 |
| General & administrative | 645 | 609 |
| Income tax expense (benefit) | 55 | (61) |
| Total operating expenses | $22177 | $24343 |

---

For the three months ended May 31, 2025, total operating expenses decreased $2.2 million, or 8.9%, compared to the three months ended May 31, 2024.

For the three months ended May 31, 2025, interest and debt financing expenses decreased $0.5 million, or 3.9%, compared to the three months ended May 31, 2024. The decrease is primarily attributable to a decrease of 4.8% in average outstanding debt from $833.0 million for the three months ended May 31, 2024 to $792.8 million for the three months ended May 31, 2025.

For the three months ended May 31, 2025 and May 31, 2024, the weighted average interest rate on our outstanding indebtedness was relatively unchanged at 5.58% and 5.58%, respectively.

As of May 31, 2025 and February 28, 2025, the SBA debentures represented 21.4% and 21.4% of overall debt, respectively.

For the three months ended May 31, 2025, base management fees decreased $0.7 million, or 13.0%, from $5.0 million to $4.3 million compared to the three months ended May 31, 2024. The decrease in base management fees results from the 13.0% decrease in the average value of our total assets, less cash and cash equivalents, from $1,129.6 million for the three months ended May 31, 2024 to $982.4 million for the three months ended May 31, 2025.

For the three months ended May 31, 2025, incentive management fees decreased $1.1 million to $2.5 million, or 29.2%, compared to $3.6 million the three months ended May 31, 2024. The incentive fee on income decreased from $3.6 million to $2.5 million for the three months ended May 31, 2024 and 2025, respectively, reflecting the decrease in net investment income during the three months ended May 31, 2025 as compared to the three months ended May 31, 2024. The incentive fee on capital gains decreased from a $0.0 million expense for the three months ended May 31, 2024 to a $0.0 million benefit for the three months ended May 31, 2025, reflecting the incentive fee on net realized and unrealized depreciation recognized during both these periods, with the liability floor capped at zero.

For the three months ended May 31, 2025, professional fees decreased $0.3 million, or 30.0% compared to the three months ended May 31, 2024.

For the three months ended May 31, 2025, administrator expenses increased $0.2 million, or 16.3% compared to the three months ended May 31, 2024, reflecting the contractual changes to the administrator agreement cap.

For the three months ended May 31, 2025, general and other expenses increased $0.04 million, or 6.0% compared to the three months ended May 31, 2024.

As discussed above, the decrease in interest and debt financing expenses for the three months ended May 31, 2025 compared to the three months ended May 31, 2024 is primarily attributable to an decrease in the average dollar amount of outstanding debt. For the three months ended May 31, 2025 and May 31, 2024, the average borrowings outstanding under the Encina Credit Facility was $32.5 million and $34.8 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Encina Credit Facility was 8.86% and 9.89%, respectively. For the three months ended May 31, 2025 and May 31, 2024, the average borrowings outstanding under the Live Oak Credit Facility was $32.4 million and $12.9 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Live Oak Credit Facility was 8.50% and 9.53%, respectively. For the three months ended May 31, 2025 and May 31, 2024, the average borrowings outstanding of SBA debentures was $170.0 million and $214.0 million, respectively. For the three months ended May 31, 2025 and May 31, 2024, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.04% and 3.36%, respectively. For the three months ended May 31, 2025 and May 31, 2024, the average borrowings outstanding of our Notes Payable was $557.9 million and $571.4 million, respectively. For the three months ended May 31, 2025 and May 31, 2024, the weighted average interest rate on the Notes Payable was 6.00% and 6.06%, respectively.

The weighted average dollar amount of our unsecured notes for the three months ended May 31, 2025 and May 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** |
|  | **May 31,<br> 2025** | **May 31,<br> 2024** |
|  | **($ in thousands)** | **($ in thousands)** |
| 7.75% 2025 Notes | $5.0 | $5.0 |
| 6.25% 2027 Notes | 15.0 | 15.0 |
| 4.375% 2026 Notes | 175.0 | 175.0 |
| 4.35% 2027 Notes | 75.0 | 75.0 |
| 6.00% 2027 Notes | 105.5 | 105.5 |
| 7.00% 2025 Notes | 12.0 | 12.0 |
| 8.00% 2027 Notes | 46.0 | 46.0 |
| 8.125% 2027 Notes | 60.4 | 60.4 |
| 8.75% 2024 Notes |  | 20.0 |
| 8.50% 2028 Notes | 57.5 | 57.5 |

---

For the three months ended May 31, 2025 and May 31, 2024, there were income tax expense (benefits) of $0.05 million and $(0.06) million, respectively. This relates to net deferred federal and state income tax expense (benefit) with respect to operating gains and losses and income derived from equity investments held in entities that are treated as corporations for U.S. federal income tax purposes, as well as current U.S. federal and state income taxes on those operating gains and losses when realized.

***Net realized gains (losses) on sales of investments***

For the three months ended May 31, 2025, we had $64.3 million of sales, repayments, exits or restructurings resulting in $2.9 million of net realized gains.

**Three Months ended May 31, 2025**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Issuer** | **Asset Type** | **Gross<br> Proceeds** | **Cost** | **Net<br> Realized<br> Gain (Loss)** |
| HemaTerra Holdings Company, LLC | First Lien Term Loan & Equity Interests | $- | $(97441.00) | $97441 |
| Identity Automation Systems | First Lien Term Loan & Equity Interests | (2569730) | (4735273) | 2165543 |
| Netreo Holdings, LLC | First Lien Term Loan & Equity Interests |  | (638355) | 638355 |

---

We received escrow payments from the prior sales of our investments in HemaTerra Holdings Company, LLC and Netreo Holdings, LLC.

The $2.2 million of net realized gains was from the sale of the equity positions in our Identity Automation Systems.

For the three months May 31, 2024, we had $75.7 million of sales, repayments, exits, or restructurings resulting in $21.2 million of net realized gains.

**Three Months ended May 31, 2024**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Issuer** | **Asset Type** | **Gross<br> Proceeds** | **Cost** | **Net<br> Realized<br> Gain (Loss)** |
| Zollege PBC | First Lien Term Loan & Equity Interest | $3204883 | $18315717 | $(15110834) |
| Netreo Holdings, LLC | Equity Interests | 2260337 | 8344500 | (6084163) |

---

The $15.1 million of net realized losses was from the restructuring of our Zollege PBC investment.

The $6.1 million of net realized losses was from the sale of the equity position in our Netreo Holdings, LLC investment.

***Net change in unrealized appreciation (depreciation) on investments***

For the three months ended May 31, 2025, our investments had a net change in unrealized appreciation of $0.9 million compared to a net change in unrealized depreciation of $13.9 million for the three months ended May 31, 2024.

The most significant cumulative net change in unrealized appreciation (depreciation) for the three months ended May 31, 2025 were the following (dollars in thousands):

**Three Months ended May 31, 2025**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Issuer** | **Asset Type** | **Cost** | **Fair Value** | **Total Unrealized Appreciation (Depreciation)** | **YTD Change<br> in Unrealized<br> Appreciation<br> (Depreciation)** |
| Identity Automation Systems | First Lien Term Loan & Equity Interests | $- | $- | $- | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1108) |
| Zollege PBC | First Lien Term Loan & Equity Interests | 2020 | 5039 | 3019 | 1102 |
| Stretch Zone Franchising, LLC | First Lien Term Loan & Equity Interests | 26810 | 25485 | (1326) | 748 |

---

The $1.1 million net change in unrealized appreciation in our investment in Zollege PBC was driven by improved Company performance.

The $1.1 million net change in unrealized depreciation in our investment in Identity Automation Systems was driven by the sale of the equity position, resulting in a reversal of previously recognized unrealized appreciation reclassified to realized gain.

The $0.7 million net change in unrealized appreciation in our investment in Stretch Zone Franchising, LLC was driven by decreased company leverage.

The most significant cumulative net change in unrealized appreciation (depreciation) for the three months ended May 31, 2024 were the following (dollars in thousands):

**Three Months ended May 31, 2024**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Issuer** | **Asset Type** | **Cost** | **Fair Value** | **Total Unrealized Appreciation (Depreciation)** | **YTD Change<br> in Unrealized<br> Appreciation<br> (Depreciation)** |
| Zollege PBC | First Lien Term Loan & Equity Interests | $1652 | $2017 | $365 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14530 |
| Netreo Holdings, LLC | First Lien Term Loan & Equity Interests |  |  |  | 3803 |
| Saratoga Investment Corp. CLO 2013-1, Ltd. | Structured Finance Securities | 19822 | 4425 | (15397) | (2896) |
| ARC Health OpCo LLC | First Lien Term Loan & Equity Interests | 37513 | 35390 | (2123) | (1988) |
| Saratoga Senior Loan Fund I JV, LLC | Equity Interests | 9375 | 7379 | (1996) | (1497) |
| Artemis Wax Corp | First Lien Term Loan & Equity Interests | 60253 | 63254 | 3001 | (1480) |

---

The $14.5 million net change in unrealized appreciation in our investment Zollege PBC was driven by the restructuring of the investment, resulting in a reversal of previously recognized unrealized depreciation reclassified to realized loss.

The $3.8 million net change in unrealized appreciation in our investment Netreo Holdings, LLC was driven by the sale of the equity position, resulting in a reversal of previously recognized unrealized depreciation reclassified to realized loss.

The $2.9 million net change in unrealized depreciation in our investment Saratoga Investment Corp. CLO 2013-1, Ltd. was driven by the quarterly cash distribution, as well as a reduction in the carrying value of certain defaulted loans in the portfolio, as well as overall market conditions.

The $2.0 million of net change in unrealized depreciation in our investment ARC Health OpCo LLC was driven by declines in company performance and capital structure changes.

The $1.5 million net change in unrealized depreciation in our investment Saratoga Senior Loan Fund I, JV, LLC was driven by the impact of overall market conditions.

The $1.5 million of net change in unrealized depreciation in our investment Artemis Wax Corp. was driven by the quarterly cash distribution, along with overall market conditions.

***Changes in net assets resulting from operations***

For the three months ended May 31, 2025, we recorded a net increase in net assets resulting from operations of $13.9 million. Based on 15,344,510 weighted average common shares outstanding as of May 31, 2025, our per share net increase in net assets resulting from operations was $0.91 for the three months ended May 31, 2025. For the three months ended May 31, 2024, we recorded a net increase in net assets resulting from operations of $6.6 million. Based on 13,683,314 weighted average common shares outstanding as of May 31, 2024, our per share net increase in net assets resulting from operations was $0.48 for the three months ended May 31, 2024.

**FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES**

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle-market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, the Encina Credit Facility and the Live Oak Credit Facility, our continued access to the SBA debentures future borrowings and future offerings of debt and equity securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan ("DRIP"), our equity ATM Program (as defined below), and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current NAV per share and we are limited in our ability to sell our common stock at a price below NAV per share, we have been and may continue to be limited in our ability to raise equity capital.

In addition, we intend to distribute to our stockholders substantially all of our operating taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, in accordance with certain applicable provisions of the Code and the Treasury regulations and a revenue procedure issued by the Internal Revenue Service ("IRS"), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. We may rely on the revenue procedure in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%, reduced to 150% effective April 16, 2019 following the approval received from our board of directors, including a majority of our independent directors, on April 16, 2018. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 163.8% as of May 31, 2025 and 162.9% as of February 28, 2025. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other public and private debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies, to pay dividends or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Due to the diverse capital sources available to us at this time, we believe we have adequate liquidity to support our near-term capital requirements.

***Encina Credit Facility***

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Encina Lender Finance, LLC on October 4, 2021 (the "Encina Credit Facility").

 

*Commitment*. We entered into the Credit and Security Agreement (the "Encina Credit Agreement") relating to the Encina Credit Facility in the initial facility amount of $50.0 million (the "Encina Facility Amount").

 

*Availability*. We can draw up to the lesser of (i) the Encina Facility Amount and (ii) the Borrowing Base. The Borrowing Base is an amount equal to (i) the difference of (A) the product of the applicable advance rate which varies from 50.0% to 75.0% depending on the type of loan asset (Defaulted Loans being excluded in that they carry an advance rate of 0%) and the value, determined in accordance with the Encina Credit Facility (the "Adjusted Borrowing Value"), of certain "eligible" loan assets pledged as security for the loan (the "Borrowing Base Value") and (B) the Excess Concentration Amount, as calculated in accordance with the Encina Credit Facility, plus (ii) any amounts held in the Prefunding Account and, without duplication, Excess Cash held in the Collection Account, less (iii) the product of (a) the amount of any undrawn funding commitments we have under any loan asset and (b) the Unfunded Exposure Haircut Percentage, and less (iv) $100,000. Each loan asset we held as of the date on which the Encina Credit Facility was closed was valued as of that date and each loan asset that we acquire after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things and under certain circumstances, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Encina Credit Facility contains limitations on the type of loan assets that are "eligible" to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an "eligible" loan asset, we may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

The Encina Credit Facility requires certain minimum drawn amounts. For the period beginning on the closing date and ending April 4, 2022, the minimum funding amount was $12.5 million. For the period beginning on April 5, 2022 through maturity, the minimum funding amount is the greater of $25.0 million and 50% of the Encina Facility Amount in effect from time to time.

 

*Collateral*. The Encina Credit Facility is secured by assets of Saratoga Investment Funding II LLC ("SIF II") and pledged to Encina under the Encina Credit Facility. SIF II is a wholly owned special purpose entity formed for the purpose of entering into the Encina Credit Facility.

 

*Interest Rate and Fees*. Under the Encina Credit Facility, funds were borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 0.75%, plus an applicable margin of 4.00%. The Encina Credit Agreement includes benchmark replacement provisions which permit the Administrative Agent and the borrower to select a replacement rate upon the unavailability of LIBOR. In addition, we pay the lenders a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility for the duration of the term of the Encina Credit Facility. Accrued interest and commitment fees are payable monthly in arrears. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Encina Credit Facility.

 

*Collateral Tests*. It is a condition precedent to any borrowing under the Encina Credit Facility that the principal amount outstanding under the Encina Credit Facility, after giving effect to the proposed borrowings, not exceed the Borrowing Base (the "Borrowing Base Test"). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the "Collateral Tests"):

&nbsp;&nbsp;&nbsp;&nbsp;o *Interest Coverage Ratio.* The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees
and expenses relating to the Encina Credit Facility, to accrued interest and commitment fees payable to the lenders under the Encina
Credit Facility for the last 6 payment periods must equal at least 175.0%.

&nbsp;&nbsp;&nbsp;&nbsp;o *Overcollateralization Ratio.* The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of "eligible" pledged loan assets
plus the fair value of certain ineligible pledged loan assets (in each case, subject to certain adjustments) to outstanding borrowings
under the Encina Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

The Encina Credit Facility also may require payment of outstanding borrowings or replacement of pledged loan assets upon our breach of our representation and warranty that pledged loan assets included in the Borrowing Base are "eligible" loan assets. Such ineligible collateral loans will be excluded from the calculation of the Borrowing Base and may lead to a Borrowing Base Deficiency, which may be cured by effecting one or more (or any combination thereof) of the following actions: (A) deposit into or credit to the collection account cash and eligible investments, (B) repay outstanding borrowings (together with certain costs and expenses), (C) sell or substitute loan assets in accordance with the Encina Credit Facility, or (D) pledge additional loan assets as collateral. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by us.

 

*Priority of Payments*. The priority of payments provisions of the Encina Credit Facility require, after payment of specified fees and expenses, that collections of interest from the loan assets and, to the extent that these are insufficient, collections of principal from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met.

 

*Operating Expenses*. The priority of payments provision of the Encina Credit Facility provides for the payment of certain of our operating expenses out of collections on interest and principal in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $200,000 per annum.

 

 

*Covenants; Representations and Warranties; Events of Default*. The Encina Credit Agreement contains customary representations and warranties, affirmative covenants, negative covenants and events of default. The Encina Credit Agreement does not contain grace periods for breach by us of any negative covenants or of certain of the affirmative covenants, including, without limitation, those related to preservation of the existence and separateness of the Company. Other events of default under the Encina Credit Agreement include, among other things, the following:

&nbsp;&nbsp;&nbsp;&nbsp;o our failure to maintain an Interest Coverage Ratio of less than 175%;

&nbsp;&nbsp;&nbsp;&nbsp;o our failure to maintain an Overcollateralization Ratio of less than 200%;

&nbsp;&nbsp;&nbsp;&nbsp;o the filing of certain ERISA or tax liens on our assets or the Equity holder;

&nbsp;&nbsp;&nbsp;&nbsp;o failure by Specified Holders to collectively, directly or indirectly, own and control at least 51% of the outstanding equity interests of Saratoga Investment Advisor, or (y) possess the right to elect (through contract, ownership of voting securities or otherwise) at all times a majority of the board of directors (or similar governing body) of Saratoga Investment Advisor and to direct the management policies and decisions of Saratoga Investment Advisor, or (ii) the dissolution, termination or liquidation in whole or in part, transfer or other disposition, in each case, of all or substantially all of the assets of, Saratoga Investment Advisor;

&nbsp;&nbsp;&nbsp;&nbsp;o indictment or conviction of Saratoga Investment Advisors or any "key person" for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any "key person" and, in the case of "key persons," without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed to replace such key person within 30 days;

&nbsp;&nbsp;&nbsp;&nbsp;o resignation, termination, disability or death of a "key person" or failure of any "key person" to provide active participation in Saratoga Investment Advisors' daily activities, all without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed within 30 days.

*Fees and Expenses*. We paid certain fees and reimbursed Encina Lender Finance, LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Encina Lender Finance, LLC in connection with the Encina Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing. These amounts totaled $1.4 million.

On January 27, 2023, we entered into the first amendment to the Encina Credit Agreement to, among other things:

● increased the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

● changed the underlying benchmark used to compute interest under the Encina Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

● increased the applicable effective margin rate on borrowings from 4.00% to 4.25%;

● extended the revolving period from October 4, 2024 to January 27, 2026;

● extended the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a "Facility Increase") from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to the Encina Facility Increase from $75.0 million to $150.0 million;

● revised the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

● amended the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Encina Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

As of May 31, 2025, we had $32.5 million outstanding borrowings under the Encina Credit Facility. Our borrowing base under the Encina Credit Facility at May 31, 2025 was $79.5 million.

***Live Oak Credit Facility***

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Live Oak Banking Company on March 27, 2024 (the "Live Oak Credit Agreement").

*Commitment.* We entered into the Credit and Security Agreement (the "Live Oak Credit Agreement") relating to the Live Oak Credit Facility in the initial facility amount of $50.0 million (the "Live Oak Facility Amount").

*Availability*. We can draw up to the lesser of (i) the Live Oak Facility Amount and (ii) the Borrowing Base. The Borrowing Base is an amount equal to (i) the difference of (A) the product of the applicable advance rate which varies from 50.0% to 75.0% depending on the type of loan asset (Defaulted Loans being excluded in that they carry an advance rate of 0%) and the value, determined in accordance with the Encina Credit Facility (the "Adjusted Borrowing Value"), of certain "eligible" loan assets pledged as security for the loan (the "Borrowing Base Value") and (B) the Excess Concentration Amount, as calculated in accordance with the Encina Credit Facility, plus (ii) any amounts held in the Prefunding Account and, without duplication, Excess Cash held in the Collection Account, less (iii) the product of (a) the amount of any undrawn funding commitments we have under any loan asset and (b) the Unfunded Exposure Haircut Percentage, and less (iv) $100,000. Each loan asset we held as of the date on which the Live Oak Credit Facility was closed was valued as of that date and each loan asset that we acquire after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things and under certain circumstances, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Live Oak Credit Facility contains limitations on the type of loan assets that are "eligible" to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an "eligible" loan asset, we may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially averse to the lenders.

The Live Oak Credit Facility requires certain minimum drawn amounts. For the period beginning on the closing date of March 27, 2025, and ending March 27, 2027, the minimum funding amount was $12.5 million. For the period beginning on March 28, 2025, through maturity, the minimum funding amount is the greater of $25.0 million and 50% of the Live Oak Facility Amount in effect from time to time.

*Collateral*. The Live Oak Credit Facility is secured by assets of Saratoga Investment Funding III LLC ("SIF III") and pledged to Live Oak under the Live Oak Credit Facility. SIF III is a wholly owned special purpose entity formed for the purpose of entering into the Live Oak Credit Facility.

*Interest Rate and Fees*. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to the greater of the prevailing Adjusted Term SOFR and 0.75%, plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility's utilization. In addition, we pay the lenders a commitment fee of 0.50% per year on the unused amount of the Live Oak Credit Facility for the duration of the term of the Live Oak Credit Facility. Accrued interest and commitment fees are payable monthly in arrears. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Live Oak Credit Facility.

*Collateral Tests.* It is a condition precedent to any borrowing under the Live Oak Credit Facility that the principal amount outstanding under the Live Oak Credit Facility, after giving effect to the proposed borrowings, not exceed the Borrowing Base (the "Borrowing Base Test"). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the "Collateral Tests"):

● *Interest Coverage Ratio*. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Live Oak Credit Facility, to accrued interest and commitment fees payable to the lenders under the Live Oak Credit Facility for the last 6 payment periods must equal at least 175.0%.

● *Overcollateralization Ratio*. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of "eligible" pledged loan assets plus the fair value of certain ineligible pledged loan assets (in each case, subject to certain adjustments) to outstanding borrowings under the Live Oak Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

The Live Oak Credit Facility also may require payment of outstanding borrowings or replacement of pledged loan assets upon our breach of our representation and warranty that pledged loan assets included in the Borrowing Base are "eligible" loan assets. Such ineligible collateral loans will be excluded from the calculation of the Borrowing Base and may lead to a Borrowing Base Deficiency, which may be cured by effecting one or more (or any combination thereof) of the following actions: (A) deposit into or credit to the Collection Account cash and Eligible Investments, (B) repay Advances (together with all accrued and unpaid costs and expenses of the Agents, Custodian, Collateral Administrator, Securities Intermediary and the Lenders), (C) sell or substitute Collateral Loans in accordance with Article X, or (D) pledge additional Collateral Loans as Collateral.

*Priority of Payments.* The priority of payments provisions of the Live Oak Credit Facility require, after payment of specified fees and expenses, that collections of interest from the loan assets and, to the extent that these are insufficient, collections of principal from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met.

*Operating Expenses*. The priority of payments provision of the Live Oak Credit Facility provides for the payment of certain of our operating expenses out of collections on interest and principal in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $200,000 per annum.

*Covenants; Representations and Warranties; Events of Default*. The Live Oak Credit Agreement contains customary representations and warranties, affirmative covenants, negative covenants and events of default. The Live Oak Credit Agreement does not contain grace periods for breach by us of any negative covenants or of certain of the affirmative covenants, including, without limitation, those related to preservation of the existence and separateness of the Company. Other events of default under the Live Oak Credit Agreement include, among other things, the following:

&nbsp;&nbsp;&nbsp;&nbsp;o our failure to maintain an Interest Coverage Ratio of less
than 175%;

&nbsp;&nbsp;&nbsp;&nbsp;o our failure to maintain an Overcollateralization Ratio of
less than 200%;

&nbsp;&nbsp;&nbsp;&nbsp;o the filing of certain ERISA or tax liens on our assets or
the Equity holder;

&nbsp;&nbsp;&nbsp;&nbsp;o failure by Specified Holders to collectively, directly or
indirectly, own and control at least 51% of the outstanding equity interests of Saratoga Investment Advisor, or (y) possess the right
to elect (through contract, ownership of voting securities or otherwise) at all times a majority of the board of directors (or similar
governing body) of Saratoga Investment Advisor and to direct the management policies and decisions of Saratoga Investment Advisor, or
(ii) the dissolution, termination or liquidation in whole or in part, transfer or other disposition, in each case, of all or substantially
all of the assets of, Saratoga Investment Advisor;

&nbsp;&nbsp;&nbsp;&nbsp;o indictment or conviction of Saratoga Investment Advisors
or any "key person" for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment
Advisors or any "key person" and, in the case of "key persons," without a reputable, experienced individual reasonably
satisfactory to Live Oak Lender Finance appointed to replace such key person within 30 days;

&nbsp;&nbsp;&nbsp;&nbsp;o resignation, termination, disability or death of a "key
person" or failure of any "key person" to provide active participation in Saratoga Investment Advisors' daily
activities, all without a reputable, experienced individual reasonably satisfactory to Live Oak Lender Finance appointed within 30 days.

*Fees and Expenses*. We paid certain fees and reimbursed Live Oak Lender Finance, LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Live Oak Banking Company in connection with the Live Oak Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing. These amounts totaled $0.8 million.

As of May 31, 2025 there was $37.5 million in outstanding borrowings under the Live Oak Credit Facility. During the applicable period, we were in compliance with all of the limitations and requirements under the Live Oak Credit Agreement. Our borrowing base under the Live Oak Credit Facility at May 31, 2025 was $86.8 million

 ****

***SBA-guaranteed debentures***

In addition, we, through two current wholly owned subsidiaries, sought and obtained licenses from the SBA to operate an SBIC. In this regard, our wholly owned subsidiaries, SBIC II LP, and SBIC III LP, received an SBIC license from the SBA on August 14, 2019, and September 29, 2022, respectively. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Our wholly owned subsidiary SBIC LP fully repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2023, and SBIC LP subsequently merged with and into the Company.

The SBIC license allows our SBIC Subsidiaries to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

The SBIC Subsidiaries are regulated by the SBA. SBA regulations currently limit the amount that our SBIC Subsidiaries may individually borrow up to a maximum of $175.0 million of SBA debentures if the SBIC Subsidiary has at least $87.5 million in regulatory capital, subject to the SBA's approval. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million. The SBIC Subsidiaries are able to borrow funds from the SBA against regulatory capital (which generally approximates equity capital in the respective SBIC) and is subject to customary regulatory requirements, including, but not limited to, periodic examination by the SBA.

We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC Subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows us increased flexibility under the asset coverage test by permitting us to borrow up to $350.0 million more than we would otherwise be able to absent the receipt of this exemptive relief. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our independent directors, approved of our becoming subject to a minimum asset coverage ratio of 150% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150% asset coverage ratio became effective on April 16, 2019.

As of May 31, 2025 SBIC II LP had $87.5 million in regulatory capital and $131.0 million in SBA-guaranteed debentures outstanding and SBIC III LP had $87.5 million in regulatory capital and $39.0 million in SBA-guaranteed debentures outstanding.

 ****

***Unsecured notes***

 

*7.75% 2025 Notes*

 

On July 9, 2020, we issued $5.0 million in aggregate principal amount of our 7.75% fixed-rate notes due in 2025 (the "7.75% 2025 Notes") for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option, subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the Notes. The 7.75% 2025 Notes are not listed and have a par value of $25.00 per note.

At May 31, 2025, the total amount of 7.75% 2025 Notes outstanding was $5.0 million.

 

*6.25% 2027 Notes*

On December 29, 2020, we issued $5.0 million in aggregate principal amount of our 6.25% fixed-rate notes due in 2027 (the "6.25% 2027 Notes"). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at our option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

On January 28, 2021, we issued an additional $10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million (the "Additional 6.25% 2027 Notes"). The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.

At May 31, 2025, the total amount of 6.25% 2027 Notes outstanding was $15.0 million.

 

*4.375% 2026 Notes*

On March 10, 2021, we issued $50.0 million in aggregate principal amount of the 4.375% notes due 2026 (the "4.375% 2026 Notes") for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a "make-whole" premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.3 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

On July 15, 2021, we issued an additional $125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the "Additional 4.375% 2026 Notes") for net proceeds for approximately $123.5 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting discount of $2.5 million and the offering expenses of approximately $0.2 million payable by us. The net proceeds from the offering were used to redeem all of the outstanding 6.25% 2025 Notes (as described above), and for general corporate purposes in accordance with our investment objective and strategies. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes.

At May 31, 2025, the total amount of 4.375% 2026 Notes outstanding was $175.0 million.

 

*4.35% 2027 Notes*

On January 19, 2022, we issued $75.0 million in aggregate principal amount of our 4.35% fixed-rate Notes due in 2027 (the "4.35% 2027 Notes") for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at our option at any time prior to November 28, 2026, at par plus a "make-whole" premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes.

At May 31, 2025 the total amount of 4.35% 2027 Notes outstanding was $75.0 million.

*6.00% 2027 Notes*

On April 27, 2022, we issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the "6.00% 2027 Notes") for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds were $9.7 million after deducting underwriting commissions of approximately $0.3 million. Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol "SAT" with a par value of $25.00 per note.

On August 15, 2022, we issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the "Additional 6.00% 2027 Notes") for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Additional offering costs incurred were approximately $0.03 million. Additional financing costs of $0.03 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.

At May 31, 2025 the total amount of 6.00% 2027 Notes outstanding was $105.5 million.

 

*7.00% 2025 Notes*

On September 8, 2022, we issued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the "7.00% 2025 Notes") for net proceeds of $11.6 million after deducting underwriting discounts of approximately $0.4 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.05 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

At May 31, 2025 the total amount of 7.00% 2025 Notes outstanding was $12.0 million.

 

*8.00% 2027 Notes*

 

On October 27, 2022, we issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the "8.00% 2027 Notes") for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.2 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.73 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol "SAJ" with a par value of $25.00 per note.

At May 31, 2025 the total amount of 8.00% 2027 Notes outstanding was $46.0 million.

 

 

*8.125% 2027 Notes*

On December 13, 2022, we issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the "8.125% 2027 Notes") for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.875 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol "SAY" with a par value of $25.00 per note.

At May 31, 2025, the total amount of 8.125% 2027 Notes outstanding was $60.4 million.

 

*8.75% 2025 Notes* 

 

On March 31, 2023, we issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the "8.75% 2025 Notes") for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, we issued an additional $10.0 million in aggregate principal amount of the 8.75% 2024 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year. On February 2, 2024, pursuant to the terms of the indenture governing the 8.75% 2025 Notes, we elected to exercise our option to extend the maturity date of the 8.75% 2025 Notes from March 31, 2024 to March 31, 2025. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2025 Notes have been capitalized and are being amortized over the term of the 8.75% 2025 Notes. On March 31, 2025, we repaid $20.0 million in aggregate principal amount of the issued and outstanding 8.75% 2025 Notes.

 

*8.50% 2028 Notes*

 

On April 14, 2023, we issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the "8.50% 2028 Notes") for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year. The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at our option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol "SAZ" with a par value of $25.00 per note.

At May 31, 2025, the total amount of 8.50% 2028 Notes outstanding was $57.5 million*.*

 

 

At May 31, 2025 and February 28, 2025, the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **May 31, 2025** | **May 31, 2025** | **February 28, 2025** | **February 28, 2025** |
|  | **Fair Value** | **Percentage of Total** | **Fair Value** | **Percentage of Total** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Cash and cash equivalents | $131563 | 11.0% | $148218 | 12.6% |
| Cash and cash equivalents, reserve accounts | 92724 | 7.8 | 56505 | 4.8 |
| First lien term loans | 841577 | 70.5 | 867866 | 73.4 |
| Second lien term loans | 6600 | 0.6 | 6388 | 0.5 |
| Structured finance securities | 16635 | 1.4 | 14772 | 1.2 |
| Unsecured loan | 27390 | 2.3 | 16534 | 1.4 |
| Equity interests | 76116 | 6.4 | 72518 | 6.1 |
| Total | $1192605 | 100.0% | $1182801 | 100.0% |

---

***Equity Capital Activities***

 

*Share Repurchases*

On September 24, 2014, we announced the approval of the Share Repurchase Plan. Since September 24, 2014, the Share Repurchase Plan has been extended annually, and we have periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan. Most recently, on January 7, 2025, our board of directors extended the Share Repurchase Plan for another year to January 15, 2026, which currently permits up to 1.7 million shares of common stock to be repurchased under the Share Repurchase Plan. As of May 31, 2025, we purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three months ended May 31, 2025, we did not purchase any shares pursuant to the Share Repurchase Plan.

 

*Public Equity Offering*

On July 13, 2018, we issued 1,150,000 shares of common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. We also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock, which was not exercised.

*Equity ATM Program*

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, we amended our equity distribution agreement to add BB&T Capital Markets and B. Riley FBR, Inc. as sales agents in our ATM offering. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, we had sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs).

On July 30, 2021, we entered into an equity distribution agreement (the "Equity Distribution Agreement") with Ladenburg Thalmann & Co. Inc. ("Ladenburg") and Compass Point Research and Trading, LLC ("Compass Point"), each as distribution agents, through which we may offer for sale, from time to time, up to $150.0 million of our common stock through the Agents (as defined below), or to them, as principal for their account (the "ATM Program").

On July 6, 2023, we amended the Equity Distribution Agreement to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $300.0 million from $150.0 million On July 19, 2023, we amended the Equity Distribution Agreement to add an additional distribution agent, Raymond James & Associates, Inc. ("Raymond James"). On May 15, 2024, we amended the Equity Distribution Agreement to add an additional distribution agent, Lucid Capital Markets, LLC ("Lucid" and together with Ladenburg, Compass Point, and Raymond James, the "Agents"). The sales price per share of our common stock offered under the ATM Program, less the Agents' commission, will not be less than the NAV per share of our common stock at the time of such a sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

As of May 31, 2025, we sold 8,089,547 shares for gross proceeds of $214.3 million at an average price of $26.37 for aggregate net proceeds of $212.6 million (net of transaction costs). During the three months ended May 31, 2025, we sold 244,831 shares for gross proceeds of $6.4 million at an average price of $26.31 for aggregate net proceeds of $6.4 million (net of transaction costs).

***Dividend Distributions***

 ****

We have distributed or intend to distribute sufficient dividends to eliminate taxable income for our completed tax years. If we fail to satisfy the 90% distribution requirement or otherwise fail to qualify as a RIC in any tax year, we would be subject to U.S. federal income tax in that year on all of our taxable income imposed at corporate rates, regardless of whether we made any distributions to our shareholders. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Our distributions from May 31, 2025 back to inception were as follows:

---

| | |
|:---|:---|
| **Payment date** | **Cash<br> Dividend** |
| **Tax Year Ended February 28, 2026** | |
| &nbsp;&nbsp;&nbsp;September 24, 2025 | 0.25<sup>(55)</sup> |
| &nbsp;&nbsp;&nbsp;August 21, 2025 | 0.25<sup>(54)</sup> |
| &nbsp;&nbsp;&nbsp;July 24, 2025 | 0.25<sup>(53)</sup> |
| &nbsp;&nbsp;&nbsp;June 24, 2025 | 0.25<sup>(52)</sup> |
| &nbsp;&nbsp;&nbsp;May 22, 2025 | 0.25<sup>(51)</sup> |
| &nbsp;&nbsp;&nbsp;April 24, 2025 | 0.25<sup>(50)</sup> |
| &nbsp;&nbsp;&nbsp;March 25, 2025 | 0.74<sup>(49)</sup> |
|  | $2.24 |
| **Tax Year Ended February 28, 2025** |  |
| &nbsp;&nbsp;&nbsp;December 19, 2024 | $1.09<sup>(48)</sup> |
| &nbsp;&nbsp;&nbsp;September 26, 2024 | 0.74<sup>(47)</sup> |
| &nbsp;&nbsp;&nbsp;June 27, 2024 | 0.74<sup>(46)</sup> |
| &nbsp;&nbsp;&nbsp;March 28, 2024 | 0.73<sup>(45)</sup> |
|  | $3.30 |
| **Tax Year Ended February 29, 2024** |  |
| &nbsp;&nbsp;&nbsp;December 28, 2023 | $0.72<sup>(44)</sup> |
| &nbsp;&nbsp;&nbsp;September 28, 2023 | 0.71<sup>(43)</sup> |
| &nbsp;&nbsp;&nbsp;June 29, 2023 | 0.70<sup>(42)</sup> |
| &nbsp;&nbsp;&nbsp;March 30, 2023 | 0.69<sup>(1)</sup> |
|  | $2.82 |
| **Tax Year Ended February 28, 2023** |  |
| &nbsp;&nbsp;&nbsp;January 4, 2023 | $0.68<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;September 29, 2022 | 0.54<sup>(3)</sup> |
| &nbsp;&nbsp;&nbsp;June 29, 2022 | 0.53<sup>(4)</sup> |
| &nbsp;&nbsp;&nbsp;March 28, 2022 | 0.53<sup>(5)</sup> |
|  | $2.28 |
| **Tax Year Ended February 28, 2022** |  |
| &nbsp;&nbsp;&nbsp;January 19, 2022 | $0.53<sup>(6)</sup> |
| &nbsp;&nbsp;&nbsp;September 28, 2021 | 0.52<sup>(7)</sup> |
| &nbsp;&nbsp;&nbsp;June 29, 2021 | 0.44<sup>(8)</sup> |
| &nbsp;&nbsp;&nbsp;April 22, 2021 | 0.43<sup>(9)</sup> |
|  | $1.92 |
| **Tax Year Ended February 28, 2021** |  |
| &nbsp;&nbsp;&nbsp;February 10, 2021 | $0.42<sup>(10)</sup> |
| &nbsp;&nbsp;&nbsp;November 10, 2020 | 0.41<sup>(11)</sup> |
| &nbsp;&nbsp;&nbsp;August 12, 2020 | 0.40<sup>(12)</sup> |
|  | $1.23 |
| **Tax Year Ended February 29, 2020** |  |
| &nbsp;&nbsp;&nbsp;February 6, 2020 | $0.56<sup>(13)</sup> |
| &nbsp;&nbsp;&nbsp;September 26, 2019 | 0.56<sup>(14)</sup> |
| &nbsp;&nbsp;&nbsp;June 27, 2019 | 0.55<sup>(15)</sup> |
| &nbsp;&nbsp;&nbsp;March 28, 2019 | 0.54<sup>(16)</sup> |
|  | $2.21 |

---

---

| | |
|:---|:---|
| **Payment date** | **Cash<br> Dividend** |
| **Tax Year Ended February 28, 2019** |  |
| &nbsp;&nbsp;&nbsp;January 2, 2019 | $0.53<sup>(17)</sup> |
| &nbsp;&nbsp;&nbsp;September 27, 2018 | 0.52<sup>(18)</sup> |
| &nbsp;&nbsp;&nbsp;June 27, 2018 | 0.51<sup>(19)</sup> |
| &nbsp;&nbsp;&nbsp;March 26, 2018 | 0.50<sup>(20)</sup> |
|  | $2.06 |
| **Tax Year Ended February 28, 2018** |  |
| &nbsp;&nbsp;&nbsp;December 27, 2017 | $0.49<sup>(21)</sup> |
| &nbsp;&nbsp;&nbsp;September 26, 2017 | 0.48<sup>(22)</sup> |
| &nbsp;&nbsp;&nbsp;June 27, 2017 | 0.47<sup>(23)</sup> |
| &nbsp;&nbsp;&nbsp;March 28, 2017 | 0.46<sup>(24)</sup> |
|  | $1.90 |
| **Tax Year Ended February 28, 2017** |  |
| &nbsp;&nbsp;&nbsp;February 9, 2017 | $0.45<sup>(25)</sup> |
| &nbsp;&nbsp;&nbsp;November 9, 2016 | 0.44<sup>(26)</sup> |
| &nbsp;&nbsp;&nbsp;September 5, 2016 | 0.20<sup>(27)</sup> |
| &nbsp;&nbsp;&nbsp;August 9, 2016 | 0.43<sup>(28)</sup> |
| &nbsp;&nbsp;&nbsp;April 27, 2016 | 0.41<sup>(29)</sup> |
|  | $1.93 |
| **Tax Year Ended February 29, 2016** |  |
| &nbsp;&nbsp;&nbsp;February 29, 2016 | $0.40<sup>(30)</sup> |
| &nbsp;&nbsp;&nbsp;November 30, 2015 | 0.36<sup>(31)</sup> |
| &nbsp;&nbsp;&nbsp;August 31, 2015 | 0.33<sup>(32)</sup> |
| &nbsp;&nbsp;&nbsp;June 5, 2015 | 1.00<sup>(33)</sup> |
| &nbsp;&nbsp;&nbsp;May 29. 2015 | 0.27<sup>(34)</sup> |
|  | $2.36 |
| **Tax Year Ended February 28, 2015** |  |
| &nbsp;&nbsp;&nbsp;February 27, 2015 | $0.22<sup>(35)</sup> |
| &nbsp;&nbsp;&nbsp;November 28, 2014 | 0.18<sup>(36)</sup> |
|  | $0.40 |
| **Tax Year Ended February 28. 2014** |  |
| &nbsp;&nbsp;&nbsp;December 27, 2013 | $2.65<sup>(37)</sup> |
|  | $2.65 |
| **Tax Year Ended February 28, 2013** |  |
| &nbsp;&nbsp;&nbsp;December 31, 2012 | $4.25<sup>(38)</sup> |
|  | $4.25 |
| **Tax Year Ended February 29, 2012** |  |
| &nbsp;&nbsp;&nbsp;December 30, 2011 | $3.00<sup>(39)</sup> |
|  | $3.00 |
| **Tax Year Ended February 28, 2011** |  |
| &nbsp;&nbsp;&nbsp;December 29, 2010 | $4.40<sup>(40)</sup> |
|  | $4.40 |
| **Tax Year Ended February 28, 2010** |  |
| &nbsp;&nbsp;&nbsp;December 31, 2009 | $18.25<sup>(41)</sup> |
|  | $18.25 |

---

(1) Based
on shareholder elections, the dividend consisted of approximately $7.1 million in cash and 45,818 newly issued shares of common stock,
or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion
was calculated based on a price of $23.11 per share, which equaled 95% of the volume weighted average trading price per share of the
common stock on March 17, 20, 21, 22, 23, 24, 27, 28, 29, and 30, 2023.

(2) Based on shareholder elections, the dividend consisted of approximately $6.8 million in cash and 53,615 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.26 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21, 22, 23, 27, 28, 29 and 30 2022 and January 3 and 4, 2023.

(3) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 52,312 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.00 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 16, 19, 20, 21, 22, 23, 26, 27, 28 and 29, 2022.

(4) Based on shareholder elections, the dividend consisted of approximately $5.1 million in cash and 48,590 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.40 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 17, 21, 22, 23, 24, 27, 28 and 29, 2022.

(5) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 42,825 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.89 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 18, 21, 22, 23, 24, 25 and 28, 2022.

(6) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 41,520 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 5, 6, 7, 10, 11, 12, 13, 14, 18 and 19, 2022.

(7) Based on shareholder elections, the dividend consisted of approximately $4.9 million in cash and 38,016 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.77 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2021.

(8) Based on shareholder elections, the dividend consisted of approximately $4.1 million in cash and 33,100 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.03 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 16, 17, 18, 21, 22, 23, 24, 25, 28 and 29, 2021.

(9) Based on shareholder elections, the dividend consisted of approximately $3.9 million in cash and 38,580 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.69 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 9,12, 13, 14, 15, 16, 19, 20, 21 and 22, 2021.

(10) Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 41,388 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.75 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 28, 29 and February 1, 2, 3, 4, 5, 8, 9 and 10, 2021.

(11) Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9 and 10, 2020.

(12) Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.

(13) Based on shareholder elections, the dividend consisted of approximately $5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3, 4, 5 and 6, 2020.

(14) Based on shareholder elections, the dividend consisted of approximately $4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25 and 26, 2019.

(15) Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.65 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2019.

(16) Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.

(17) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018 and January 2, 2019.

(18) Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2018.

(19) Based on shareholder elections, the dividend consisted of approximately $2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2018.

(20) Based on shareholder elections, the dividend consisted of approximately $2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $19.91 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26, 2018.

(21) Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.

(22) Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.

(23) Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

(24) Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

(25) Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.

(26) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.

(27) Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.

(28) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.

(29) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.

(30) Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.

(31) Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.

(32) Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.

(33) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5, 2015.

(34) Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.

(35) Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

(36) Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

(37) Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.

(38) Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

(39) Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

(40) Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

(41) Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

&nbsp;&nbsp;&nbsp;&nbsp;(42) Based on shareholder elections, the dividend consisted of approximately $7.6 million in cash and 29,627 newly issued shares of common stock, or 0.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.29 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 20, 21, 22, 23, 26, 27, 28, and 29, 2023.

(43) Based on shareholder elections, the dividend consisted of approximately $8.4 million in cash and 35,196 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.41 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2023.

(44) Based on shareholder elections, the dividend consisted of approximately $8.9 million in cash and 37,394 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 14, 15, 18, 19, 20, 21, 22, 26, 27, and 28, 2023.

(45) Based on shareholder elections, the dividend consisted of approximately $9.0 million in cash and 45,490 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2024.

(46) Based on shareholder elections, the dividend consisted of approximately $9.1 million in cash and 46,803 newly issued shares of common stock, or 10.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.76 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 13, 14, 17, 18, 20, 21, 24, 25, 26, and 27, 2024.

(47) Based on shareholder elections, the dividend consisted of approximately $9.0 million in cash and 54,999 newly issued shares of common stock, or 10.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.08 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25, and 26, 2024.

(48) Based on shareholder elections, the dividend consisted of approximately $13.7 million in cash and 81,471 newly issued shares of common stock, or 11.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.80 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 6, 9, 10, 11, 12, 13, 16, 17, 18, and 19, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;(49) Based on shareholder elections, the dividend consisted of approximately $9.9 million in cash and 60,611 newly issued shares of common stock, or 12.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.96 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 12, 13, 14, 17, 18, 19, 20, 21, 24, and 25, 2025.

 ****

&nbsp;&nbsp;&nbsp;&nbsp;(50) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 20,086 newly issued shares of common stock, or 11.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.02 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 10, 11, 14, 15, 16, 17, 21, 22, 23, and 24, 2025.

 ****

(51) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 20,784 newly issued shares of common stock, or 12.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.02 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on May 9, 12, 13, 14, 15, 16, 19, 20, 21, and 22, 2025.

(52) Based on shareholder elections, the dividend consisted of approximately
$3.4 million in cash and 19,750 newly issued shares of common stock, or 11.7% of our outstanding common stock prior to the dividend payment.
The number of shares of common stock comprising the stock portion was calculated based on a price of $23.09 per share, which equaled 95%
of the volume weighted average trading price per share of the common stock on June 10, 11, 12, 13, 16, 17, 18, 20, 23, and 24, 2025.

(53) These dividends were declared on June 12, 2025, and the cash and newly issued shares of the common stock will be determined at a future date.

(54) These dividends were declared on June 12, 2025, and the cash and newly issued shares of the common stock will be determined at a future date.

(55) These dividends were declared on June 12, 2025, and the cash and newly issued shares of the common stock will be determined at a future date.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Our asset coverage ratio, as defined in the 1940 Act, was 163.8% as of May 31, 2025 and 162.9% as of February 28, 2025.

***Subsequent Events***

 ****

On June 12, 2025, the Company declared the following dividends for the quarter ended August 31, 2025. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP.

 

---

| | | | |
|:---|:---|:---|:---|
| **Month** | **Amount per Share** | **Record Date** | **Payment Date** |
| June 2025 | $0.25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;July 8, 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;July 24, 2025 |
| July 2025 | $0.25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;August 6, 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;August 21, 2025 |
| August 2025 | $0.25 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;September 4, 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;September 24, 2025 |

---

 

***Contractual obligations***

 ****

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** |
| <br>**Long-Term Debt Obligations** |<br>**Total** | **Less Than <br> 1 Year** | **1 - 3<br> Years** | **3 - 5<br> Years** | **More Than<br> 5 Years** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| &nbsp;&nbsp;&nbsp;Encina Credit Facility | $32500 | $32500 | $- | $- | $- |
| &nbsp;&nbsp;&nbsp;Live Oak Credit Facility | $37500 | $- | $37500 | $- | $- |
| &nbsp;&nbsp;&nbsp;SBA debentures | 170000 |  |  | 20000 | 150000 |
| &nbsp;&nbsp;&nbsp;6.25% 2025 Notes |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;8.75% 2025 Notes |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;7.75% 2025 Notes | 5000 | 5000 |  |  |  |
| &nbsp;&nbsp;&nbsp;4.375% 2026 Notes | 175000 | 175000 |  |  |  |
| &nbsp;&nbsp;&nbsp;4.35% 2027 Notes | 75000 |  | 75000 |  |  |
| &nbsp;&nbsp;&nbsp;6.25% 2027 Notes | 15000 |  | 15000 |  |  |
| &nbsp;&nbsp;&nbsp;6.00% 2027 Notes | 105500 |  | 105500 |  |  |
| &nbsp;&nbsp;&nbsp;8.00% 2027 Notes | 46000 |  | 46000 |  |  |
| &nbsp;&nbsp;&nbsp;8.125% 2027 Notes | 60375 |  | 60375 |  |  |
| &nbsp;&nbsp;&nbsp;8.5% 2028 Notes | 57500 |  | 57500 |  |  |
| &nbsp;&nbsp;&nbsp;7.00% 2025 Notes | 12000 | 12000 | - | - | - |
| Total Long-Term Debt Obligations | $791375 | $224500 | $396875 | $20000 | $150000 |

---

 ****

***Off-balance sheet arrangements***

As of May 31, 2025 and February 28, 2025, our off-balance sheet arrangements consisted of $136.4 million and $126.7 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to our discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in our consolidated statements of assets and liabilities and are not reflected in our consolidated statements of assets and liabilities.

A summary of the unfunded commitments outstanding as of May 31, 2025 and February 28, 2025 is shown in the table below (dollars in thousands):

---

| | | |
|:---|:---|:---|
|  | **May 31,<br> 2025** | **February 28,<br> 2025** |
| **At Company's discretion** | | |
| &nbsp;&nbsp;&nbsp;ActiveProspect, Inc. | $10000 | $10000 |
| &nbsp;&nbsp;&nbsp;Artemis Wax Corp. | 23500 | 23500 |
| &nbsp;&nbsp;&nbsp;Ascend Software, LLC | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;C2 Educational Systems, Inc. |  | 2000 |
| &nbsp;&nbsp;&nbsp;Davisware, LLC |  | 1000 |
| &nbsp;&nbsp;&nbsp;JDXpert | 4500 | 4500 |
| &nbsp;&nbsp;&nbsp;LFR Chicken LLC | 10000 | 10000 |
| &nbsp;&nbsp;&nbsp;Pepper Palace, Inc. | 1200 | 1200 |
| &nbsp;&nbsp;&nbsp;Procurement Partners, LLC |  |  |
| &nbsp;&nbsp;&nbsp;Saratoga Senior Loan Fund I JV, LLC | 8548 | 8548 |
| &nbsp;&nbsp;&nbsp;VetnCare MSO, LLC | 10000 | 10000 |
| &nbsp;&nbsp;&nbsp;StockIQ Technologies, LLC | 5000 | - |
| &nbsp;&nbsp;&nbsp;Total | $77748 | $75748 |
| **At portfolio company's discretion - satisfaction of certain financial and nonfinancial covenants required** |  |  |
| &nbsp;&nbsp;&nbsp;Axero Holdings, LLC -– Revolving Credit Facility | 500 | 500 |
| &nbsp;&nbsp;&nbsp;Axiom Medical Consulting, LLC | 1000 | 1500 |
| &nbsp;&nbsp;&nbsp;BQE Software, Inc. | 250 | 2250 |
| &nbsp;&nbsp;&nbsp;Cloudpermit Intermediate Holding Company | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;Davisware, LLC |  | 1750 |
| &nbsp;&nbsp;&nbsp;Exigo, LLC – Revolving Credit Facility | 625 | 625 |
| &nbsp;&nbsp;&nbsp;Gen4 Dental Partners Holdings, LLC | 2381 | 2857 |
| &nbsp;&nbsp;&nbsp;Granite Comfort, LP | 11637 | 11637 |
| &nbsp;&nbsp;&nbsp;Innergy, Inc. | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;Inspect Point Holding, LLC | 2000 | 1500 |
| &nbsp;&nbsp;&nbsp;Modis Dental Partners OpCo, LLC | 4500 | 8900 |
| &nbsp;&nbsp;&nbsp;Pepper Palace, Inc. – Revolving Credit Facility |  | 600 |
| &nbsp;&nbsp;&nbsp;Stretch Zone Franchising, LLC |  | 1500 |
| &nbsp;&nbsp;&nbsp;VetnCare MSO, LLC | 6709 | 7319 |
| &nbsp;&nbsp;&nbsp;StockIQ Technologies, LLC | 2000 |  |
| &nbsp;&nbsp;&nbsp;SmartAC.com, Inc. | 17000 | - |
|  | 58602 | 50938 |
| Total | $136350 | $126686 |

---

We believe our assets will provide adequate coverage to satisfy these unfunded commitments. As of May 31, 2025, we had cash and cash equivalents of $131.6 million and $32.5 million in available borrowings under the Encina Credit Facility, and $37.5 million in available borrowings under the Live Oak Credit Facility.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Our business activities contain elements of market risk. We consider the fluctuation in interest rates to be our principal market risk. Managing this risk is essential to our business. Accordingly, we have systems and procedures designed to identify and analyze our risks, to establish appropriate policies and thresholds and to continually monitor this risk and thresholds by means of administrative and information technology systems and other policies and processes.

Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, including relative changes in different interest rates, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest-bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire leveraged loans, high yield bonds and other debt investments and the value of our investment portfolio.

Our investment income is affected by fluctuations in various interest rates, including SOFR and the prime rate. Substantially all of our portfolio is, and we expect will continue to be, comprised of floating rate investments that utilize SOFR or an alternate rate. The Federal Reserve held interest rates steady in the first and second quarter of 2025, following three consecutive rate reductions in the third and fourth quarter of 2024. The Federal Reserve has indicated that there may be additional rate cuts in the future; however, future reductions to benchmark rates are not certain. In an elevated interest rate environment, our cost of funds would increase, which could reduce our net investment income if there was not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve's tightening cycle could result in a recession in the United States, which would likely decrease interest rates. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR, are not offset by corresponding increases in the spread over such base rates that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities. Our interest expense is affected by fluctuations in SOFR on our Encina and Live Oak Credit Facilities.

At May 31, 2025, we had $791.4 million of borrowings outstanding. In addition, as of May 31, 2025, there were $32.5 million borrowings outstanding under the Encina Credit Facility and $37.5 million borrowings outstanding under the Live Oak Credit Facility as of May 31, 2025. As of May 31, 2025, on a fair value basis, approximately 4.9% of our debt investments bear interest at a fixed-rate and approximately 95.1% of our debt investments bear interest at a floating rate. As of May 31, 2025, 100% of our floating rate debt investments are subject to interest rate floors. Additionally, both the Encina Credit Facility and the Live Oak Credit Facility are subject to a floating interest rate and is currently paid based on floating Term SOFR rate.

We have analyzed the potential impact of changes in interest rates on interest income from investments. Assuming that our investments as of May 31, 2025 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately $8.6 million to our interest income. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately $8.6 million to our interest income.

Changes in interest rates would have no impact to our current interest and debt financing expenses, except for our borrowings under our Encina and Live Oak credit facilities. All of our remaining borrowings are fixed-rate borrowings. Assuming that our Encina and Live Oak borrowings as of May 31, 2025 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately $0.7 million to our interest expense. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately $0.7 million to our interest expense.

Although management believes that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the statements of assets and liabilities and other business developments that could magnify or diminish our sensitivity to interest rate changes, nor does it account for divergences in SOFR and the commercial paper rate, which have historically moved in tandem but, in times of unusual credit dislocations, have experienced periods of divergence. Accordingly, no assurances can be given that actual results would not materially differ from the potential outcome simulated by this estimate.

For further information, the following table shows the approximate annualized increase or decrease in the components of net investment income due to hypothetical base rate changes in interest rates, assuming no changes in our investments and borrowings as of May 31, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <br>**Basis**<br>**Point**<br>**Change** | **Increase**<br>**(Decrease)**<br>**in Interest**<br>**Income** | **(Increase)**<br>**Decrease**<br>**in Interest**<br>**Expense** | **Increase**<br>**(Decrease) in Net**<br>**Interest**<br>**Income** | **Increase**<br>**(Decrease) in Net**<br>**Interest**<br>**Income\*** | **Increase**<br>**(Decrease) in Net**<br>**Investment**<br>**Income per Share** |
|  | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| -400 | $(24370) | $2571 | $(21799) | $(17439) | $(1.12) |
| -300 | (22901) | 2100 | (20801) | (16641) | (1.07) |
| -200 | (17102) | 1400 | (15702) | (12562) | (0.81) |
| -100 | (8580) | 700 | (7880) | (6304) | (0.41) |
| -50 | (4292) | 350 | (3942) | (3154) | (0.20) |
| -25 | (2148) | 175 | (1973) | (1578) | (0.10) |
| 25 | 2157 | (175) | 1982 | 1586 | 0.10 |
| 50 | 4315 | (350) | 3965 | 3172 | 0.20 |
| 100 | 8629 | (700) | 7929 | 6343 | 0.41 |
| 200 | 17259 | (1400) | 15859 | 12687 | 0.82 |
| 300 | 25888 | (2100) | 23788 | 19030 | 1.23 |
| 400 | 34517 | (2800) | 31717 | 25374 | 1.63 |

---

\* Adjusts Net Interest Income for the impact of the first incentive fee on Net Investment Income

**ITEM 4. CONTROLS AND PROCEDURES**

&nbsp;&nbsp;&nbsp;&nbsp;(a) As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Exchange Act. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

&nbsp;&nbsp;&nbsp;&nbsp;(b) There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the quarter ended May 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION** 

**Item 1. Legal Proceedings**

Neither we nor our wholly owned subsidiaries, Saratoga Investment Funding LLC, Saratoga Investment Funding II, LLC, Saratoga Investment Corp. SBIC II LP, or Saratoga Investment Corp. SBIC III LP, are currently subject to any material legal proceedings.

**Item 1A. Risk Factors** 

In addition to information set forth in this report, you should carefully consider the "Risk Factors" discussed in our most recent Annual Report on Form 10-K filed with the SEC, which could materially affect our business, financial condition and/or operating results. There have been no material changes during the three months ended May 31, 2025 to the risk factors discussed in "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended February 28, 2025. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds** 

*Issuer Purchases of Equity Securities*

 

On September 24, 2014, we announced the approval of an open market share repurchase plan that originally allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the "Share Repurchase Plan"). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and we have periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 8, 2024, our board of directors extended the Share Repurchase Plan for another year to January 15, 2025. As of May 31, 2025, we had purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three months ended May 31, 2025, we did not purchase any shares of common stock pursuant to the Share Repurchase Plan.

**Item 3. Defaults Upon Senior Securities** 

None.

**Item 4. Mine Safety Disclosures** 

Not applicable.

**Item 5. Other Information**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) For the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company has entered into (i) any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

**Item 6. Exhibits**

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description** |
| 3.1(a) | [Articles of Incorporation of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.'s Form 10-Q for the quarterly period ended May 31, 2007).](http://www.sec.gov/Archives/edgar/data/1377936/000095012307009887/y36920exv3w1.htm) |
| 3.1(b) | [Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.'s Current Report on Form 8-K filed August 3, 2010).](http://www.sec.gov/Archives/edgar/data/1377936/000095012310071403/y85912exv3w1.htm) |
| 3.1(c) | [Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.'s Current Report on Form 8-K filed August 13, 2010).](http://www.sec.gov/Archives/edgar/data/1377936/000095012310077033/y86144exv3w1.htm) |
| 3.2 | [Third Amended and Restated Bylaws of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.'s Current Report on Form 10-Q filed January 6, 2021)](http://www.sec.gov/Archives/edgar/data/1377936/000121390021000658/f10q1120ex3-2_saratoga.htm) |
| 4.1 | [Specimen certificate of Saratoga Investment Corp.'s common stock, par value $0.001 per share. (incorporated by reference to Saratoga Investment Corp.'s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010).](http://www.sec.gov/Archives/edgar/data/1377936/000104746910007816/a2199934zex-99_d1.htm) |
| 4.2 | [Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.'s Current Report on Form 8-K filed on August 3, 2010).](http://www.sec.gov/Archives/edgar/data/1377936/000095012310071403/y85912exv10w4.htm) |
| 4.3 | [Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.'s Current Report on Form 8-K filed on September 24, 2014).](http://www.sec.gov/Archives/edgar/data/1377936/000119312514350990/d794071dex201.htm) |
| 4.4 | [Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.'s Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-186323 filed April 30, 2013).](http://www.sec.gov/Archives/edgar/data/1377936/000104746913005204/a2214878zex-99_d4.htm) |
| 4.5 | [Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.'s registration statement on Form N-2 Pre-Effective Amendment No. 1, File No. 333-196526, filed on December 5, 2014).](http://www.sec.gov/Archives/edgar/data/1377936/000119312514434783/d791359dex99d10.htm) |
| 4.6 | [Fifth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 7.75% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.'s Quarterly Report on Form 10-Q, filed on January 10, 2023).](http://www.sec.gov/Archives/edgar/data/1377936/000121390023002013/f10q1122ex4-6_saratoga.htm) |
| 4.7 | [Seventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 6.25% Notes due 2027 (incorporated by reference to Saratoga Investment Corp.'s Quarterly Report on Form 10-Q, filed on January 10, 2023).](http://www.sec.gov/Archives/edgar/data/1377936/000121390023002013/f10q1122ex4-7_saratoga.htm) |
| 4.8 | [Eighth Supplemental Indenture between the Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2026 (incorporated by reference to Exhibit 4.2 to the Registrant's Current Report on Form 8-K (File No. 814-00732) filed on March 10, 2021).](http://www.sec.gov/Archives/edgar/data/1377936/000121390021014572/ea137359ex4-2_saratoga.htm) |
| 4.9 | [Ninth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2027 (incorporated by reference to the Registrant's Current Report on Form 8-K (File No. 814-00732) filed on January 19, 2022).](http://www.sec.gov/Archives/edgar/data/1377936/000121390022002669/ea154117ex4-2_saratoga.htm) |
| 4.10 | [Tenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 6.00% Note due 2027 (incorporated by reference to the Registrant's Current Report on Form 8-K (File No. 814-00732) filed on April 27, 2022)](http://www.sec.gov/Archives/edgar/data/1377936/000121390022021904/ea158818ex4-2_saratoga.htm). |
| 4.11 | [Eleventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 7.00% Notes due 2025 (incorporated by reference to the Registrant's Quarterly Report on Form 10-Q, filed on January 10, 2023).](http://www.sec.gov/Archives/edgar/data/1377936/000121390023002013/f10q1122ex4-11_saratoga.htm) |
| 4.12 | [Twelfth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association, as trustee, relating to the 8.00% Notes due 2027 (incorporated by reference to the Saratoga Investment Corp.'s Current Report on Form 8-K (File No. 813-00732) filed on October 27, 2022).](http://www.sec.gov/Archives/edgar/data/1377936/000121390022066744/ea167631ex4-2_saratoga.htm) |
| 4.13 | [Thirteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.125% Notes due 2027 (incorporated by reference to the Registrant's Current Report on Form 8-K, filed on December 13, 2022).](http://www.sec.gov/Archives/edgar/data/1377936/000121390022079500/ea169874ex4-2_saratoga.htm) |

---

---

| | |
|:---|:---|
| 4.14 | [Fifteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.50% Notes due 2028 (incorporated by reference to Saratoga Investment Corp.'s Current Report on Form 8-K filed on April 14, 2023).](http://www.sec.gov/Archives/edgar/data/1377936/000121390023029874/ea176949ex4-2_saratoga.htm) |
| 4.15 | [Form of 7.75% Notes due 2025 (incorporated by reference to Exhibit 4.6 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390023002013/f10q1122ex4-6_saratoga.htm) |
| 4.16 | [Form of 6.25% Notes due 2027 (incorporated by reference to Exhibit 4.7 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390023002013/f10q1122ex4-7_saratoga.htm) |
| 4.17 | [Form of 4.375% Notes due 2026 (incorporated by reference to Exhibit 4.8 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390021014572/ea137359ex4-2_saratoga.htm) |
| 4.18 | [Form of 4.35% Notes due 2027 (incorporated by reference to Exhibit 4.9 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390022002669/ea154117ex4-2_saratoga.htm) |
| 4.19 | [Form of 6.00% Notes due 2027 (incorporated by reference to Exhibit 4.10 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390022021904/ea158818ex4-2_saratoga.htm) |
| 4.20 | [Form of 7.00% Notes due 2027 (incorporated by reference to Exhibit 4.11 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390023002013/f10q1122ex4-11_saratoga.htm) |
| 4.21 | [Form of 8.00% Notes due 2027 (incorporated by reference to Exhibit 4.12 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390022066744/ea167631ex4-2_saratoga.htm) |
| 4.22 | [Form of 8.125% Notes due 2027 (incorporated by reference to Exhibit 4.13 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390022079500/ea169874ex4-2_saratoga.htm) |
| 4.23 | [Form of 8.50% Notes due 2028 (incorporated by reference to Exhibit 4.14 hereto).](http://www.sec.gov/Archives/edgar/data/1377936/000121390023029874/ea176949ex4-2_saratoga.htm) |
| 31.1\* | [Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934](ea024644901ex31-1_saratoga.htm) |
| 31.2\* | [Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934](ea024644901ex31-2_saratoga.htm) |
| 32.1\* | [Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.1350)](ea024644901ex32-1_saratoga.htm) |
| 32.2\* | [Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)](ea024644901ex32-2_saratoga.htm) |
| 101.INS | Inline XBRL Instance Document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

\* Filed herewith

**ITEM 16. FORM 10-K SUMMARY**

None.

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **SARATOGA INVESTMENT CORP.** | **SARATOGA INVESTMENT CORP.** |
| Date: July 8, 2025 | By: | /s/ CHRISTIAN L. OBERBECK |
|  |  | Christian L. Oberbeck |
|  |  | *Chief Executive Officer* |
|  | By: | /s/ HENRI J. STEENKAMP |
|  |  | Henri J. Steenkamp |
|  |  | *Chief Financial Officer and Chief Compliance Officer* |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO**

**RULE 13a-14(a) and 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED**

I, Christian L. Oberbeck, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q of Saratoga Investment Corp. (the "registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: July 8, 2025 |  |
|  | /s/ CHRISTIAN L. OBERBECK |
|  | Christian L. Oberbeck |
|  | Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO**

**RULE 13a-14(a) and 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED**

I, Henri J. Steenkamp, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q of Saratoga Investment Corp. (the "registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant 's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: July 8, 2025 |  |
|  | /s/ HENRI J. STEENKAMP |
|  | Name: Henri J. Steenkamp |
|  | Chief Financial Officer and Chief Compliance Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

The certification set forth below is being submitted in connection with the accompanying Quarterly Report of Saratoga Investment Corp. on Form 10-Q (the "Report") for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Section 1350 of Chapter 63 of Title 18 of the United States Code.

Christian L. Oberbeck, the Chief Executive Officer, certifies that, to the best of his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Saratoga Investment Corp.

---

| | |
|:---|:---|
| Date: July 8, 2025 |  |
|  | /s/ CHRISTIAN L. OBERBECK |
|  | Christian L. Oberbeck |
|  | *Chief Executive Officer* |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

The certification set forth below is being submitted in connection with the accompanying Quarterly Report of Saratoga Investment Corp. on Form 10-Q (the "Report") for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Section 1350 of Chapter 63 of Title 18 of the United States Code.

Henri J. Steenkamp, the Chief Financial Officer, Chief Compliance Officer and Secretary of Saratoga Investment Corp. certifies that, to the best of his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of Saratoga Investment Corp.

---

| | |
|:---|:---|
| Date: July 8, 2025 |  |
|  | /s/ HENRI J. STEENKAMP |
|  | Name: Henri J. Steenkamp |
|  | *Chief Financial Officer and Chief Compliance Officer* |

---